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The aims of the study 
Proteins are synthesized on the ribosomes in the cytoplasm. Upon the completion 
of synthesis, most proteins must fold into precise three-dimensional structures to be 
biologically active. Cytoplasmic proteins fold and stay in the cytoplasm; however, those 
proteins destined for the bacterial inner membrane, periplasm, cell envelope, and 
extracellular space, must generally maintain an at least partially unfolded conformation 
under most circumstances before they reach their ultimate compartment where they can 
fold properly. During these processes, many proteins require the assistance of folding 
modulators, in order to adopt native structures.  
When a polypeptide is released into the periplasm, it needs to fold into its native 
conformation, and may also need to acquire post-translational modifications. Though the 
periplasmic folding environment is thought to be relatively chaperone-deficient compared 
to the cytoplasm, there are periplasmic chaperones, foldases, and proteases that contribute 
to the folding and modification of periplasmic proteins. They include 1) chaperones: Skp, 
FkpA, SurA, LolA, Spy, PapD and FimC; 2) peptidyl-prolyl cis-trans isomerases 
(PPIases): SurA, FkpA, PpiA and PpiD; 3) thio-disulfide oxidoreductases: DsbA, DsbB, 
DsbC, DsbD, DsbG, DsbE and CcmH. 4) proteases: DegP, Prc, Pet, and OmpT. Cells 
have also developed sophisticated quality-control systems to monitor protein folding. 
They respond to protein unfolding or misfolding, usually by the upregulation of genes 
encoding folding modulators and proteases.  
Chaperones interact with, stabilize, or promote the net folding/refolding process of 
protein substrates. Foldases including PPIases and thiol-disulfide oxidoreductases are real 
protein folding catalysts which act to accelerate the rate limiting steps during substrate 
folding. Both molecular chaperones and foldases are actively involved in the protein 
folding/refolding processes, and overexpression of them is a very promising approach to 
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the optimization of the folding environment. Proteases, on the other hand, degrade 
abnormal extracytoplasmic proteins and maintain the homeostasis of the cell envelope. 
The coordination of these folding modulators ensures the proper function of the cell 
under physiological conditions and cell survival under stress conditions. Understanding 
the function, mechanism, regulation, and cooperation of these folding modulators would 
enlarge the scope of optimizing the extracytoplasmic folding environment, and improve 
heterologous protein production in the periplasm. 
Through powerful chromosomal engineering and directed evolution technologies, 
new or improved functions have been gained for known periplasmic folding modulators. 
This raises at least four important questions: 1) what factors determine the function of a 
periplasmic folding modulator? 2) How can one evaluate the folding status of a protein in 
vivo? 3) How complete is the list of known periplasmic chaperones and folding catalysts? 
4) Is there any possibility of optimizing the folding environment for specific heterologous 
proteins? 
To gain some insight into the first question, I studied the functional evolution of 
members of the thiol-disulfide oxidoreductases. I mutated the characteristic active site, 
CXXC, in a strongly reducing oxidoreductase, thioredoxin, and forced the bacteria to 
select for mutants that act as oxidizing oxidoreductases. I found that the CXXC motif is 
important in its role of governing many of the properties of members of the thioredoxin 
superfamily. This is a good example of the way that nature can use a single particular 
scaffold to evolve several different functions of different enzymes.  
The success in investigating the functional relationship of thiol-disulfide 
oxidoreductases inspired me to further explore the folding environment of bacterial 
periplasm. Apparently, nature has been proven to be very powerful in evolving mutations 
for novel functions. Therefore, there is great potential to further optimize heterologous 
protein production in the periplasm and to look for novel folding modulators. To explore 
the second and the third question, I developed a dual selection system that links protein 
folding to antimicrobial resistance. Cells survive in the presence of higher concentration 
of two antimicrobials only when they express stable and well folded test proteins. By 
applying this "fold or die" principle regarding bacteria together with chromosomal 
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mutagenesis techniques, we selected for bacteria that enhanced their ability to fold the 
test protein. With this selection system, I was able to identify a new periplasmic 
chaperone called Spy.  Our approach opened up a new route towards chaperone discovery 
and in custom tailoring the folding of heterologous proteins.  
Chapter one of my thesis summarizes the extracytoplasmic protein quality control 
system. Firstly, I describe important periplasmic folding modulators, their functions, and 
their discovering process. I then introduce important members of the thiol-disulfide 
oxidoreductases family, especially pointing out features that might be important for their 
functions. Next, the periplamic stress responses to protein unfolding or misfolding 
conditions are discussed. Finally, the previously established β-lactamase selection system 
is introduced, which provides a means of measuring protein stability in vivo.  
Chapter two is modified from my previous publication ―The CXXC motif is more 
than a redox rheostat‖
1
 on the work of complementing DsbA with active site-altered 
thioredoxin. The detailed results, experiment procedures, and the significance of this 
work are discussed. 
Chapter three is modified from the manuscript in review ―Genetic selection 
designed to stabilize proteins uncovers a chaperone called Spy‖. It describes a dual 
selection system for finding new periplasmic folding modulators, and the identification of 
a novel chaperone Spy using this system. Functional characterization of Spy as a highly 
effective chaperone is also presented. 
Finally, in Chapter four I discuss these important results, and the future directions, 
such as identifying the in vivo substrates of Spy, exploring its working mechanism based 
on its crystal structure, and custom tailoring the folding of other proteins, such as the 
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Proteins are often unstable. Although much is known about protein folding in vitro, 
how proteins fold and function in the cell is a fundamental important question. The 
Protein folding process is assisted by molecular chaperones and folding catalysts in vivo. 
Understanding how chaperones are regulated and how they function may provide new 
avenues for developing protein folding modulators. We used directed evolution which 
combines DNA manipulation and powerful selection procedures for beneficial mutations 
in proteins to specifically address these questions. 
My work focused on two distinct, though closely related problems, both of which 
have to do with the directed evolution of the periplasmic folding environment of bacteria. 
My first set of experiments concerned the relationship between the CXXC active site and 
the functional properties of thiol-disulfide oxidoreductases. Thiol-disulfide 
oxidoreductases are involved in catalyzing disulfide bond formation, isomerization and 
reduction during protein folding. We selected for mutants in the CXXC motif of a 
reducing oxidoreductase, thioredoxin, that complement null mutants in the very oxidizing 
oxidoreductase, DsbA. We found that altering the CXXC motif affects not only the 
reduction potential of thioredoxin, but also the ability of the protein to interact with 
folding protein substrates and reoxidants. Furthermore, the CXXC motif also impacts the 
ability of thioredoxin to function as a disulfide isomerase. Our results indicate that the 
CXXC motif has the remarkable ability to confer a large number of very specific 
properties on thioredoxin related proteins, in addition to their usual roles of regulating 
redox potentials.  
  The second phase of my work sought to optimize the in vivo folding of proteins 
by linking folding to antibiotic resistance, thereby forcing bacteria to either effectively 
fold the selected proteins or perish. Here we were able to show that when Escherichia 
coli is challenged to fold a very unstable protein, it responds by overproducing a protein 
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called Spy, which increases the steady state level of unstable proteins up to nearly 700 
fold. In vitro studies demonstrate that Spy functions as a very effective ATP-independent 
chaperone that suppresses protein aggregation and aids protein refolding. Our strategy 
opens up new routes for chaperone discovery and the custom tailoring of the in vivo 
folding environment. Spy forms thin flexible cradle-shape dimers, with an apolar concave 
surface.  Spy is unlike the structure of any previously solved chaperone making Spy the 
prototypical member of a new class of small chaperones that facilitate protein refolding 
in the absence of energy cofactors.   We propose a model for Spy action where it protects 
proteins in vivo by binding to the surface of unstable proteins coating them with a thin 
layer that inhibits proteolysis and/or aggregation.   
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Chapter 1  
The protein folding environment in the periplasm of Escherichia coli 
1.1 Protein folding in vivo 
In 1973, Anfinsen raised the concept that all the information to govern the folding 
of a protein is contained in its amino acid sequence
2
. There is much evidence for this, as 
numerous proteins have been shown to fold spontaneously in vitro
3-5
. However, the 
folding process is more complicated in a living cell than in a test tube due to the complex 
nature of the cellular folding environment.  
The cytoplasm is extremely crowded, where macromolecular concentrations can 
reach up to 400 grams per liter
6
. The bacterial periplasm has been shown to be three 
times more viscous than the cytoplasm
7
, implying an even greater protein concentration. 
Environmental conditions such as increased temperature create problems in protein 
folding and solubility. Therefore, proper folding of proteins inside the protease rich cell 
in a timely fashion is a tremendous challenge. Indeed, the folding process is a multi-scale 
dynamic process, if one considers the synergies between protein synthesis, targeting, 
folding, modification, and degradation.  
It was previously thought that small (less than 100 residues), single-domain host 
proteins may achieve their native conformation spontaneously owing to their fast folding 
kinetics
8
,  and that host proteins with large, multidomains or overexpressed recombinant 
proteins generally need the help of folding modulators
9-11
. More recent research 
suggested that all proteins may fold via one or more intermediate states that act as 
stepping stones to their native states (reviewed in Ref. 
12
). Those folding intermediates, 
especially when kinetically stable, have the tendency to rapidly collapse into non-native 
conformations. The fact that partially folded proteins tend to aggregate more readily in a 
highly crowded cellular environment
13
 may explain the need for folding modulators. 
Based on functionality and mode of action, those folding modulators can be divided into 
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several categories including 1) classical molecular chaperones, 2) foldases, 3) proteases, 
and 4) a group of highly specialized chaperones that provide the steric conformation 
necessary for folding
14, 15
.   
1.1.1 Protein folding modulators participate in protein quality control 
Molecular chaperones are defined as ―any protein which interacts, stabilizes, or 
helps a non-native protein to acquire its native conformation, but is not present in the 
final functional structure‖
11
.  They are not truly folding catalysts since they do not 
accelerate the rate-limiting steps in the folding pathway. Instead, molecular chaperones 
facilitate protein folding mainly by binding to folding intermediates or stress partially 
unfolded proteins to maintain these non-native species in soluble or translocation-
competent states. Such binding is generally through the non-covalent hydrophobic 
interaction of regions on the chaperone and hydrophobic amino acid side chains on the 
substrate proteins. These side chains are normally buried in native proteins, but exposed 
in unfolded or partially folded polypeptides.  Binding of chaperones to substrates should 
help to shield the hydrophobic regions on substrates from solvents or from each other. 
Therefore, premature aggregation or inappropriate arrangement of protein regions is 
reduced by the action of chaperones.   
If a chaperone only does what is described above, it is called ―a holding 
chaperone‖
16
.  In contrast, some ―folding chaperones‖ promote the net folding/refolding 
of substrate proteins using conformational changes coupled with ATP hydrolysis, such as 
members from the Hsp60, Hsp70, and Hsp90 families (reviewed in Refs. 
11, 17
). ATP-
regulated substrate release allows folding to proceed; therefore, these ―folding 
chaperones‖ optimize the efficiency of folding, in addition to preventing substrate 
aggregation along the folding pathway
11
. Due to the lack of ATP in the periplasm, 
periplasmic folding chaperones must use other mechanisms to couple substrate binding 
and release. A third category of chaperones is known as the ―disaggregation chaperone‖. 
These chaperones are not involved in the folding process, but instead, use energy 
provided by ATP hydrolysis to actively solubilize protein aggregates so that the proteins 
can be refolded (reviewed in Ref. 
18
). In most cases, they work in collaboration with 
folding chaperones.  
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On the other hand, the foldases are true folding catalysts since they accelerate the 
rate-limiting steps during substrate folding, such as disulfide bond formation and 
peptidyl-prolyl cis-trans isomerization. Both molecular chaperones and foldases are 
actively involved in the protein folding/refolding process, and their overexpression is 
very promising as an approach of optimizing the folding environment.  
More recently, a class of chaperones that provide highly specific steric (structural) 
information to their target proteins has been identified (as reviewed in Ref 
19
). These 
target proteins are usually impossible to fold into their native structure on a biologically-
relevant time scale due to large kinetic barriers that slow the folding process. The folded 
states of these target proteins are usually less stable, or only marginally more stable, than 
their unfolded states. The steric chaperones seem to overcome high energy barriers and 
therefore accelerate folding. After removal of the steric chaperones, the folded target 
proteins are trapped in the folded states by high energy barriers. Thus it seems that these 
chaperones direct proteins to violate Anfinsen’s rule, which states that the folded state of 
a protein contains the minimal free energy. Other possible exceptions to Anfinsen’s rule 
are the intrinsically disordered proteins. Although these proteins do not have regular three 
dimensional structures, cells in fact tolerate and select for such proteins since they are 
usually associated with important cellular functions
20-22
. Examples for steric chaperones 
include bacterial protease-prodomains, lipase specific foldase (Lif), and fimbrial 
periplasmic chaperones such as PapD
19
. 
Finally, as another branch of the quality control system, cells have developed ways 
to proteolytically remove irreversibly damaged proteins. This maintains cellular 
homeostasis and allows the recycling of amino acids. Proteases are involved in these 
processes. Under certain circumstances, misfolded proteins form protease-resistant 
aggregates known as inclusion bodies, thus escaping the protein folding quality-control 
system.  
It is noteworthy that the lines separating the various folding modulators are not 
obvious
23
. A foldase might have chaperone activity (such as protein disulfide isomerase 
DsbC
24





), and a chaperone may perform the peptidyl-prolyl cis-trans isomerization 
function (such as SurA
26
).  
1.1.2 Periplasmic folding modulators* 
The periplasm is estimated to make up 5-16% of the volume of the entire cell
27-29
.  
The periplasmic environment is very different from the cytoplasmic environment. Due to 
the permeability of the outer membrane, which allows free passage of hydrophilic 
molecules smaller than about ~700Da
30
), the properties of the periplasm are largely 
dependent on the surrounding medium. As a consequence, the pH and ionic strength 
reflect the extracellular environment and are thus subject to fluctuation. In addition, the 
periplasm contains the peptidoglycan layer, which is involved in maintaining cell shape
31
. 
In contrast to the reducing, highly buffered, and energy-rich environment in the 
cytoplasm, the periplasm is an oxidizing, relatively unbuffered compartment that lacks 
any obviously energy source, such as ATP that is required for many cytoplasmic folding 
chaperones to work. Therefore, the periplasmic folding modulators must use different 
mechanisms to couple substrate binding and release.  
Only a few periplasmic chaperones and folding catalysts have been identified so 
far. Based on the substrate specificity, periplasmic chaperones can be divided into 
specific and general chaperones. Specific chaperones include SurA and LolA, which help 
the folding of outer membrane proteins or lipoproteins, respectively. PapD and FimC and 
their related proteins are also specialized chaperones that function in pili biogenesis. Skp, 
FkpA, and HdeA are the only known periplasmic general chaperones. Skp probably has 
the broadest range of substrates, including both outer membrane proteins and periplasmic 
proteins
32
, or recombinant proteins expressed in the periplasm
33-35
. FkpA was shown only 
to protect periplasmic proteins or recombinant proteins expressed in the periplasm but not 
the outer membrane proteins
36, 37
.  In contrast to FkpA and Skp, which fulfill chaperone 
function under normal physiological conditions, HdeA mediates acid resistance in 
                                                 






. It prevents acid denatured proteins from aggregation and 
aids in their refolding when shifted to neutral pH
40
.  
Peptidyl prolyl cis/trans isomerases (PPIases) catalyze the cis-trans isomerization 
of peptide bonds with proline (Xaa-pro bond; Xaa, any amino acid before proline), which 
is a rate-limiting step in the folding process of many proteins
41
. SurA, PpiD, FkpA and 
PpiA are known periplasmic PPIases. It is noted that SurA and FkpA also perform 
chaperone functions, while PpiA and PpiD are solely peptidyl prolyl cis/trans isomerases.  
Thiol-disulfide oxidoreductases catalyze disulfide bond formation and 
isomerization reactions. They include DsbA and DsbB for disulfide oxidation, and DsbC, 
DsbD, and DsbG for disulfide isomerization. They also include DsbE (CcmG) and CcmH 
involved in cytochrome biogenesis. 
In the periplasm, the accumulation of misfolded protein is alleviated by more than 
20 proteases/peptidases (a list of periplasmic proteases/peptidases is available at 
http://www.cf.ac.uk/biosi/staffinfo/ehrmann/tools/proteases/allproteases.html). Among 
these, DegP (HtrA, Do) plays a leading role in removing the misfolded proteins 
(reviewed in Refs. 
42, 43
).  DegP has been shown to mediate degradation of a number of 
misfolded cell envelope proteins in vivo
25, 44-46
. However, DegP does not cleave well-
folded proteins
25




1.1.3 Identification of periplasmic folding modulators 
Surprisingly, only a few chaperones have been identified directly through their 
abilities to stabilize proteins or promote protein folding processes. These chaperones, 
such as PapD, are usually encoded in the same operon as the proteins they stabilize
47
. 
Therefore, identification of these specialized chaperones was relatively straightforward.  
The genes encoding chaperones have also been isolated because of mutational 
phenotypes. These phenotypes might not be obviously related to chaperone functions. For 
example, surA (for survival) was originally identified as a gene essential for survival in 
the stationary phase
48
. The gene hdeA was identified as a gene important for survival at 
low pH. It is generally accepted that low pH causes protein denaturation; however, the 
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chaperone role of HdeA remained undiscovered, even after the crystal structure of this 
protein had been solved. Instead, the identification of many chaperones was because of 
their increased expression at elevated growth temperatures
49
.  Alternatively, proteins 
were suggested as having a chaperone-like activity when they were found to bind to or 
interact with specific proteins. For instance, Skp was found to bind to outer membrane 
proteins in a pull-down assay using the outer membrane porin, OmpF
50
. LolA was 
identified as a periplasmic carrier protein that facilitates the release of an outer membrane 
lipoprotein, Lpp, from the inner membrane
51
.  
Identification of periplasmic folding catalysts was historically much more 
straightforward than the identification of periplasmic chaperones. For one reason, they 
catalyze specific reactions, and deletion of important folding catalysts often leads to 
easily distinguishable phenotypes. Therefore, folding catalysts were identified through 
complementation experiments. For instance, DsbG was identified as its overexpression 
reduced the dithiothreitol sensitivity of strains lacking a functional disulfide bond 
formation system
52
. On the other hand, these folding catalysts have characteristic 
domains (PPIase domain or thioredoxin domain) that might be used to identify new 
members based on sequence homology or structural similarity. Examples include the 
identification of FkpA based on its sequence homology to the PPIase domain of 




Due to the difficulty of identifying chaperones directly based on their chaperone 
activities, people may wonder how complete the list of known chaperones is. One aim of 
my graduate study was to try to explore the possibility of identifying new periplasmic 
chaperones and folding catalysts. Previously, the lack of an easily detectable phenotype 
due to a chaperone deficiency has limited the direct uncovering of new chaperones. Our 
lab has set up a powerful selection system that links the folding status of an unstable test 
protein to a distinguishable phenotype: antibiotic resistance. With this system, we 
reasoned that new chaperones might be uncovered based on their ability to stabilize the 
test protein and therefore confer antibiotic resistance. A detailed description of this 
system is in section 1.3.  
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1.1.4 Extracytoplasmic stress responses 
Any unfavorable growth condition that would lead to protein denaturation and 
accumulation of misfolded cell envelope proteins may activate extracytoplasmic stress 
responses. As a result, cells upregulate or downregulate the level of a series of proteins to 
combat stress. Actually, many of the proteins involved in protein quality control have 
been characterized from studies on the stress responses. E. coli has at least five (σE, Cpx, 
Bae, Psp and Rcs) extracytoplasmic stress response pathways that allow it to monitor 
extracytoplasmic homeostasis (reviewed in Ref. 
54
). Each of these five stress response 
pathways monitors different stresses and regulates different sets of genes.  There is, 
however, a degree of overlap between different response pathways. One feature that 
distinguishes the extracytoplasmic stress response systems from cytoplasmic responses is 
the individual localization of the sensor protein and the effector. When the stress is 
sensed, the signal must cross the cytoplasmic membrane to reach the transcription 
regulator.  
1.1.4.1 Two-component signaling transduction systems: Cpx, Bae and Rcs 
The basic two-component system involves a sensor kinase and response-regulator 
protein
55
. The sensor kinase directly phosphorylates its cognate regulator protein in 
response to a specific signal. Phosphorylation of the regulator modulates its activity.  
The Cpx (conjugative pilus expression) pathway mainly responds to stress in the 
periplasm and is induced by elevated pH, altered inner membrane composition, and 
misfolding or overproduction of cell envelope proteins
56
.  Its sensor protein, CpxA, is a 
transmembrane protein located in the inner membrane. CpxA senses the stress signal with 
its periplasmic domain, autophosphorylates at a conserved histidine, and then transfers 
this phosphate to a conserved aspartate of the cytoplasmic regulator CpxR (Figure 1.1). 
CpxR then activates genes responsible for envelope physiology, such as degP, dsbA, ppiA 
and ppiD. One small periplasmic protein, CpxP, is also upregulated. It serves as a 
negative modulator of the Cpx pathway by binding to the periplasmic sensing domain of 
CpxA. Under normal growth conditions, binding of CpxP to CpxA keeps CpxA 
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unphosphorylated. Under stress conditions, CpxP is cleaved by DegP, thus relieving 
inhibition of CpxA. 
The Bae (bacteria adaptative response) pathway is involved in the detoxification in 
the periplasm of harmful compounds such as antibiotics, bile salts, and detergents. It only 
regulates a few genes; most of them encoding drug exporters, such as mdtABCD and 
acrD. One interesting gene of this regulon, spy, is very strongly upregulated at the 
mRNA level when Bae is active
57
. Spy has been previously known to massively 
overexpress during spheroplasting (a process that allows periplasmic components to leak 
out) and is also regulated by the Cpx pathway
57
. Similar to the Cpx pathway, the Bae 
system uses a histidine kinase (BaeS), and a transcription factor (BaeR) to mediate the 
stress response (Figure 1.1). In Chapter 3 I describe how I discovered Spy to be a novel 
periplasmic chaperone.  
The Rcs (regulator of capsular synthesis) pathway senses envelope composition. It 
is activated by any perturbation to the peptidoglycan layer, and contributes to intrinsic 
antibiotic resistance
58
. The signal transduction cascade includes an outer membrane 
protein, RcsF, inner membrane proteins RcsC and RcsD, and cytoplasmic proteins RcsB 
and RcsA.  
1.1.4.2 Other extracytoplasmic stress response: E and Psp 
The 
E
 pathway is induced by heat shock, and mainly monitors outer membrane 
protein misfolding. Its activation is a proteolytic cascade that results in the destruction of 
the membrane-bound anti-sigma factor RseA and the sequential release of the 
transcription factor 
E
 (reviewed in Ref. 
59
). Under normal growth conditions, RseA 
binds to and inhibits 
E
 with RseB stabilizing the interaction between RseA and 
E
. In 
the presence of stress, RseA is cleaved in a two-step process: first by DegS from the 
periplasmic side and then by RseP from the cytoplasmic side (Figure 1.1). DegS was 
proposed to sense protein misfolding signals in the periplasm. Cleavage of RseA leads to 
the release of its cytoplasmic domain with 
E
 still bound. Then the cytoplasmic proteases 
ClpXP digest the cytoplasmic domain of RseA and releases
E
. he transcription factor 
E
 regulates a large number of genes encoding folding modulators, including degP, skp, 
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fkpA, surA, dsbC etc. 
E
 regulon overlaps substantially with that of Cpx, indicating the 
partial functional redundancy of the two systems. 
 
Figure 1.1 The Cpx, 
E
, and Bae stress response pathways 
The activation process of each pathway is described in the text. Representative genes belonging 
to each regulon are listed at the bottom.  
 
The Psp (phage shock protein) response monitors the integrity of the inner 
membrane and maintains the proton-motive force
60
.  PspF is an activator of 
54
-
containing RNA polymerase, and is normally inhibited by PspA. In the presence of stress 
signals, inner membrane protein PspB and PspC titrate away PspA, releasing PspF and 
initiating the Psp response. 
1.2 Thiol-disulfide oxidoreductase: unique enzymes with a similar fold 
One of the most important posttranslational modifications for exported proteins is 
the formation of disulfide bonds, which when present are important for the oxidative 
folding, activity, and stability of the proteins that contain them. Exported proteins show a 
strong bias for containing an even numbers of cysteines
61
, implying that the majority of 
degP, ppiA, ppiD, secA, spy, 
ompC, ompF, acrD, mdtABCD, 
cpxP, rpoE, rseABC, et.al 
rpoE, rpoD, rpoH, rseABC, 
rseP, degP, skp, fkpA, surA, 
dsbC, yaeT, micA, et.al 







cysteines are involved in disulfide bonds. Disulfide bond formation and isomerization 
result from thiol-disulfide exchange reactions between the substrate proteins and the 
thiol-disulfide oxidoreductases that are active in the periplasmic space (reviewed in 
Refs.
62, 63
). Most thiol-disulfide oxidoreductases belong to the thioredoxin superfamily. 
They contain a protein fold related to thioredoxin and usually have an active site motif 
that contains the sequence CXXC
64, 65
. These enzymes play an important role in protein 
folding and stability and are also responsible for bacterial pathogenicity
66
.  
Thiol-disulfide oxidoreductases are found in all living organisms. Thiol-disulfide 
oxidoreductases present in the periplasmic space act as thiol-disulfide oxidases or 
isomerases, while those found in the cytoplasm perform mainly reductive steps. 
1.2.1 The thioredoxin fold and the CXXC active site 
The basic tertiary structure of the thioredoxin superfamily that include a large 
number of thiol-disulfide oxidoreductases was first observed in the protein thioredoxin in 
1975, and is called the thioredoxin fold
67
. The thioredoxin fold is a distinct structural 
motif consisting of four β strands and three flanking α helices
67
 (Figure 1.2).  Thiol-
disulfide oxidoreductases having the thioredoxin fold belong to the thioredoxin 
superfamily.  Although a basic scaffold of the thioredoxin superfamily, the thioredoxin 
fold is not restricted to the thioredoxin superfamily. Other  E. coli proteins containing the 
thioredoxin fold include glutathione S-transferases, glutathione peroxidases, and alkyl 
hydroperoxidases (peroxiredoxins) 
65, 68
.   
Members of the thioredoxin superfamily in E. coli include thioredoxin 1&2, 
glutaredoxin 1,2,3&4, DsbA, DsbC, DsbD, DsbG, DsbE, and a glutaredoxin-like protein, 
NrdH
69, 70
. These proteins have low sequence similarity and perform distinct functions 
(Figure 1.3 on page 14). 
Another important feature that distinguishes members of the thioredoxin 
superfamily from other thioredoxin fold-containing proteins is the presence of an active 
site motif with a CXXC sequence, where X is any amino acid. The CXXC active site is 
located at the N-terminus of the α1 helix of the thioredoxin fold
68
 (Figure 1.2). The active 
site contains the redox cysteine pairs and the XX dipeptide that is very important in 
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controlling the redox properties of the protein in which it is found71, 72. Several research 
groups have shown that it is possible to alter the redox properties of these 
oxidoreductases by changing the XX dipeptide in the CXXC motif. When changing the 
CXXC motif of one oxidoreductase to the sequence of another, the function of the 
original enzyme may be substantially altered. In some cases, the modified protein is even 
able to perform some of the activities of the protein from which the XX sequence was 
derived 73-75. 
 
Figure 1.2 Architecture of the thioredoxin fold 
The figure is modified from Fig 1& 3 in Ref. 68.  a, The β-sheet and α-helices of the thioredoxin 
fold can be subdivided into an N-terminal βαβ motif (boxed) and a C-terminal ββα motif (boxed), 
being connected by a loop of residues that incorporates a third helix. Thioredoxin contains one 
additional β-strand and one additional α-helix (white arrow and rectangle). b, structures of 
thioredoxin and DsbA. In DsbA, a second domain consisting of α-helices (white) is inserted into 




The effect of the XX dipeptide in the active site might be attributed to steric 
influences of their side chains. DsbA has a CPHC active site. The first residue of the XX 
dipeptide is proline, a residue that due to its ring structure comformationally restricts 
peptides to a greater extent than any of the other 18 amino acids with side chains. When 
the disulfide bond is formed in the active site of DsbA, the conformational restriction 
effect of proline might destabilize the disulfide bond, making it easy to break. If this is 
the case, it would contribute to the strong oxidizing activity of DsbA. Proline is also 
present at the active site of thioredoxin (CGPC), but is in the second position. 
Considering the large conformation space provided by the glycine residue, proline in the 
active site of thioredoxin might have only a marginal conformational effect
76
.  In addition 
to these purely mechanical considerations, the XX dipeptide might also affect the 
electrostatic environment of the active site. For instance, the histidine residue in the 
active site of DsbA is known to stabilize the thiolate anion of Cys3077. The XX peptide 
has also been shown to influence the redox potential of the enzyme and the pKa of the N-
terminal cysteine in the CXXC motif. More extensive studies on the XX dipeptide 
suggested more of its functions, as described in Chapter 2.  
1.2.2 Redox potential and pKa 
The redox potential and pKa of the N-terminal active site cysteine are two important 
properties that influence the reactivity of thiol-disulfide oxidoreductases.  
Redox potential measures the tendency of a chemical species to acquire electrons 
and thereby be reduced. It has long been proposed that redox potential affects the 
functions of proteins in the thioredoxin superfamily71, 73, 75. The intrinsic redox potentials 
of individual thiol-disulfide oxidoreductases can be quite different (Table 1.1). The 
oxidizing activity of a thiol-disulfide oxidoreductase is usually correlated with a high 
redox potential; while a reducing oxidoreductase often has a low redox potential. DsbA, 
with one of the highest redox potentials, is one of the most oxidizing oxidoreductases. It 
has been proposed that the XX dipeptide in the CXXC active site strongly influences the 
redox potential of the oxidoreductase73, 75, 78. 
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Table 1.1 Redox potential of different oxidoreductases 
Protein Disulfide  Redox potential (mV) 
DsbA 30-33 -122 
DsbB 41-44 -69 
104-130 -186 
DsbC 98-101 -140 
DsbD α subunit 104-110 -229 
DsbD γ subunit 461-464 -241 
DsbG 126-129 -126 
Thioredoxin 33-36 -270 
DsbL 29-32 -95 
 
Table is modified from Table. 1 in Ref. 76. DsbL was recently identified to have an even higher 
redox potential than DsbA79.  
 
The pKa value of a compound or a chemical group refers to the pH at which the 
compound/ chemical group is half ionized. The pKa value of a cysteine determines the 
extent of ionization of the thiol group at any pH, and consequently, indicates the 
reactivity of the thiol group in thiol-disulfide exchange reactions. It also indicates the 
intrinsic chemical reactivity of the sulfur atom, including its reactivity when it is part of a 
disulfide bond
80
. Cys30 (the N-terminal cysteine in the CXXC active site) in DsbA has an 
extremely low pKa value of 3.5, compared to the pKa value of a normal cysteine of about 
8.7
80
. It had been suggested that all of the following properties contribute to the 
exceptional oxidizing power of DsbA: the low pKa value of Cys30, the high redox 
potential, and the energetic difference between the reduced and oxidized form of DsbA, 
with the oxidized form being less stable
81
. Importantly, the PH dipeptide in the active site 
of DsbA has been found to be critical in determining all of these important properties of 
DsbA
81
. Substitution of the PH dipeptide with other amino acid residues increased the 
pKa of Cys30, decreased the energetic difference between the oxidized and reduced form 





1.2.3 Representative thiol-disulfide oxidoreductases and their functions 
Thiol-disulfide oxidoreductases are located in the periplasm, the inner membrane, 
and the cytoplasm of E. coli. The pathways for thiol-disulfide oxidation, reduction, and 




Figure 1.3 Major thiol-disulfide oxidoreductases in E. coli. 
The figure was adapted from Fig.1 of Ref. 69 and information from Ref. 82. Members of the 
thioredoxin superfamily are boxed. Members perform different functions: reduction (black 
arrow), oxidation (broken arrow), and disulfide bond isomerization (two arrows). The functions 
of DsbG, DsbE and NrdH are less well characterized. The thiol-disulfide oxidoreductase DsbB 
does not belong to the thioredoxin superfamily due to the lack of the thioredoxin fold. 
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1.2.3.1 Disulfide bond formation-DsbA and DsbB 
The formation of disulfide bonds can occur spontaneously in the presence of 
oxygen, but this generally occurs relatively slowly. In the periplasm, disulfide bond 
formation is almost exclusively catalyzed by the thiol-disulfide oxidoreductase DsbA
83
. 
This 21 kDa protein donates its disulfide bond to substrate proteins via an unstable mixed 
disulfide intermediate. This mixed disulfide is resolved when another cysteine from the 
substrate attacks the mixed disulfide bond, resulting in the breakage of the intermediate 
and the net transfer of a disulfide bond from DsbA to the substrate. The oxidized form of 
DsbA is less stable than the reduced form. Therefore, it has the tendency to transfer its 
disulfide bond to substrate proteins
84
. In addition to its strong oxidizing thiol-disulfide 





Figure 1.4 Mechanism of disulfide formation and isomerization in the bacterial 
periplasm. 
The figure is modified from Fig.6 in Ref. 65. a, DsbA resides in the periplasm of E. coli and 
introduces disulfide bonds into newly translocated polypeptides. For the system to be catalytic, 
reduced DsbA is reoxidized by the inner membrane protein DsbB. DsbB transfers electrons to the 
respiration chain with the final electron acceptor molecular oxygen. b, incorrect disulfide bonds 
are reshuffled by the periplasmic protein DsbC. DsbC is kept reduced by inner membrane protein 
DsbD. DsbD gains its reducing equivalents from the cytosolic protein thioredoxin (TrxA), which 
ultimately gains its reduced equivalents from NADPH (Figure 1.3). 
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Reduced DsbA is reoxidized by the inner membrane protein DsbB which transfers 
electrons to quinones in the respiratory chain (Figure 1.4 a). DsbB possesses four 
transmembrane helices and two periplasmic loops, which both contain catalytic 
cysteines
86, 87
. Cys41 and Cys44 are located in the smaller periplasmic loop within a 
CXXC motif. Cys104 and Cys133 reside on the bigger periplasmic loop, which contains 
regions that interact with DsbA.  The reoxidation of DsbA occurs via a mixed disulfide 
bond between Cys104 of DsbB and Cys30 of DsbA. Cys33 of DsbA then attacks the 
mixed disulfide bond between DsbA and DsbB and resolves it
87
. Reoxidation of DsbA 
involves the relocation of disulfide bonds between the four catalytic cysteines of DsbB. 
Cys44 of DsbB is transiently reduced during this process, leading to the formation of 
Cys44-uniquinone charge-transfer complex
88, 89
. This results in a strong absorbance peak 
at 510 nm that can be used to monitor the interaction of DsbA and DsbB as described in 
Chapter 2.  
1.2.3.2 Disulfide bond isomerization-DsbC, DsbD and DsbG 
Since DsbA has a strongly oxidizing redox potential, it tends to form non-native 
disulfide bonds quite frequently, especially when the correct disulfide bond requires 
linking cysteines that are not consecutive in sequence. The misconnected disulfide bond 
is corrected by the disulfide isomerase DsbC (Figure 1.4 b). Isomerization is the process 
of reshuffling non-native disulfide bonds. This process involves sequential disulfide bond 
reduction and reoxidation. Reduced DsbC attacks the incorrect disulfide bond forming a 
mixed disulfide intermediate.  This either leads to complete reduction of the incorrect 
disulfide bonds, or formation of a correct disulfide bond if the right pairing cysteine 
attacks and resolves the mixed disulfide
62
. DsbC is a V-shaped dimer with an uncharged 
cleft at the dimer interface that serves as a potential substrate binding site. Because of this 
structural feature, DsbC possibly has chaperone activity
24
.  
Organization of DsbC domains also showed striking similarity with the periplasmic 
chaperone FkpA
56
. Both enzymes are dimeric, with a C-terminal domain carrying the 
active site for disulfide isomerization or peptidyl-prolyl isomerization, a helix linker, and 
an N-terminal domain for dimerization and chaperone activity. Fusion of the dimerization 
domain and helix linker of FkpA with two DsbA proteins results in a V-shaped enzyme. 
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This new enzyme performs similarly to DsbC, suggesting that FkpA and DsbC might use 
similar mechanisms to couple chaperone activity and isomerase activity
90
. It also suggests 
that the functional evolution of proteins is the process of adding appendix structures to a 
more conserved structural scaffold, such as the thioredoxin domain or the PPIase domain. 
To fulfill its function as an isomerase, DsbC is always kept in the reduced form by 
the inner membrane protein DsbD. DsbD gains electrons from the cytoplasmic protein 
thioredoxin, which ultimately acquires electrons from NADPH. DsbD also reduces 
DsbG, a protein that is probably also a disulfide isomerase. DsbG shares 24% sequence 
identity with DsbC, and is thought to be less effective in disulfide isomerization and have 
a narrower substrate range
91
. However, through laboratory evolution, the isomerase 
activity of DsbG could be substantially improved to resemble that of DsbC
92
. Recent 
studies have suggested that DsbG, together with DsbC, controls the global sulfenic acid 




1.2.3.3 Disulfide bond reduction: thioredoxins and glutaredoxins 
Cytoplasmic proteins do not normally form disulfide bonds, although some proteins 
such as Hsp33 form transient disulfide bonds to regulate their functions under specific 
conditions
94
. Thiol groups in cytoplasmic proteins are kept reduced by two pathways: the 
thioredoxin pathway and the glutaredoxin/glutathione pathway. In total, E. coli has six 
thioredoxin or glutaredoxin proteins, namely thioredoxin 1, thioredoxin 2, glutaredoxin 1, 
glutaredoxin 2, glutaredoxin 3, and glutaredoxin 4
65
. Throughout my thesis, 
―thioredoxin‖ refers to thioredoxin 1, which is encoded by the trxA gene.  
In the thioredoxin pathway, thioredoxin reductase uses the reducing equivalents 
from NADPH to maintain the reducing state of thioredoxin (Figure 1.3). Thioredoxin in 
turn can reduce disulfide bonds in various proteins, such as DsbD, peroxiredoxins, 
methionine sulfoxides, ribonucleotide reductase, and Hsp33 (reviewed in Ref. 
95
). 
Thioredoxin therefore is involved in many important cellular reactions such as 





The glutathione/glutaredoxin system also uses NADPH in this case to reduce 
glutathione via glutathione oxidoreductase. Glutathione is then able to reduce the 
glutaredoxins (Figure 1.3). Like thioredoxins, glutaredoxins are involved in many cellular 




1.2.4 Directed evolution of thiol-disulfide oxidoreductase 
The thioredoxin fold in the example of thioredoxin itself is stable to up to 80˚C. 
Therefore, it is not surprising that during evolution many different enzymes have used 
this fold as a scaffold. Directed evolution that combines strong mutagenesis conditions 
and specific selection techniques allows us to mimic millions of years of evolution of the 
functions of enzymes within days.  This technique, applied to members of the thioredoxin 
superfamily, has generated a large amount of valuable information for thiol-disulfide 
oxidoreductases
99-101
. The information gained from these experiments not only confirms 
the suitability of the thioredoxin scaffold as a basic structural and functional block, but 
also suggests the possibility of adding new functions to the existing functions of an 
enzyme. 
For example, the substitution of the CGPC active site in thioredoxin by the CPHC 
active site as in DsbA makes thioredoxin a thiol-disulfide oxidase similar to DsbA
99
. 
Thioredoxin with its active site changed to CACC partially complements DsbA by the 
acquisition of a 2Fe–2S iron–sulfur cluster
100
. DsbC also partially complements DsbA if 
the regions in DsbC important for dimerization have been modified 
101
. DsbG with a 
single mutation in its surface-exposed regions causes DsbG to resemble DsbC
92
.  These 
examples suggest that the functions and substrate specificities of members from the 
thioredoxin superfamily can evolve through only a few amino acid changes.  
In Chapter 2, we used the systematic approach of mutating the CXXC motif of 
thioredoxin to make it resemble DsbA. With this approach, we gained insight into the key 
features of this widely conserved motif.  
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1.3 Monitoring protein folding in vivo 
Periplasmic expression in E. coli has long been used to produce biologically active 
recombinant proteins of pharmaceutical importance. However, the production of large 
and complex recombinant proteins, especially eukaryotic proteins, is often limited by 
poor folding or low yields. These problems might be attributed to different folding 
conditions or redox environment in the prokaryotic periplasm, compared with the 
endoplasmic reticulum (ER) of eukaryotic organisms. We wondered if it is possible to 
improve the folding environment of the periplasm by employing techniques of 
chromosomal mutagenesis. As a prerequisite we needed to set up a system that 
conveniently monitors protein folding in vivo. Most proteins, upon expression, do not 
confer a phenotype that can be adapted to a selection or screen method. Protein activity 
measurements, on the other hand, are often limited by strict requirement of protein purity 
and therefore may not be applicable for high-throughput assays using crude cell lysates.   
1.3.1 The -lactamase system 
To circumvent the problems mentioned in the above section, our laboratory used a 
strategy to make a fusion protein of the test protein with a reporter protein, which 
conveys a selectable phenotype if it is well folded.  The test protein is inserted into a 
permissive site of the reporter so that the folding of the test protein would greatly affect 
the folding status of the reporter protein. As a result, the phenotype conferred by the 
reporter would reflect the folding of the test protein.  
One example of such a fusion protein previously developed in our laboratory is the 
-lactamase system
102  
(Figure 1.5).  It is a powerful genetic system that directly links 
increased protein folding kinetics and thermodynamic stability to increased antibiotic 
resistance, establishing a quantitative in vivo measure of protein stability
102
. In this 
system, a guest protein is inserted via a glycine-serine (GS) linker into a permissive site 
in the TEM-1 -lactamase. In the absence of efficient folding modulators, the unstable/ 
poorly folded guest protein is prone to degradation by periplasmic proteases. Proteolysis 
of the guest protein separates -lactamase into two parts. The two parts of -lactamase 
are ultimately degraded, leading to a decrease of the host’s resistance towards -lactam 
20 
 
antibiotics, such as penicillin V (PenV). On the other hand, well-folded guest proteins 
able to maintain a stable strucuture are protease resistant, leading to the assembly of a 
functional fusion protein that gives resistance to PenV. This system was therefore 
proposed to distinguish well-folded/stable proteins from poorly folded/unstable ones, by 
the means of conferring different levels of antibiotic resistance.  
 
 
Figure 1.5 The -lactamase system links the PenV resistance to the stability of the 
inserted protein 
The figure is modified from Fig.1 and Fig.2 in ref. 102. The level of penicillin resistance in vivo 
may be related to the folding status of the inserted protein.  Poorly folded proteins are degraded 
by periplasmic proteases (represented by scissors), which leads to the irreversible separation of 
the two parts of -lactamase and low level of PenV resistance.Well folded proteins are resistant to 
proteolysis, forming an active -lactamase fusion and resulting high level of PenV resistance. 
PenVS = penicillin V sensitive. PenVR = penicillin V resistant. N-term: N-terminal part. C-term: 
C-terminal part. GS: the flexible glycine-serine linker. Right bottom corner shows a typical result 
from a spot titer experiment. Growth of the cells expressing different fusion proteins (such as 
bla’-Im7 F15A-bla’, meaning Im7 F15A inserted into -lactamase) was compared.  F15A and 
L34A mutations destabilize Im7, making the variants fold worse than Im7 wild type; while V27A 
is a stabilizing mutation that improves the folding of Im7. Stabilization of Im7 leads to increased 
PenV resistance so that higher dilutions of the cells can grow on PenV plate, and vice versa.  
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This hypothesis was tested by insertion of three different guest proteins into -
lactamase: immunity protein 7 (Im7), a bacterial protein without cofactors or disulfides, 
granulocyte colony-stimulating factor (GCSF), a eukaryotic protein containing three 
disulfides, and maltose binding protein (MBP), a large bacterial periplasmic protein. Each 
of these three proteins has a well-studied in vitro folding pathway, and several 
destabilizing mutations are known
102
. It was clearly shown for each protein that the 
introduction of these destabilizing mutations led to an increased sensitivity to PenV 
(Figure 1.5 and Fig 3 in Ref. 
102
). Moreover, for all of the three proteins including many 
of their mutants tested, a direct correlation between antibiotic resistance and the 
thermodynamic stabilities of the guest protein was found
102
. The highest antibiotic 
resistance always resulted from cells expressing -lactamase being fused with the most 
stable test proteins. This suggests that the level of antibiotic resistance could be used as 
an indicator for the folding status of the guest protein. Therefore, one can theoretically 
select for cells containing a well-folded guest protein by simply plating cells on 
increasing concentrations of antibiotics. Indeed, by using the tripartite fusions between 
-lactamase and unstable proteins,  this system was successful in obtaining dramatically 
stabilized protein variants
102
.  It is noted that the -lactamase system provides a robust 
readout for protein folding/stability and a method for selecting stabilizing protein variants 
without requiring knowledge of the structure, function or activity of the test protein. 
We hypothesized that this system might actually be able to select for host variants 
that alter the in vivo folding environment in ways that enhance protein folding or 
stability. If such variants could be obtained, we reasoned that their analysis might provide 
insight into the in vivo folding process. Chapter 3 describes the use of an enhanced 
version of this system to identify a new periplasmic chaperone called Spy. More 
applications of this system are discussed in Chapter 4. 
1.3.2 Other systems generated to monitor protein folding in vivo 
A few systems have been generated in other laboratories to qualitatively or 
quantitatively measure protein folding in vivo and to select for more stabilized protein 
variants. These systems include phage display methods and the green fluorescent protein 
(GFP) folding reporter system. One example of phage display methods is the Proside 
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(protein stability increased by directed evolution) system, which couples increased 
protease resistance of protein variants with the infectivity of a filamentous phage fd 
103
. 
The folding reporter protein used in this system is the gene-3-protein (g3p) of the fd 
phage, which mediates the infectivity of the phage to E. coli.  Test proteins or peptides 
are inserted between two of the three domains of the g3p protein
103
.  The resulting 
chimeric protein is then subjected to proteolysis in vitro and selected for improved 
stability of the inserted part based on phage’s infectivity. The method is, however, limited 
by the size of the inserted protein since it requires that the insertion does not abolish the 
assembly or infectivity of the phage. In the GFP folding reporter system, a test protein is 
fused to the N-terminus of GFP
104
. As a result, the folding and/or solubility of the 
upstream test protein affect the folding of GFP, and only correct folding of GFP leads to 
fluorescence. Through rounds of mutagenesis and screening for fluorescence, stabilized 
variants of test proteins can be identified. To solve the problems such as truncation 
artifacts (proteolytic destruction of the N-terminal test protein can relieve the interference 
of the test protein on the folding of GFP, and lead to false positive results), improved 
versions of GFP reporters have been developed
105
. These improved GFP reporters are 
circularly permuted so that insertions are now placed between two parts of GFP. The 
GFP reporter system and our -lactamase system both provide robust measurement of 
protein stability in vivo. They differ in that the GFP system is a screening method which 
does not kill bacteria, while the -lactamase system is a selection method which links to 
the survival of the bacteria.  
1.4 Conclusion 
E. coli has developed sophisticated systems both to assist protein folding in the 
periplasm and to respond to protein misfolding. Thiol-disulfide oxidoreductases are 
important enzymes mediating post-translational modification in proteins and aiding in 
protein folding. The thioredoxin fold and the active site CXXC are important for the 
functional properties of thiol-disulfide oxidoreductases. The -lactamase selection system 
links the folding of unstable test proteins to antibiotic resistance, providing a means to 
conveniently monitor protein folding in vivo. This system together with mutagenesis 
techniques are useful in the chaperone discovery process.  
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Chapter 2  
The CXXC motif is more than a redox rheostat
†
 
Abstract: The CXXC active site motif of thiol-disulfide oxidoreductases is thought 
to act as a redox rheostat, whose sequence determines its reduction potential and with that 
its functional properties.  We tested this idea by selecting for mutants in the CXXC motif 
of a reducing oxidoreductase, thioredoxin, that complement null mutants in a very 
oxidizing oxidoreductase, DsbA. We found that altering the CXXC motif affects not only 
the reduction potential of the protein, but also affects the ability of the protein to function 
as a disulfide isomerase, and also impacts its interaction with folding protein substrates 
and reoxidants. Surprisingly, nearly all our thioredoxin mutants had increased activity in 
disulfide isomerization in vitro and in vivo. Our results indicate that the CXXC motif has 




Thiol-disulfide oxidoreductases are found in all living organisms. They catalyze the 
oxidation of protein thiols and the reduction and isomerization of disulfide bonds in 
proteins. They are thus critical for protein folding reactions. Thiol-disulfide 
oxidoreductases present in the periplasmic space act as oxidases or isomerases, while 
those in the cytoplasm perform mainly reductive steps. The CXXC active site of these 
                                                 
† This chapter is modified from the publication ―The CXXC motif is more than a redox rheostat. 
Quan, S., Schneider, I., Pan, J., Hacht, A.V. & Bardwell, J.C. The Journal of biological chemistry (2007)‖. 
I performed all the experiments in the paper. JCAB designed and supvised the project. JP provided 
conceptual advice. IS set up the initial selection conditions for thioredoxin mutants. AH helped me with 




thioredoxin-related proteins is essential for their activity
65, 106, 107
. The sequence of the 
XX dipeptide located between the cysteines in the active site motif is very important in 
controlling the redox properties of the protein in which it is found
71, 72
; so much so that it 
has been termed a redox rheostat
108
.  Several groups have shown that it is possible to alter 
the redox properties of these oxidoreductases by mutating the XX dipeptide in the CXXC 
motif. When changing the CXXC motif of one oxidoreductase to the sequence of another, 
the function of the original enzyme may be substantially altered. In some cases, the 
modified protein is even able to perform some of the activities of the protein from which 
the XX sequence was derived
73-75
. The effect these mutations have on the activity of the 
protein has been generally attributed to the effect they have on the redox potential of the 
protein
73, 75, 78
. We decided to test this hypothesis by selecting for mutants in the CXXC 
motif of the reducing protein thioredoxin that allow it to complement the very oxidizing 
protein DsbA. 
The formation of disulfide bonds in E. coli requires DsbA
83
. DsbA oxidizes 
proteins secreted into the periplasm by rapidly exchanging its disulfide with reduced pairs 
of cysteines present in substrate proteins
84
. Reduced DsbA is reoxidized by the 
membrane protein DsbB
109
.  DsbA has the highest redox potential known (E°’= –121 
mV) among members of the thioredoxin related thiol-disulfide oxidoreductases. This is 
thought to be important for DsbA to be capable of rapidly oxidizing substrate proteins 
and keeping the periplasm in an oxidized state
81
. This high redox potential is understood 
in terms of the electrostatic forces in the vicinity of the active site disulfide, CPHC 
motif
81, 110
. Although the forces behind that control the redox potential of DsbA are well 
studied, the in vivo importance of this extremely high redox potential is not entirely clear. 
DsbA variants carrying mutations in the dipeptide in the CXXC active site can still 
function like wild-type DsbA in supporting normal cellular processes despite their less 
oxidizing redox potentials
81, 111
. In addition, no clear relationship exists between the 
redox potential of DsbA mutants and their ability to complement DsbA null strains
81
. 
Other members of the thioredoxin superfamily, when mutated, are capable of at 
least partially complementing dsbA when secreted into the periplasm. Jonda et al. tested 
four thioredoxin CXXC variants (harboring the XX dipeptides from the active site of 
DsbA, protein disulfide isomerase (PDI), glutaredoxin, and thioredoxin reductase) for 
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their ability to restore motility to a dsbA
—
 strain. They found that the DsbA, PDI and 
glutaredoxin-type sequence variants could partially complement dsbA
―99
. While 
thioredoxin is found nearly universally
112
, DsbA is mainly restricted to the γ and β 
subgroup of proteobacteria, a clade that arose about 2.2 billion years ago
113
, suggesting 
that thioredoxin and DsbA may have diverged at about this time. DsbA and thioredoxin 
overall only share 10% sequence identity
114
. Thus it is surprising that relatively minor 
alterations in the thioredoxin active site sequence can allow it to partially complement the 
very distantly related protein, DsbA. 
The redox potential of thioredoxin is 160 mV lower than that of DsbA (E°’ of 
thioredoxin = –270 mV
73
), and this is thought to contribute to its ability to keep the 
cytoplasmic protein cysteines reduced
115
. Previously, the ability of thioredoxin mutants to 
rescue dsbA
—
 mutants was mainly attributed to their increased redox potentials, which 
bring them closer to the extremely oxidizing redox potential of DsbA
72
. However, it 
should be noted that DsbC, which has an in vivo function as an isomerase, is nearly as 
oxidizing as DsbA. DsbC has a redox potential of –129 mV
116
, while that of DsbA is –
121 mV
84
. Yet DsbC in its function as an isomerase, reshuffle incorrect disulfide bonds, 
while DsbA oxidizes disulfide bonds. Thus, there are clearly more properties affecting 
the function of disulfide oxidoreductases than their redox potentials. 
Previous studies on the role of the CXXC motif on the functional properties of 
thioredoxin-like proteins have typically limited their approach to changing the active site 
sequences of thioredoxin family members so that they precisely match those sequences of 
other family members. Then the properties of the mutated proteins were determined. We 
decided to take a much more comprehensive approach of randomly mutating the CXXC 
motif and then selecting active mutants in order to determine which features of the 
CXXC motif are involved in allowing thioredoxin to complement DsbA. With this 
approach, we hoped to gain insight into the key features of this widely conserved motif. 
We also hoped to further understand what makes DsbA such an effective disulfide 
catalyst and explore the functional similarities between thioredoxin and DsbA. The 
powerful selections available for DsbA activity and the wealth of information on 
thioredoxin provide an ideal situation to extensively investigate the relationships between 
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the active site sequence, the redox potential, and the in vivo function of DsbA as an 
oxidase. 
In a process similar to natural selection, we made random alterations in the CXXC 
motif of E. coli thioredoxin and then applied selective pressure on cells, demanding a 
dsbA
+
 phenotype. We found that the sequence of the CXXC motif has the remarkable 
ability not just in controlling the redox potential of thioredoxin related proteins, but also 
in controlling their ability to isomerize disulfides and their ability to interact with their 
reoxidants and folding proteins. Surprisingly, many of our complementing thioredoxin 
mutants were even more efficient than is wild-type DsbA in disulfide isomerization. 
2.2 Results 
2.2.1 Construction of thioredoxin mutant library 
We decided to systematically explore the role played by the central ―X‖ residues of 
the CXXC active site motif of thiol-disulfide oxidoreductases. To do this we randomly 
mutated this motif in the reducing protein, thioredoxin, and asked which mutants 
complement a null mutant in the oxidizing protein, DsbA. The plasmid pssTRX contains 
the coding sequences of thioredoxin fused to the export signal of DsbA
99
. This plasmid 
was randomly mutated in the active site CXXC using multi site-directed mutagenesis. 
The resulting plasmid library was transformed into the dsbA
—
 strain JP120 (see strain list 
on page 48). About 10,000 transformants were obtained on LB plates containing 200 
g/ml ampicillin. To judge the mutation frequency, 96 colonies were randomly chosen 
and plasmid DNA was prepared and sequenced. The sequencing results showed that 40% 
of the clones contained mutated CXXC sequences with an almost equal distribution of 
the four nucleotides A (36%) T (20%) G (24%) C (20%) in the mutated sites, indicating 
the mutagenesis was nearly random. Our aim in this mutagenesis was to obtain the vast 
majority of the 400 possible dipeptide combinations in the CXXC active site. Our library 
size of about 4000 and the almost equal distribution of nucleotides in the mutants made it 




2.2.2 Identification of thioredoxin mutants that complement dsbA 
All the transformants generated from the random CXXC mutagenesis were replica- 
plated to plates containing 15 M CdCl2 to select for a dsbA
+
 phenotype. Cadmium is a 
toxic divalent metal ion
117
.  The high affinity of cadmium for protein thiol groups is 
believed to be the major biochemical basis of cadmium toxicity
118, 119
.  In bacteria, dsbA
—
 





to these free thiol groups and inhibits their proper folding
120, 121
. DsbA null strains are 
especially Cd
2+
 sensitive, failing to grow when exposed to 4 M Cd
2+
. In contrast, wild-
type strains are resistant to up to 400 M Cd
2+
. JP120 transformed with plasmid encoding 
wild-type thioredoxin showed only residual growth at 15 M Cd
2+
. This provides a 
powerful selection for the dsbA
+
 phenotype. By selecting for cadmium resistance in a 
dsbA
—
 strain, we expected to recover thioredoxin mutants that could at least partially 
substitute for DsbA. We obtained 231 colonies resistant to 15 M Cd
2+
 from the 4000 
mutant colonies screened. Sequencing of the plasmids contained in these strains revealed 
37 different combinations of amino acids present in the CXXC motif. We verified that 
the mutations present on the plasmids were sufficient for complementation of cadmium 
resistance by re-transforming the mutant plasmid DNA into the dsbA
—
 strain JP120. We 
classified the cadmium resistance of the various mutants, by plating different dilutions of 
mid-log phase cultures onto LB ampicillin plates containing various CdCl2 concentrations 
(Figure 2.1 and data not shown). The mutants were rank ordered from highest cadmium 
resistance to lowest.  To verify that the cadmium resistance of these thioredoxin mutants 
reflects their ability to oxidize proteins, we tested Cd
R
 isolates for their ability to restore 
motility, a phenotype characteristic of dsb
+
 strains. To be motile, E. coli must properly 
assemble its bacterial flagella, and to do this, a critical disulfide in the flagellar 
component FlgI must be introduced. Thus, dsb strains are nonmotile
122
. A good 
correlation exists (R=0.95) between the extent of motility and the degree of cadmium 
resistance (Figure 2.2). These results indicate that the thioredoxin mutants we had 







Figure 2.1 Thioredoxin active site mutants show various resistances to cadmium. 
Mid-log phase cells were normalized to A600=1. Serial dilutions of cultures from 10
0 to 10-4 were 
spotted on LB plates containing different concentration of cadmium. Cadmium resistance for 
each thioredoxin variant was ranked 1-7, from weak to strong, based on growth on LB ampicillin 
plates containing 7.5 M, 10 M and 15 M Cd2+ after 18h incubation at 37ºC. Only the 7.5 M 
Cd2+ plate is shown. The DsbA containing strain (ER1821, see strain list on page 48) showed the 
highest cadmium resistance and ranked 8. Variants are identified by their dipeptide sequence 
―XX‖ within the CXXC active site motif. AT is a dsbA-non-complementing thioredoxin mutant. 
 
Figure 2.2 Correlation of motility and cadmium resistance for thioredoxin mutants. 
Motility (% of dsbA strain) was plotted as a function of cadmium resistance (rank) for wild-type 
thioredoxin (wt) and 19 variants, including the non-complementing mutants RS, AT, HE, TA and 




2.2.3 Analysis of the dipeptide sequences in the CXXC motif of thioredoxin 
mutants 
We then analyzed the dipeptide sequences in the CXXC motif of the plasmids that 
confer a dsbA
+
 phenotype (Figure 2.3). We reasoned that the most cadmium resistant 
mutants were likely to survive the selection most often. We found a reasonable 
correlation (R=0.7) between the degree of cadmium resistance and the frequency at 
which mutants were obtained (Figure 2.4). Interestingly, for the more N-terminal position, 
the most frequently discovered amino acid is proline (65%), which was found about 16-
fold more frequently than the 4% frequency expected by chance (Figure 2.3). It is worth 
noting that proline is found in the corresponding position of E. coli DsbA and in many 
DsbA homologs (76%) (Table 2.1). Thus, there seems to be a very strong bias towards 
proline at the N-terminal position. For the more C-terminal position in the CXXC motif, 
we obtained basic (His, Lys, Arg) or aromatic amino acids (Tyr, Phe) most frequently 
(51% and 32%, respectively). Histidine, tyrosine and phenylalanine were respectively 
found 9, 9 and 4-fold more frequently than expected by chance. The expected frequency 
for arginine is high because it is specified by 6 codons; however, the observed frequency 
was still 1.7-fold higher than expected by chance (Figure 2.3). These observations clearly 
indicate the preference for basic or aromatic amino acids at the more C-terminal position, 
and are consistent with the frequencies observed in naturally occurring DsbA homologs 
(79% for basic and 13% for aromatic amino acids at the more C-terminal position) (Table 
2.1). Note that all these expected frequencies are what one calculates for the N- and C-
terminal positions independently. The observed frequencies for the dipeptide sequences 
of the complementing mutants are on average 18-fold higher than the dipeptide 




Figure 2.3 DsbA-complementing thioredoxin mutants CXXC active site motif with 
the sequence Cys-Pro-basic (or aromatic)-Cys. 
Twelve amino acids were obtained at the more N-terminal position (top) and 14 were obtained at 
the more C-terminal position (bottom). Frequencies are given as percent of total. Expected 
frequency of each amino acid was calculated by adding together the frequencies of each of the 
natural codons of that amino acid. These codon frequencies were calculated by multiplying the 
abundance of each single nucleotide (A 36%, T 20%, G 24%, and C 20%) that was observed in 




Figure 2.4 Correlation of cadmium resistance and observed and expected 
frequencies for the cadmium resistant thioredoxin mutants. 
Note that the expected frequencies for all the cadmium resistant mutants range from only 0.064% 
to 0.746%, are much lower than the observed frequencies. For the PH mutant, the expected 
frequency is 218 fold lower than the observed frequency. 
 
The mutant that most frequently survived the cadmium selection has the CPHC 
motif, observed in 58 out of 231 clones (25%), which is exactly the same CXXC 
sequence most frequently found in DsbA homologs in evolution. The expected frequency 
of this dipeptide in unselected clones is 218-fold lower. The short CPHC motif, which 
was optimized by evolution to work in DsbA, also seems to be optimized in conferring 
DsbA-like properties on thioredoxin, a protein that only shares 10% sequence identity 
with DsbA and is separated from DsbA by about 2 billion years of evolution
68
.  We find 





Table 2.1 Analysis of dipeptide sequences in CXXC motif of DsbA and thioredoxin 
mutants 
Amino acid in the more N-terminal 
positionin in CXXC (%) 
Amino acid in the more C-terminal 


















Proline 76 65 Histidine 79 27 
Arginine - 13 Tyrosine 8 26 
Lysine - 8 Arginine - 17 
Glycine 5 4 Lysine - 7 
Alanine 0.5 3 Phenylalanine 5 6 
Asparagine - 3 Asparagine 3 6 
Serine 6 1 Alanine 4 3 
Histidine 1 1 Serine - 3 
Glutamine 1 0.4 Proline 0.5 1 
Glutamic acid 1 0.4 Methionine - 1 
Threonine 1 0.4 Glycine - 1 
Tryptophan - 0.4 Leucine - 1 
Isoleucine 5 - Tryptophan 0.5 0.4 
Valine 3 - Glutamine - 0.4 
Leucine 1 -    
The frequencies of occurrence for each of the amino acids in the N- and C-terminal positions in 
the CXXC motif of DsbA homologs from 181 species are compared with the frequencies for our 
laboratory evolved thioredoxin mutants showing resistance to 15 µM cadmium. The frequency 
for each amino acid is presented as a percentage, with the amino acids listed in the order with 
which they were found in the lab evolved thioredoxin mutants. 
 
2.2.4 Kinetics of oxidation of thioredoxin mutants by DsbB in vitro 
 One trivial reason for the increased ability of our thioredoxin mutants to 
complement the dsbA
+
 phenotype might be an increased expression level or an increased 
fraction of the oxidized form. Neither of these was the case, as quantitative western blots 
showed that the expression levels of the different thioredoxin mutants are almost identical 
to each other and to the level of expression observed for wild type (0.53-1.1 fold of wild 
type). AMS trapping showed that all the thioredoxin mutants are in the oxidized state. 
33 
 
Our mutants are DsbB dependent in vivo as judged by their inability to allow 
bacterial motility in a dsbB
― 
strain (data not shown), suggesting that they are functioning 
by replacing DsbA in the periplasm.  It is possible that our thioredoxin mutants are active 
in oxidizing proteins because they can be effectively oxidized by DsbB. To test this idea, 
we evaluated the oxidation efficiency of different thioredoxin mutants by DsbB using the 
enzyme monitored turnover method described by Gibson et al. 
123
. This method utilizes 
the time course of the decay of an enzyme intermediate upon reaction with an excess of 
substrate in order to determine kcat and apparent Km values. A purple charge-transfer 
complex intermediate characterized by a strong absorbance peak at 510 nm is formed 
during the oxidation of DsbA by DsbB
88, 89
. Our experiments revealed that wild-type 
thioredoxin as well as its CXXC variants also induce an absorbance peak at 510 nm, 
which almost certainly corresponds to a very similar intermediate as is seen between 
DsbB and DsbA. We analyzed the enzyme monitored turnover absorbance curves at 510 
nm and used these data to derive Vmax and Km values for both wild-type DsbA and wild-
type thioredoxin and a large number of our thioredoxin mutants (Figure 2.5 and Table 
2.2). A Km of 14  1 M and a Vmax of 0.74  0.01 S
–1
 were obtained for the oxidation of 
wild-type thioredoxin by DsbB, similar to the previously published Km of 20  7 M
99
. 
Surprisingly, these values are very similar to those of DsbA for DsbB (8  1 M).  Thus, 
it appears that wild-type thioredoxin interacts with DsbB about as efficiently as DsbA 
does.  This reduced the likelihood that our mutants can achieve their increased activity by 
increasing their catalytic efficiency with DsbB. Indeed, within the group of active 
thioredoxin mutants the correlation between in vivo motility values and their catalytic 
efficiency with DsbB is very poor. For simplicity, we refer to our thioredoxin mutants 
using only the dipeptide sequence of the active site; thus, the mutant with the CPHC 
sequence is referred to as ―PH‖.  We do note however, that the PH mutant, which has the 
best motility, does have a much better catalytic efficiency, i.e. a higher Vmax/Km value 




Figure 2.5 Enzyme monitored turnover by stopped flow. 
A, Absorbance change at 510 nm upon mixing 80 µM DsbA or wild-type thioredoxin (wt Trx) 
with 10 µM DsbB and 200 µM Q1 in PND buffer at 10°C (see experimental procedures for 
details). B, V vs. [S] curves derived from traces in panel A by program A. The hyperbolic fits 













































DsbA - 100 8 - -121 8 0.31 0.041 2.0×106 3.8 
DsbA complementing mutants 
PH 25 45 7 4 -210 22 1.03 0.049 7.6×105 50.5 
PY 5.6 39 7 6 -197 7 0.09 0.014 ND 40.0 
PF 0.4 32 6 6 -197 4 0.07 0.016 ND 49.3 
PR 14 27 6 3 -203 121 2.19 0.018 2.4×105 12.1 
PK 6 24 5 3 -207 121 2.09 0.018 ND 15.0 
PS 2.6 21 4 6 -219 11 0.23 0.022 2.8×105 18.4 
RY 7.4 21 5 7 -215 5 0.21 0.036 ND 98.3 
PM 1.3 18 4 3 -216 21 0.41 0.020 ND 9.5 
GY 0.4 18 3 6 -220 4 0.15 0.035 ND 57.0 
GW 0.4 18 3 6 -220 7 0.21 0.033 ND 40.0 
WR 0.4 17 3 3 -215 105 4.80 0.041 ND 10.7 
KY 4.8 16 5 7 -214 10 0.51 0.051 1.6×106 79.1 
NY 1.3 14 3 6 -214 6 0.21 0.033 ND 53.2 
AY 3 14 3 7 -219 6 0.22 0.039 ND 47.0 
Non-complementing mutants 
RS 0 7 2 3 -225 43 0.92 0.022 ND 18.4 
TA 0 6 1 1 -236 - - - ND 1.0 
GP(wt) 0 5 2 6 -270 14 0.74 0.048 9.0×104 6.7 
AT 0 5 1 3 -224 - - - 3.4×104 1.7 
GG 0 5 1 3 -234 68 1.07 0.016 ND 6.1 
HE 0 3 1 6 -229 28 0.35 0.013 ND 5.4 
Results are shown for DsbA, wild-type thioredoxin and 19 thioredoxin active site variants studied 
by phenotypical assays and biochemical assays. From PH to AY are the DsbA-complementing 
thioredoxin mutants. A value of 0 of observed frequency indicated the mutants were non-
complementing. In the pool of DsbA non-complementing mutants, AT and TA are not 
measurably oxidized by DsbB so that the Km and Vmax values could not be determined. ND: not 
determined. 
 
Importantly, we tested the interaction of DsbB and five non-complementing control 
mutants (RS, TA, AT, GG, HE). No in vitro interaction can be detected between DsbB 
and AT or TA mutants. Thus, the inactivity of 40% of our mutants might be connected to 
their inability to interact with DsbB (Table 2.2).  In contrast, all of the motile mutants 
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tested are able to interact with DsbB to some degree.  Another trend we observed is that 
all the mutants with aromatic amino acids at the more C-terminal position had lower Km 
values (Table 2.2), while some of the mutants with a basic amino acid in this position had 
large Km values. This observation may indicate that the aromatic amino acid-containing 
mutants have a stronger tendency to form a substrate-enzyme complex with DsbB. 
Intriguingly, aromatic residues are also common in nature, found in 13% of DsbA 
homologs and are present in almost 100% of DsbC sequences. DsbC is E. coli’s principle 
disulfide isomerase
124
.  We concluded from these experiments that the ability to be 
reoxidized by DsbB is necessary but not sufficient for thioredoxin mutants to be able to 
complement DsbA. 
2.2.5 Measuring the redox potentials of thioredoxin mutants 
 One of the most prevalent hypotheses in the disulfide catalyst field is that the 
redox potential determines the function of thiodoxin-related thiol-disulfide 
oxidoreductases
71, 73, 75
. Thus, we determined the standard redox potentials of our 
thioredoxin mutants (Table 2.2).  We found that the complementing mutants all showed 
an increased redox potential relative to wild type thioredoxin (average increase of 58 
mV). On its own, this would help confirm that an increased redox potential is key in the 
ability of mutants to complement DsbA. However, in an important control experiment, 
we found that the five non-complementing control mutants also exhibited an increased 
redox potential relative to wild type thioredoxin. Although these were uniformly less 
oxidizing, the difference between the two groups was very small (Table 2.2). We 
observed a correlation between motility and redox potential for the complementing 
mutants (Figure 2.6). The more oxidizing the mutant, the better it is at complementing. 
The PH mutant is the most DsbA-like phenotypically, and not coincidentally, has the 
most DsbA-like sequence. However, with a redox potential of –210 mV, it is not the most 
oxidizing of the complementing mutants, which range from –220 to –197 mV. 
Importantly, it is only slightly more oxidizing than the non-complementing mutants, 
whose redox potentials range from –236 to –224 mV, or poorly complementing mutants 
like AY (–219mV) or NY (–214mV). Thus, while a more oxidizing redox potential may 
37 
 
be a prerequisite for allowing thioredoxin to functionally replace DsbA, it is clearly not 
the complete story. 
 
Figure 2.6 Correlation of standard redox potential (E°’) and motility for thioredoxin 
mutants. 
Curve was derived from 19 thioredoxin variants. Wild-type thioredoxin and DsbA were not used 
to calculate the correlation since their redox potentials are extremely low (for thioredoxin) or high 
(for DsbA). Note that the redox potential for the most motile thioredoxin mutant PH is not as high 
as other motile thioreodoxin mutants. 
 
2.2.6 Thioredoxin mutants have enhanced protein oxidation and isomerase activity 
in vitro and in vivo 
To obtain a more direct measure of the in vivo function of our thioredoxin mutants, 
we decided to examine how efficiently our thioredoxin mutants could oxidize substrate 
proteins in vitro. As a model substrate, we chose hirudin, a 65-residue protein with three 
disulfide bonds in the native state and a well-established model substrate for DsbA
125, 126
.  
This protein has a well studied disulfide linked in vitro folding pathway, it is 
commercially available, and the folding intermediates can be easily separated on HPLC. 
This is in contrast to the few known E. coli substrates for DsbC such as RNaseI, which 
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have none of these properties. To determine the rate at which our mutants oxidized the 
thiols in hirudin we followed their increase in the fluorescence that accompanies their 
incubation with reduced hirudin. A disulfide in the active site of thioredoxin acts to 
quench its tryptophan fluorescence
127
. The kinetics of the reaction are shown in Figure 
2.8, with the second order rate constants for the oxidation of reduced hirudin by DsbA, 
thioredoxin and its variants shown in the figure legend. The complementing mutants were 
3- to 11-fold faster at oxidizing hirudin than is wild type thioredoxin. A good correlation 
exists between these rate constants and their ability to restore motility in vivo, strongly 
suggesting that increased ability to oxidize proteins is crucial to their enhanced in vivo 
activity (Figure 2.7).  One of the mutants (KY) is actually nearly as fast as DsbA’s very 
rapid kinetics.  DsbA is known for its extremely fast disulfide exchange reaction rates, 
which are about 3 orders of magnitude above known values for mono and dithiols
84
. 
DsbA is also much more reactive than thioredoxin; for example, DTT reduces DsbA 
about 1000 times faster than it does thioredoxin
128
. We find it noteworthy that some of 
our mutants approach the very rapid disulfide exchange kinetics of DsbA. 
 
 
Figure 2.7 The second-order rate constants (k2) of hirudin oxidative folding reaction 




Figure 2.8 Kinetics of the oxidation of reduced hirudin by DsbA, thioredoxin, and 
its variants. 




) for the interaction of reduced hirudin and DsbA, 
thioredoxin, or its mutants were obtained by fitting the observed pseudo first-order rate constants 
(kobs; S
-1) against hirudin concentrations (M). The slopes are the apparent second-order rate 
constants for the reaction, and the values are as follows: DsbA, 2.0 × 106 M-1 S-1; KY mutant,   
1.0 × 106 M-1 S-1; PH mutant, 7.6 × 105 M-1 S-1; PS mutant, 2.8 × 105 M-1 S-1; PR mutant,             
2.4 × 105 M-1 S-1; thioredoxin (GP(wt), where wt is wild-type), 9.0 × 104 M-1 S-1; and AT mutant,                      
3.4 × 104 M-1 S-1. 
 
We then wanted to test if our mutants were more efficient than wild type 
thioredoxin in the overall oxidative folding of hirudin, a process that involves both 
disulfide oxidation and isomerization steps. We were very pleased to find that all the 
DsbA-complementing mutants exhibited an enhanced ability to oxidatively refold 
reduced hirudin. They were not only more efficient compared to wild-type thioredoxin 
but in a real surprise, were also faster compared to wild type DsbA, showing complete 
refolding of hirudin at time points where wild type DsbA is just getting started (Figure 
2.9 and Table 2.2).  We find this surprising because DsbA has presumably been 
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optimized for the oxidative folding of proteins over millions of years of evolution, yet by 
changing just two residues in a related protein we appear to have been able to isolate a 
mutant protein that is superior to DsbA in the oxidative folding of at least one protein. 
 
 
Figure 2.9 DsbA-complementing thioredoxin mutants fold reduced hirudin 
efficiently. 
Reduced hirudin (24 µM) was incubated with oxidized glutathione (200 µM) in phosphate buffer. 
Then catalytic amount of oxidized thioredoxin variants or DsbA (1 µM) were added to initiate 
each folding reaction (see experimental procedures for details).  Two hours after initiation, 
hirudin folding intermediates were separated by reverse-phase HPLC. The absorbance traces are 
aligned on the same time scale. Each trace is labeled by the catalyst added or by the name of the 
control. From left to right, the traces follow the order of decreased motility of the strains 
containing the corresponding thioredoxin variants or DsbA. The dashed lines indicate fully 
reduced (R) and native (N) hirudin. 
 
The oxidative refolding of reduced hirudin involves two processes, an initial 
oxidation reaction, followed by isomerization of incorrect disulfides to generate native 
hirudin. Our thioredoxin mutants were better than DsbA in overall oxidative folding of 
hirudin and not quite as good as DsbA in the initial oxidation step, leading us to predict 
that they had  isomerization ability that is superior to that of DsbA. 
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Using scrambled hirudin as a substrate we indeed found that our mutants can 
generate native hirudin from a disulfide scrambled hirudin substrate faster than can DsbA 
(Figure 2.10 A). Two of those tested (KY and PH) were very efficient, at least as 
effective as DsbC, the principle disulfide isomerase E. coli (Figure 2.10 A). This is 
surprising because the phenotype we selected for is the ability to complement DsbA (an 
oxidase) and not DsbC (an isomerase). We note that wild type thioredoxin does show 
some isomerase activity in vivo and in vitro, as has previously been reported 
129, 130
.  We 
note that scrambled hirudin is a very heterogenous substrate, consisting of at least 8 
different species that are separable by HPLC (Figure 2.10 A). The thioredoxin mutants 
are apparently capable of accelerating the isomerization of these different species, 
strongly implying that these mutants are active in the isomerization of a variety of 
substrates. 
To test if our mutants also have an improved ability to isomerize protein disulfides 
in vivo we tested if they could complement the copper sensitivity of null mutants in DsbC. 
Plasmids containing thioredoxin active site variants were transformed to the dsbC null 
strain BW25113 dsbC::kan. Copper can catalyze the formation of incorrect disulfides, 
including disulfide linked oligomers, which DsbC appears to be able to resolve
124
. Eight 
of the 14 of the active mutants we tested were either as copper resistant as dsbC
+
 strains 
or nearly as copper resistant.  This was in contrast to the 5 inactive mutants where all but 
one was no more copper resistant than the empty vector (which had a copper resistance 
rank of 3) (Figure 2.10 B, Table 2.2 and data not shown). Our mutants seem to act by 
both increasing their ability to oxidize and isomerize disulfides in proteins. 
 The mutants that seemed to show the best isomerase activity in vivo and in vitro 
are those with an aromatic or histidine amino acid in the C-terminal position of the 
CXXC motif (Table 2.2). (The side chain of histidine can also be considered aromatic; it 
meets the electron rule of aromatic amino acids in one of its protonation states.)  Previous 
work on the in vivo folding of a multi-disulfide protein in E. coli by DsbC mutants with a 
randomized CXXC central dipeptide suggested a strong preference for hydrophobic and 
particularly aromatic amino acids at the C-terminal position
111
. Our study found a higher 
average rate of hirudin refolding for mutants with aromatic amino acids in the active site 
than for those with basic amino acids. This result is consisten with our hypothesis that the 
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aromatic amino acid-containing active site dipeptide mutants of thioredoxin may function 
as disulfide isomerases. 
 
Figure 2.10 Thioredoxin active-site variants function as isomerases in vitro and in 
vivo. 
A. scrambled hirudin (21 µM) was incubated with equal amount of freshly reduced thioredoxin 
variants, DsbA, and DsbC in the ismomerization buffer (see experimental procedures for details). 
Five minutes after initiation, hirudin folding intermediates were separated by reverse-phase 
HPLC. N, native hirudin. DsbA-complementing thioredoxin mutants folded scrambled hirudin 
more efficiently than did DsbA; some were even comparable with DsbC. The non-
complementing AT mutant was worse than wild-type (wt) thioredoxin. B. thioredoxin mutants, as 
well as the wild type, conferred various copper resistances to a dsbC ¯ strain. Mid-log phase cells 
were normalized to A600=1. Serial dilutions of cultures from 10
0 to 10-6 were spotted on BHI plate 
containing 5mM CuCl2 . Copper resistance for each thioredoxin CXXC variant was ranked 1-7, 






In a process similar to natural selection, we identified amino acid combinations of 
the dipeptide in the CXXC motif of thioredoxin mutants that complement the oxidizing 
thiol-disulfide oxido-reductase DsbA. We show that this CXXC motif is a major factor in 
determining the function of the protein, in ways that go well beyond simple changes in 
the redox potential.   Our results closely recapitulate evolution. A strong preference was 
found for proline at the more N-terminal position of the motif and a basic or aromatic 
amino acid at the more C-terminal position, very similar to what is observed for natural 
DsbA sequences.  The CXXC sequence that best complemented DsbA deletion mutants 
was CPHC, exactly the same sequence that is most commonly found in natural DsbAs. 
This implies that the CPHC motif is optimal for conferring DsbA-like properties on both 
DsbA and thioredoxin, two proteins that share only 10% sequence identity. 
The spectrum of the CXXC sequences found in our lab-evolved thioredoxins is 
slightly broader than what is found in evolution.  In natural DsbAs, the only positively 
charged residue observed is histidine, while in our lab evolved DsbA-like thioredoxins 
the preference for positively charged residues is slightly more relaxed (His 27%, Arg 
17%, Lys 7%). In our lab-evolved mutants, a positively charged residue was observed in 
the more N-terminal position 20% of the time when there was no positively charged 
residue in the C-terminal position, possibly indicating that an N-terminal positively 
charged residue may substitute for a C-terminal one. 
In DsbA, the positively charged His32 residue is known to act to form a salt bridge 
with the thiolate anion of Cys30
77
. This stabilizes the reduced form of DsbA and thus 
contributes to some of the thermodynamic driving force behind DsbA’s oxidizing 
power
81, 110
. Our observation that thioredoxin mutants frequently possess a positively 
charged residue at the C- or N-terminal positions is further evidence that this electrostatic 
interaction is important in determining the functional properties of the thioredoxin-related 
proteins. The aromatic amino acids we found may also act by stabilizing the N-terminal 
thiolate anion, in this case by a sulfur-aromatic ring interaction
131, 132
.  The π-electron 
cloud on the faces of the aromatic ring is known to interact strongly with cations
133
, so 
the ring edges are relatively positively charged and capable of interacting with negatively 
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Our results suggest that proline is strongly favored as the N-terminal amino acid in 
the CXXC motif. This was unexpected as we know of no prior evidence implicating the 
importance of proline at this position.  We reason that proline at the more N-terminal 
position may be important due to effects on the local conformation near the active site. 
The active site CPHC motif for DsbA is located at the N-terminus of the 1-helix, and 
proline tends to break helices. The positive dipole that occurs at the N-terminal end of the 
1-helix is thought to contribute to the oxidizing power of DsbA
136, 137
. The interaction 
between the N-terminal thiolate anion in the CXXC motif and the -helix dipole appears 
to be very sensitive to the microenvironment at the helix terminus
138, 139
. The precise 
positions of the proline may be important in breaking the helix and in generating the 
appropriate geometry for such an interaction. 
The efficiencies of selected thioredoxin mutants were studied in vitro; the 
interaction with their oxidant DsbB, and with a substrate protein hirudin, as well as their 
redox potentials are also determined. All DsbA-complementing thioredoxin mutants have 
increased redox potentials as expected, since an increased redox potential ensures that the 
thioredoxin mutant will pass the threshold to be an effective oxidant.  However, all five 
non-complementing mutants tested also exhibited increased redox potentials, strongly 
suggesting that an increased redox potential is not sufficient for making thioredoxin 
DsbA-like in function. That both complementing, and non-complementing mutants have 
a redox potential more oxidizing than thioredoxin is, upon reflection, not surprising; the 
function of thioredoxin in the cell is to reduce disulfides, so its sequence is likely to be 
optimized for this function.  Random mutagenesis usually leads to a decline in a protein’s 
structure and function and thus in the case of thioredoxin will be expected to move 
thioredoxin’s redox potential in a less reducing direction, towards the reducing power 
present in a minimally structured peptide. Consistent with this, the redox potentials of our 
mutants are similar to the –230 mV value observed for a CAAC motif in an α-helical 
peptide free in solution
140
. Thus, a more oxidizing redox potential, though probably 
necessary for thioredoxin mutants to complement DsbA, cannot be the only requirement. 
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The interactions of DsbA with substrate proteins and the reoxidant DsbB are 
important components of DsbA’s catalytic cycle. Surprisingly, our data did not establish 
a correlation between the efficiency of interaction with DsbB and the ability to 
complement DsbA. In fact, wild type thioredoxin interacts with DsbB about as efficient 
as does DsbA, indicating that interacting with DsbB may not be the rate limiting step in 
the catalytic cycle. However, we did observe that more rapid interaction with DsbB does 
help to improve the catalytic efficiency of the reoxidation reaction.  This was seen for the 
CPHC mutant, whose relatively high efficiency of interaction with DsbB compensates for 
its only moderately oxidizing redox potential, making it a very strongly DsbA-
complementing mutant. Although it is not a rate-determining step, abolishment of the 
interaction of thioredoxin variants with DsbB abolishes the whole catalytic cycle, 
resulting in the inability of several mutants to complement DsbA (AT and TA mutant). 
We found that all of the DsbA complementing mutants exhibited an enhanced 
ability to oxidatively refold reduced hirudin compared to wild type thioredoxin. 
Surprisingly, we found that the majority of the DsbA complementing mutants are better 
at isomerizing scrambled hirudin than is DsbA and these isomerase activities can occur in 
vivo. The observation that our mutants selected on the basis of complementing DsbA 
function in vivo had increased isomerase activity raises the interesting possibility that 
DsbA has more isomerase function in vivo than previously thought.  Although most of 
the in vivo and in vitro work on DsbA has emphasized its oxidase activity, it does exhibit 
measurable levels of isomerase activity in vitro
141
.  Copper (II) apparently acts as a 
nonspecific oxidant in vivo, generating large numbers of nonspecific disulfides, including 
disulfide linked dimers and multimers
124
.  Mutants in the gene for DsbC, which is thought 
to be E. coli’s principle isomerase, are copper sensitive, presumably because dsbC¯ 
strains are deficient in their ability to reshuffle these incorrect disulfides.  It is interesting 
to note, however, that dsbA¯dsbC¯ double mutant strains are even more copper sensitive 
than dsbC¯  strains implying that DsbA and DsbC both participate in correcting the 
incorrect disulfides generated by copper
124
.  Our finding that thioredoxin mutants that 
rescue DsbA null mutant phenotypes show enhanced isomerase activity is consistent with 
the notion that one of the properties that they are rescuing is isomerase activity.  A 
number of the mutants selected on the basis of DsbA complementation, appear by our 
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tests to have thiol-disulfide oxidase activity in vitro as efficient as DsbA and isomerase 
activity in vitro as efficient as DsbC.  If one thioredoxin related protein can ―do it all‖ 
then why has evolution chosen to evolve both a DsbA based oxidation pathway and a 
DsbC based isomerization pathway?  We do not have a clear answer to this question, but 
in general, multigene families are thought to have evolved to address questions of 
substrate specificity.  We note that in the in vivo tests for oxidation and isomerization of 
our thioredoxin mutants, though they showed considerable activity, were not as efficient 
as is wild type E. coli.  We also note that nature has chosen to give wild type DsbA an 
extremely oxidizing redox potential of E°’ of –121mV.  Although the CXXC motif is 
important in determining the redox potential of thioredoxin related proteins, it is unlikely 
to be the sole determinant.  Thus, mutations in thioredoxin that are restricted to altering 
this motif, as ours were, are unlikely to be as effective as DsbA in oxidizing dithiols. 
Despite almost 45 years of work on protein disulfide isomerases, surprisingly little 
is known about the in vivo requirements for disulfide isomerization. It is known that 
dimerization of two thioredoxin domains enhances disulfide isomerization activity
142, 143
. 
During the purification, different thioredoxin mutants eluted at approximately the same 
position as wild-type thioredoxin (monomer) on the gel filtration column, indicating it is 
unlikely that our thioredoxin mutants are dimers.  It also seems likely that the redox 
potential of the isomerase is important for its function. The mechanism of isomerization 
requires that the isomerase functions as both an acceptor and a donor of disulfides; thus, a 
priori one would expect the redox potential of the isomerase to be finely balanced so that 
it can both accept and donate disulfides. Consistent with this notion, our thioredoxin 
mutants do have a redox potential intermediate between the strongly oxidizing redox 
potential of DsbA and the relatively reducing redox potential of thioredoxn, and the redox 
potential does seem to be important in their mechanism. 
A selection for mutants in thioredoxin that complement null mutations in protein 
disulfide isomerase performed in yeast yielded mutations with a redox potential more 
oxidizing than that of the original thioredoxin
75
; however, it now appears that the 
sulfhydryl oxidation, not disulfide isomerization, is the principal function of protein 
disulfide isomerase in yeast
144
.  This probably explains why more oxidizing mutants were 
obtained using this selection. It is interesting to note that in their selection, as well as in 
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ours, only a very limited range of mutants that allowed complementation were obtained. 
Interestingly, they also found that an aromatic residue (in their case tryptophan) worked 
well to cause thioredoxin to have isomerase activity in vivo. These results suggest that 
there are very specific sequences for good isomerase function that go beyond having the 
appropriate redox potential. 
Overall, we conclude that at least three properties are required for a thioredoxin 
mutant to complement DsbA: an increased redox potential, the ability to be efficiently 
oxidized by DsbB, and the ability to oxidize substrate proteins. An increased redox 
potential seems to be the prerequisite. The other two properties, on the other hand, if 
missing, will abolish the ability to complement DsbA. The two properties sometimes can 
even compensate for relatively ―low‖ redox potential and make the mutant protein very 
active in vivo. The total efficiency as an oxidant is a good combination of the three 
aspects. 
Our work further establishes the vital importance of the CXXC residues in 
determining the functional properties of thiol-disulfide oxidoreductases of the thioredoxin 
superfamily. Remarkably, the short motif, which was optimized by evolution to work in 
DsbA; also seems to be optimized in conferring DsbA-like properties on thioredoxin, a 
protein separated from DsbA by more than 2 billion years of evolution. The ability of two 
amino acids to confer properties of one enzyme or another shows the great importance of 
these residues. In contrast to current thinking, this importance is not limited to the effect 
these changes have on the redox potential of the protein, but our work shows that these 
residues have important effects on interactions both with folding proteins and the 
reoxidant DsbB and on the ability of the protein to participate in disulfide isomerization 
reactions. We were surprised to find that thioredoxin mutants selected on their ability to 
complement the oxidizing thiol-disulfide oxidoreductase DsbA, turned out to be much 
more efficient in isomerizing disulfides than is DsbA, some were even as efficient as is 
DsbC, E. coli’s principle disulfide isomerase. 
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2.4 Experimental procedures 
2.4.1 Strains and plasmids 
The strains and plasmids used in the present study are listed in Table 2.3. 
Table 2.3 Strains and plasmids used 
Strain or plasmid Genotype or relevant characteristics Source 
Strains    
ER1821 
F—  glnV44  e14—  (McrA—) rfbD1 relA1 
endA1 spoT1 thi-1 (mcrC-mrr)114::IS10 
New England Biolabs 
JP120 ER 1821 dsbA::kan1, zih12::Tn10 Lab collection 
IS13 JP120, pssTRX This study 
JP373 ER1821, pKK233-2 Lab collection 
WP591 DHB4, trxA Ref. 
115 
BW25113, dsbC::kan 
rrnB3  ΔlacZ4787  hsdR514  Δ(araBAD)567 
Δ(rhaBAD)568  rph-1  dsbC:: kan 
From Keio collection 
Plasmids   
pssTRX 
pASK40-ss-trxA, thioredoxin exported via the 
DsbA signal sequence 
Ref. 99 
pKK233-2 Cloning vector, pBR322 origin, AmpR Pharmacia 
All strains used were derivatives of E. coli K-12 strains.  
2.4.2 Alignment of DsbA sequences 
 To identify homologs of DsbA in different bacteria, the nonredundant (nr) 
database at NCBI was searched with the E. coli K12 DsbA protein sequence (accession 
no. CAA56736 [GenBank]) using the PSI-BLAST algorithm with a threshold of 0.005. 
We used four rounds of iterations. DsbA family members can be distinguished from other 
thioredoxin family members because they contain an -helical structural motif absent 
from other thioreodoxin related proteins, such as DsbC, DsbD, DsbG and thioredoxin 
68
. 
All sequences were checked to verify that they contain sequences homologous to this -
helical domain. When sequences were available from multiple strains, one set of 
sequence data was chosen to represent that species. For paralogs existing in the same 
organism, we chose the sequence most homologous to the E. coli DsbA query sequence 
based on blast E values. In this way, nearly all of the sequences chosen are likely to be 
sequences of DsbA orthologs. Final alignment of the active site dipeptide sequences of 
DsbA homologs was done based on the sequences from 101 genera and 181 species. 
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2.4.3 Cloning and phenotypic assays 
 Construction of thioredoxin mutant library: The thioredoxin plasmid pssTRX 
with the DsbA signal sequence for periplasmic expression was a gift from R. 
Glockshuber. It was constructed by replacing the DsbA sequence in plasmid pDsbA3 
with the thioredoxin sequence at NheІ and BamHІ restriction sites
99
. This plasmid was 
randomly mutated with the Quickchange Multi Site-Directed Mutagenesis Kit 
(Stratagene) to obtain mutations in the dipeptide in the CXXC motif of thioredoxin. The 
primer used to construct the mutant collection has six degenerate nucleotides for the 
dipeptide (Primer sequence as 5’ 
TCGATTTCTGGGCAGAGTGGTGCNNNNNNTGCAAAATGATCGCCCCGATT 3’). 
Thermal cycling reaction was performed as directed; the product digested with DpnI, and 
precipitated using the DNA Pellet Paint Co-precipitant (Novagen). The precipitated DNA 
was electroporated into 50 l E. coli JP120 electrocompetent cells. Transformants were 
plated on Luria Bertrani (LB) plates supplemented with 200 g/ml ampicillin and 
incubated at 37 °C for 14 h. Colonies obtained after electroporation were replicated using 
sterile filter papers (Whatman) onto LB plates supplemented with 15 M CdCl2 and 200 
g/ml ampicillin at 37 °C for 18 h. Strains were classified by their resistance to cadmium. 
The plasmids that conferred cadmium resistance in dsbA
—
 strains were isolated via a mini 
prep kit (Promega) and the trxA genes encoded by those plasmids were sequenced. 
 Spot titers for cadmium resistance and copper resistance: Spot titers were 
performed to quantify the relative cadmium or copper resistance caused by the dipeptide 
change at the active site. Briefly mid-log phase cells (OD600  1) were serially diluted in 
sterile 170 mM NaCl solution. 2 l of each dilution was plated onto LB plates 
supplemented with 200 g/ml ampicillin and CdCl2 in a concentration of 7.5 M, 10 M 
or 15 M or onto BHI (Brain Heart Infusion) plates containing 5 mM CuCl2. After 18 h 
at 37 °C, the growth of each thioredoxin mutant was compared and the cadmium or 
copper resistance of each of the thioredoxin mutants was ranked 1-7, with higher values 
indicating increased resistance. 
 Motility assay: The motility assay was performed in M9 minimal soft agar plates 
(0.2%) supplemented with 18 amino acids (excluding cysteine and methionine), 0.4% 
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glycerol, 2 g/ml nicotinamide, 0.2 g/ml riboflavin B2, 2 g/ml thiamine B1, 2 g/ml 
biotin, 1 mM MgSO4 and with the appropriate antibiotic. Mid-log phase liquid cultures 
were diluted based on the optical density (OD) at 600 nm to normalized cell density for 1 
OD. 2 l of cells were then inoculated into the center of the motility plate. After 20 h 
incubation at 37 °C, the diameter of the swarm was measured. 
2.4.4 Biochemical and biophysical assays 
 Protein purification: Thioredoxin variants were expressed and purified in the 
periplasm of  a trxA
—
 strain WP591 as previously described
72, 99
. Protein concentrations 









 for oxidized wild-type 
thioredoxin. The extinction coefficients for thioredoxin mutants were calculated using the 
online program ProtParam (http://ca.expasy.org/tools/protparam.html)
145
. 
 AMS trapping: To examine the redox states of the thioredoxin mutants, acid-
precipitated proteins were solubilized in buffered sodium dodecyl sulfate (SDS) solution 
containing 4-acetoamido-4'-maleimidylstilbene-2,2'-disulfonate (AMS) as described 
previously
146
. The samples were incubated in the dark at 37°C for 1 hour. The alkylation 
was stopped by adding SDS-nonreducing loading buffer and analyzed by electrophoresis 
and western blotting. 
 Kinetics study for the interaction with DsbB by stopped flow: Stopped flow 
absorbance measurements were performed on a Hi-Tech Scientific SF61 instrument (1.0 
cm path length) in single-mixing mode. The typical reaction contains around 100 M of 
freshly reduced thioredoxin variants, 10 M DsbB and 200 M ubiquinone-1 (coenzyme 
Q1; Sigma). Thioredoxin variants and a DsbB/Q1 mix were incubated in PND buffer (50 
mM Sodium Phosphate, 300 mM NaCl, 0.04% dodecyl maltoside, pH 8.0) at 10 °C 
before mixing. The absorbance after mixing was recorded at 510 nm. One data set 
contains three to four successive shots. Each trace from the enzyme monitored turnover 
experiment were simulated separately according to ref. 
123
 using Program A (developed 
by Chung-Yen Chiu, Rong Chang, and Joel Dinverno under the direction of David P. 
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Ballou, University of Michigan
147
). The resulting data was further fit by SigmaPlot using 
the Michaelis-Menten equation to give the value of Km and Vmax. 
 Redox potential measurement: Proteins whose redox potentials were to be 
measured were incubated with the gamma domain of DsbD, a protein of known redox 
potential, –235 mV 
148
 . At equilibrium, different protein species were separated by 
reverse-phase HPLC and the equilibrium constant (Keq) of the reaction and the standard 
redox potential (E
o
’) of the protein were determined as described 
149
. For the mutants 
whose reduced and oxidized peaks could not be fully separated from either reduced or 
oxidized peak of γDsbD, the equilibrium constants with glutathione were measured as 
described
72
. A value of –240 mV was used for the standard redox potential of glutathione 
at pH 7.0 to calculate the standard redox potentials of the thioredoxin variants
150
. 
 Oxidative folding of hirudin: 24 M reduced hirudin and 200 M oxidized 
glutathione were incubated in 100 mM sodium phosphate buffer containing 1 mM 
EDTA, pH 7.0, at 25 °C. Oxidized thioredoxin variants were added at a catalytic 
concentration of 1 M to initiate each folding reaction. Aliquots of 120 l were removed 
after different reaction times and quenched with 15 l formic acid and 15 l acetonitrile. 
Hirudin folding intermediates were separated by reverse-phase HPLC on a C18 column at 
55 °C in a 19-25% acetonitrile gradient in 0.1% (v/v) trifluoroacetic acid. The absorbance 
was recorded at 220 nm. 
Stopped flow fluorescence measurements were performed on a KinTek SF-2004 
instrument in single-mixing mode. The typical reaction contains 0.5 M of oxidized 
protein (DsbA, thioredoxin and its variants) and 2.5, 5, 7.5 and 10 M reduced hirudin, 
respectively. The oxidized proteins and reduced hirudin were incubated in 100 mM 
sodium phosphate buffer containing 1 mM EDTA, pH 7.0 at 25 °C before mixing. An 
excitation wavelength of 295 nm and a Bandpass filter were used to monitor the 
fluorescence change of the proteins. Each stopped-flow trace was fit to a single 
exponential according to the equation: )1( tkobso eFFF , where F is the 
fluorescence emission at known times; Fo is the fluorescence emission of completely 
oxidized protein and ΔF is the difference between the fluorescence emission of 
completely reduced and oxidized protein. kobs is the peudo first-order rate constant. 
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Different kobs’s are plotted against hirudin concentrations. The slope is the observed 
second-order rate constant of the reaction. 
 Isomerization of scrambled hirudin: 21 M scrambled hirudin and 21 M freshly 
reduced protein (DsbC, DsbA, thioredoxin and its variants) were incubated in the 
isomerization buffer (20 mM sodium phosphate, 130 mM sodium chloride, 0.13% 
polyethylene glycol 8000) at 25 °C. Aliquots of 120 l were removed after different 
reaction times and quenched with 15 l formic acid and 15 l acetonitrile. Hirudin 





Chapter 3  
Genetic selection designed to custom tailor the in vivo folding environment 
uncovers a chaperone called Spy
‡
 
Abstract: Proteins are often unstable. Although much is known about protein 
folding in vitro
151
, how proteins fold and function in the cell remains an unanswered 
question of fundamental importance
152
. To optimize the in vivo folding of proteins, we 
linked protein stability to antibiotic resistance
102
, thereby forcing bacteria to effectively 
fold and stabilize proteins. When we challenged Escherichia coli to stabilize a very 
unstable protein, it responds by massively overproducing a small protein called Spy, 
which increases the level of unstable proteins up to nearly 700-fold. In vitro studies 
demonstrate that Spy functions as a very effective ATP-independent chaperone that 
suppresses protein aggregation and aids protein refolding. Our strategy opens up new 
routes for chaperone discovery and the custom tailoring of the in vivo folding 
environment.  The crystal structure of Spy shows it to be an alpha helical protein that 
                                                 
‡ This chapter is adapted from a manuscript ―Genetic selection designed to stabilize proteins 
uncovers a chaperone called Spy. Quan, S., Tapley, T., Koldewey, P., Kirsch, N., Ruane, K., Pfizenmaier, 
J., Shi, R., Hofmann, S., Foit, L., Jakob, U., Xu, Z., Cygler, M. & Bardwell, J.C.A. Submitted‖. JCAB 
designed and supervised the project. I performed a large number of the experiments in this manuscript, 
including setting up the dual selection system, mutagenesis and selection, identification of Spy, 
quantification of Im7 and Spy levels, identification of Δspy phenotype, and some of the in vitro chaperone 
activity assays. I contribute exclusively to Figs 3.1-3.9, Fig 3.11 and Tables 3.1-7 in this chapter and 
partially to Figs 3.10, 12, 13, and Fig 3.15. Other figures were prepared by TT, PK, MC, ZX and JCAB. TT 
and PK performed most of the in vitro activity assays (Figs 3.12, 13). TT and T.Franzmann performed 
analytical gel filtration and ultracentrifugation experiments (Fig 3.14). PK performed the casein binding 
and fluorescence anisotropy experiments (Fig 3.15). MC, KR and RS crystallized Spy. JCAB, MC and ZX 
analyzed the structure (Fig 3.16). JCAB analyzed Spy homologs (Fig 3.17). NK helped to analyze Im7 
expression and made some strains and tested initial condition for chaperone assays. JP helped to search for 
phenotype and made some strains. SH helped with some spot titer experiments. UJ and LF gave technical 
support and conceptual advice. JCAB wrote the manuscript and I contributed. 
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forms cradle-shape dimers with highly apolar concave surface unlike the structure of any 
previously solved chaperone. We propose a model for Spy action where it binds the 
exposed hydrophobic segments of unfolded proteins on the concave side of the cradle, 
with the flexible N terminus providing additional contacts.  Spy appears to represent the 
prototypical member of a new class of small chaperones that facilitate protein refolding 
in the absence of energy cofactors.  
 
3.1 Introduction 
The folding of many proteins is assisted by molecular chaperones and other folding 
helpers in the cell
153
. Many chaperones act by inhibiting off pathway events, such as 
aggregation and serve a broad range of substrates in a stoichiometric manner. In vitro 
assays for chaperone activity are thus almost by necessity, relatively insensitive, making 
these assays more useful in studying previously identified chaperones than in identifying 
new chaperones in crude cell lysates. Instead of being discovered directly because of their 
capacity to assist in in vivo protein folding, many chaperones were initially characterized 
because of their induction by stress conditions
154
. The lack of a sensitive and general in 
vivo assay for chaperone activity led us to wonder how complete the list of known 
chaperones is.  
Previously, our laboratory developed a genetic system that directly links increased 
protein stability to increased antibiotic resistance, which provides a selectable and 
quantitative in vivo measure of protein stability
102
. We reasoned that this system might be 
used to directly select for bacterial variants with improved protein folding characteristics, 
and in doing so, uncover new chaperones.  The selection system makes use of a tripartite 
fusion between -lactamase and unstable proteins, which effectively links the stability of 
the inserted proteins to the penicillin resistance of the host strain. Previously it has been 
shown by our laboratory that -lactamase tolerates the insertion of a well-folded protein 
in a surface loop of -lactamase at amino acid 197, and still retains enzymatic activity
102
. 
However, insertion of unstable proteins in this site negatively affects -lactamase activity 




. This strategy allowed easy selection 
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 Now we hypothesized that a similar strategy might actually be used to select for 
host variants that alter the in vivo folding environment of individual proteins by 
enhancing specifically or generally protein folding or stability.  We report here the 
development of an enhanced dual selection strategy based on the simultaneous use of two 
selectable markers, β-lactamase and DsbA.  Both of the two markers provide readouts for 
in vivo protein folding/stability.  We thought that this strategy might provide a direct 
route toward chaperone discovery, since historically, chaperone coexpression has often 
been used to enhance the expression of unstable proteins
155
.   Considering our system 
functions in the periplasm, it also may provide an opportunity to explore protein folding 
in what has generally been considered to be a relatively chaperone poor environment.   
Upon selection for host variants that stabilized a very unstable Im7 mutant, we 
obtained host variants that massively overproduce a previously not well characterized 
protein called Spy, which increases the expression level of unstable proteins up to nearly 
700-fold. In vitro studies demonstrate that Spy functions as a very effective ATP-
independent chaperone that suppresses protein aggregation and aids protein refolding.  
We obtained the crystal structure of Spy and found it to be the founding member of a new 



















Figure 3.1 Overall experimental scheme 
Fusion constructs that link the stability of the poorly folded Im7 protein to penicillin resistance 
(bla::Im7) and to cadmium resistance (dsbA::Im7) were introduced into the same E.  coli strain. 
Following host chromosomal mutagenesis by ethyl methanesulfonate (EMS) treatment, mutants 
that simultaneously enhance both penicillin and cadmium resistance were selected.  The goal is to 
find host variants that stabilize Im7.  Levels of Im7 (with or without a fusion context) present in 
these strains were measured.  The mutants were found to massively increase levels of Im7 and a 
host protein called Spy. Genetic experiments showed that increased Spy levels are necessary and 
sufficient to increase Im7 levels.  The Spy protein was examined for molecular chaperone activity 
in vitro and found to be highly effective as a chaperone in preventing protein aggregation and 
aiding in refolding. 
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3.2 Results  
3.2.1 Design of a dual tripartite fusion system to select for optimized protein 
folding in vivo 
We designed a dual selection system whereby the same unstable test protein is 
inserted into the middle of two resistance markers. As the first selectable marker, we used 
our previously established -lactamase system (Figure 3.2 a). As a second selectable 
marker, we constructed tripartite fusions with DsbA, a periplasmic protein that catalyzes 





3.2 b). Similar to the -lactamase system, the DsbA system only confers resistance of the 
bacteria towards cadmium when the test protein inserted into DsbA folds properly. 
 
Figure 3.2 A dual fusion selection for enhancing in vivo protein stability 
a, Unstable/poorly folded  test proteins inserted into β-lactamase are degraded by cellular 
proteases producing penicillin sensitive (PenVS) strains. Improving the folding of the test proteins 
so that they fold into stable strucutures increases penicillin resistance (PenVR)102. This part of the 
figure is modified from Fig.1 in ref. 102. b, Insertion of unstable test proteins into DsbA renders 
the strains expressing the fusion proteins sensitive to cadmium (CdCl2
S
). Improving the folding of 




These two markers provide an independent measure of the folding/stability of the 
inserted protein and should avoid intrinsic antibiotic resistant mutations that are irrelevant 
to protein folding (Figure 3.3). In strains that co-express both tripartite fusions, we 
reasoned that host mutations that simultaneously increased penicillin V and cadmium 
resistance would likely be positively affecting the only property that these markers appear 
to have in common; namely, the stability of the inserted protein.  
 





Bacteria develop intrinsic drug resistance by changing the membrane permeability to decrease the 
drug uptake, by enzymatic inactivation of drugs, by target modification, and by active export of 
drugs. Chromosomal mutations contributing to penicillin resistance include mutations in the 
penicillin target, cell wall transpeptidases (PBPs),  and in proteins constituting the efflux system 
for β-lactam antibiotics,  such as AcrAB-TolC156.  Mutations involved in conferring cadmium 
resistance are less characterized. Such mutations probably include mutations leading to 
overexpression of cytoplasmic GSH which quenches the toxicity of cadmium by binding to it,  
and the heavy metal transporters, ZntA and ZitB157, which pump cadmium out from the 
cytoplasm. There are few overlapping mechanisms for bacteria to acquire intrinsic PenV and 
cadmium resistance. However, precautions must be taken when analyzing the phenotypes because 
it was hypothesized that both PenV and cadmium enter the periplasm through the outer 
membrane porins, OmpF and OmpC158, 159. One can imagine that mutations decreasing the levels 
of these porins might increase bacterial resistance to PenV or cadmium. Accordingly, I confirmed 
the absence of such mutations when I analyzed the mutant strains as I describe in the following 
chapters. (qRT-PCR experiment showed that the mRNA levels of OmpC and OmpF in mutant 
strains were not significantly different from the levels in wild type strains (Table 3.4 on page 
74).) PenVR: penicillin V resistance; CdR: cadmium resistance. 
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We first needed to identify a site within DsbA that could tolerate insertions and 
where the stability of the inserted protein affected the activity of DsbA. To identify a site 
within DsbA that might tolerate protein insertions, we examined positions in DsbA that 
can tolerate circular permutation
160
, as the two events impose similar requirements on the 
structure of DsbA. In circular permutations, the N- and C-termini of a protein are fused 
and new termini are created. A variant of DsbA that is circularly permuted at amino acid 
T99 (Q100-T99) has very similar enzymatic properties and structure compared to wild-
type DsbA
160
. We found that amino acid T99 of DsbA tolerated insertion of a 30-amino 
acid serine glycine linker. Thus, we inserted our test proteins into the linker we had 
inserted at amino acid T99 (Figure 3.4). 
Immunity protein 7 (Im7) is a ~10 kDa helical protein with a well characterized 
folding pathway
161
. It binds endonuclease colicin E7 and inhibits the bactericidal activity 
of E7, allowing bacteria producing E7 to survive
162
. Insertion of variants of Im7 into 
amino acid T99 of DsbA revealed an excellent correlation between cadmium resistance 
and Im7 variant stability (Figure 3.5 b). A similar correlation between PenV resistance 
and protein stability was previously shown when variants of Im7 were inserted into β-
lactamase
102
 (Figure 3.5 a). Cadmium resistance also correlated well with penicillin 
resistance when these same Im7 variants were inserted into β-lactamase (Figure 3.5 c). 
The highest resistance to both antimicrobials came from the most s Im7 variants. These 
results suggested that host variants that act to improve the folding of Im7 and stabilize it 
should increase both penicillin and cadmium resistance and thus should be easily selected 





Figure 3.4 DsbA tolerates insertions at amino acid T99 
In circular permutations, the original N- and C-termini of a protein are fused and new termini are 
created. We reasoned that if DsbA can tolerate circular permutation, it may also tolerate protein 
insertion at the same position as where it is circularly permuted, as the two events impose similar 
requirements on the structure of DsbA. a, Variants of DsbA that are circularly permuted at amino 
acid T99 (Q100-T99) are very similar in enzymatic properties160 and in structure to wild-type 
DsbA, as seen by comparing the right and left structures in panel (a). b, Diagram of the protein 
construct (named DsbA::GSlinker) obtained by inserting a 30-amino acid glycine-serine linker 
(GGGS)2SS(GS)4(GGGS)2 at position T99 in a pBAD33 plasmid-carrying wild type DsbA. c, 
The phenotypes of the pBAD33dsbA::GSlinker construct were almost indistinguishable from a 
wild-type pBAD33dsbA clone in two tests of DsbA activity: cadmium resistance (top), and 
bacterial motility (bottom). The spot titer experiment for cadmium resistance was performed as 
described in methods in Chapter 3. The motility assay was performed as described in 
experimental procedures in Chapter 2, except for the addition of 0.2% arabinose into the media to 






Figure 3.5 Antimicrobial resistance correlates with stability of Im7 variants. 
a, Thermodynamic stability (given as ΔΔG0 relative to wild type Im7 and was determined by urea 
titration as described in Ref. 102) of Im7 protein variants  is highly correlated with the in vivo 
Penicillin resistance of tripartite β-lactamase fusions containing these variants [given as minimal 
inhibitory concentration (MIC) of PenV for variants relative to MIC for wild-type]. This part of 
the figure is adapted from Fig.4 in Ref. 102.  Red dots represent the published destabilizing Im7 
variants; blue dots represent the selected Im7 variants on the basis of their increased PenV 
resistace 102. b, Thermodynamic stability of Im7 protein variants102 is correlated with the MIC of 
cadmium of cells expressing the tripartite DsbA fusions containing these variants. c, Penicillin 
resistance of cells expressing the β-lactamase-Im7 fusion proteins correlates well with their 
cadmium resistance when they also express the DsbA-Im7 fusion proteins with the same Im7 




3.2.2 Selection to identify mutants that simultaneously increase penicillin and 
cadmium resistance 
With the dual selection system, we decided to search for host mutations that enable 
the proper folding of  Im7-L53AI54A, a very unstable Im7 variant
163
. We randomly 
mutagenized strain SQ1306, which contains the DsbA-Im7-L53AI54A fusion and the 
β-lactamase-Im7-L53AI54A fusion, with the mutagen ethyl methanesulfonate (EMS). 
We selected first for variants with enhanced penicillin resistance, and then screened these 
variants for enhanced cadmium resistance. Several precautions were taken to reduce the 
probability that any increased resistances observed were due to factors such as simple 
reversion of the destabilizing mutations, transcriptional changes, plasmid copy number 
alterations, toxin resistance, or fusion specific effects. These included cloning the Im7 
L53AI54A mutant under the control of two different promoters (β-lactamase promoter 
and pBAD), on plasmids with different copy number control mechanisms (pBR322 and 
p15A origin of replication), and using two different resistance markers in two different 
fusion contexts. 
Plate screens revealed that about 12% of our PenV resistant strains had 
simultaneously acquired resistance to 0.5 mM CdCl2. Ten independently isolated mutant 
strains (EMS1-EMS10) that were resistant to both PenV and CdCl2 were selected for 
further analysis. The strains generated in this study are listed in Table 3.6 on page 92. 
Eight of these ten host variants contained elevated levels of the tripartite β-lactamase Im7 
fusion protein (Figure 3.6) measured by western blot of total cell lysates. EMS4 and 
EMS9, containing the highest amount of the tripartite fusion protein and being resistant to 
high concentrations of both PenV and cadmium, were chosen for further analysis. Since 
preparation of the total cell extracts involved solubilization by boiling in a solution 
containing 2% SDS, this procedure is designed to measure the total amount of 
-lactamase fusion protein present in the cells, including both soluble and insoluble 
protein. This is in contrast to the periplasmic extracts prepared for the quantifications of 
Im7 protein expressed in the absence of the fusion shown in Table 3.1 and Table 3.2 (on 
page 65-66) in which only soluble protein is measured; insoluble material will be left 









increased levels of β-lactamase fusion protein 
The penicillin V and cadmium chloride resistance of the starting strain SQ1306 and strains EMS1 
through EMS10 were measured by spot titer experiment as described in Materials and Methods. 
The levels of -lactamase fusion protein in these strains were determined by Western blot 
analysis of total cell extracts. The bar graphs show levels relative to the starting strain (SQ1306) 
and represent the average of two measurements.  
One variant, EMS7, was the only one that showed a decreased level of -
lactamase-Im7 L53AI54A. However, EMS7 was extremely resistant to cadmium, 
suggesting a different mechanism for this variant to acquire resistance. This raised an 
interesting question whether the dual selection system is necessary and sufficient to 
exclude mutations that are unrelated to protein folding. I will discuss this question in 
details in Chapter 4. However, the combination of the dual selection system with an 
additional screening technique (such as detection of the levels of the fusion proteins) 
clearly demonstrated the applicability of our approach to identifying possible host folding 
modulators. 
To confirm that we had indeed obtained host variants that were affecting the 
folding and consequently protein levels of the Im7 protein itself, we expressed Im7 
L53AI54A, Im7 wild type and two other destabilized Im7 mutant proteins on their own in 
the absence of the fusion using a third promoter (pTrc) carried by a third origin of 





 strain SQ1306, which contained only low amounts of the Im7 proteins, 
both EMS4 and EMS9 strain backgrounds accumulated large amounts of Im7 proteins 
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(Figure 3.7). Quantification of the amounts of Im7 proteins present in periplasmic 
extracts using an Agent bioanalyzer showed that Im7 proteins made up 7-10% of the 
periplasmic contents in EMS4 and EMS9, a 34- to 92-fold increase over the amount 
present in wild type strains (Figure 3.7, Table 3.1 and Table 3.2).  The Im7 proteins were 
released by periplasmic extraction in the absence of detergent, indicating that they 
accumulate in a soluble form.  
3.2.3 Spy overexpression is necessary and sufficient to enhance Im7 expression 
In examining the periplasmic extracts of the Im7 overexpressing strains, we noted 
the strong induction of a 15.9 kD protein, which we identified by mass spectrometry as 
Spy (Spheroplast protein Y)
164
; this protein accounted for up to 43% of total periplasmic 




 EMS mutant strains (Figure 3.7, Figure 
3.8 and Table 3.2).  Spy expression is mainly under the control of the Bae and the Cpx 
extracytoplasmic stress response systems
57, 164, 165
, which are induced by a variety of 
stress conditions known to cause protein unfolding and aggregation
166, 167
.   
 
 
Figure 3.7 Im7 and Spy are abundant in the periplasm of EMS strains 
The PenVR and CdCl2
R resistant mutants EMS4 and EMS9 and the unmutagenized SQ1306 strain 
were transformed with plasmids encoding wild-type Im7 (wt) or the destabilized variants: 
L53AI54A, I22V, and F84A102, 163. Periplasmic extracts were prepared and analyzed by SDS-
PAGE. Im7 became 7-10% of total periplasmic proteins in EMS4 and EMS9. Strikingly, Spy 
made up to 43% of the periplasmic contents in EMS4 and EMS9 but almost invisible in SQ1306. 
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Table 3.1 Spy induction increases Im7 levels substantially 
Strains compared Relevant host genotypes* 
compared 
Im7 variant Fold increase in 
 Im7 level  
SQ1406/SQ1414 EMS4/wt L53AI54A 66±28 
SQ1410/SQ1414 EMS9/wt L53AI54A 92±44 
SQ1805/SQ1809 spy
++
/wt L53AI54A 280±145 
SQ1826/SQ1830 ΔbaeSR, spy
++
/ ΔbaeSR L53AI54A 684±162 
 
SQ1405/SQ1413 EMS4/wt wt 34±12 
SQ1409/SQ1413 EMS9/wt wt 43±24 
SQ1804/SQ1808 spy
++
/wt wt 165±93 
SQ1825/SQ1829 ΔbaeSR, spy
++
/ ΔbaeSR wt 211±83 
 
SQ1407/SQ1415 EMS4/wt I22V 51±9 
SQ1411/SQ1415 EMS9/wt I22V 48±23 
SQ1806/SQ1810 spy
++
/wt I22V 103±14 
SQ1827/SQ1831 ΔbaeSR, spy
++
/ ΔbaeSR I22V 470±176 
 
SQ1408/SQ1416 EMS4/wt F84A 43±18 
SQ1412/SQ1416 EMS9/wt F84A 67±16 
SQ1807/SQ1811 spy
++
/wt F84A 694±243 
SQ1828/SQ1832 ΔbaeSR, spy
++
/ ΔbaeSR F84A 589±102 
Data indicate extent of Im7 overproduction in various strains (see Table 3.6 on page 92 for details 
of strains). Im7 L53AI54A, wt, and two other destabilizing variants, I22V and F84A were 
expressed in EMS4, EMS9, and the unmutagenezied strain. In the EMS4 and EMS9 backgrounds, 
Spy was overexpressed due to the constitutive mutations in the baeS gene.  To directly assess the 
overexpression effect of Spy and to determine whether other BaeSR regulated gene products also 
contribute to the increased level of Im7, Spy was expressed under a Trc promoter in a wild type 
strain and a ΔbaeSR strain, which are transformed with the various Im7 plasmids, respectively.  
Fold increases in Im7 levels were quantified with an Agilent Bioanalyzer 2100 by direct 
comparison between periplasmic extracts prepared from various pairs of strains (see methods in 




 designates cells that overexpress Spy from pTrc-spy. 
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Im7 variant Spy% Im7% 
SQ1306 SQ1414 L53AI54A N.D. 0.1±0.07 
EMS4 SQ1406 L53AI54A 48±7 7±2 
EMS9 SQ1410 L53AI54A 35±13 8±2 
wt SQ1809 L53AI54A N.D. 0.02±0.01 
spy++ SQ1805 L53AI54A 43±2 7±3 
ΔbaeSR SQ1830 L53AI54A N.D. 0.01±0.004 
ΔbaeSR, spy++ SQ1826 L53AI54A 40±4 7±1 
 
SQ1306 SQ1413 wt N.D. 0.3±0.1 
EMS4 SQ1405 wt 42±5 10±1 
EMS9 SQ1409 wt 35±11 10±1 
wt SQ1808 wt N.D. 0.1±0.02 
spy++ SQ1804 wt 40±1 7±1 
ΔbaeSR SQ1829 wt N.D. 0.1±0.04 
ΔbaeSR, spy++ SQ1825 wt 41±2 10±4 
 
SQ1306 SQ1415 I22V N.D. 0.2±0.1 
EMS4 SQ1407 I22V 43±5 9±2 
EMS9 SQ1411 I22V 36±12 8±1 
wt SQ1810 I22V N.D. 0.1±0.01 
spy++ SQ1806 I22V 35±9 6±1 
ΔbaeSR SQ1831 I22V N.D. 0.01±0.006 
ΔbaeSR, spy++ SQ1827 I22V 39±3 6±1 
     
SQ1306 SQ1416 F84A N.D. 0.2±0.1 
EMS4 SQ1408 F84A 44±5 8±2 
EMS9 SQ1412 F84A 31±13 7±1 
wt SQ1811 F84A N.D. 0.01±0.004 
spy++ SQ1807 F84A 40±8 6±1 
ΔbaeSR SQ1832 F84A N.D. 0.01±0.003 
ΔbaeSR, spy++ SQ1828 F84A 40±5 6±1 
Percentage of Im7 and Spy in the total periplasm in different strains strains (see Table 3.6 on page 
92 for details of strains) was analyzed with an Agilent Bioanalyzer 2100 as described in Materials 




 designates cells that overexpress Spy from pTrc-spy. 
N.D., not detectable. 
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strains EMS1-EMS10. The periplasmic proteins were analyzed by SDS-PAGE followed by 




 strains showed increased levels of Spy except 
EMS7, which was the only host variant to show lower levels of β-lactamase fusion in our original 
screen (Figure 3.6). Spy was present in only moderate levels in EMS 8, the strain that had only 
slightly increased levels of the β-lactamase Im7 fusion protein (Figure 3.6). b, Spy is visible in 
whole cell extracts from EMS4 and EMS9.  
 
3.2.3.1 Single mutation in baeS caused overexpression of Spy 
To identify the mutation(s) that caused the massive up-regulation of Spy expression 
in EMS4 and EMS9, we sequenced the spy gene, its regulators cpxARP and baeRS, and a 
number of other candidate genes, surA, skp, fkpA, prc, degP, ptr, ompP, ompT, 
rcsABCDF, and mdtABCD and their upstream regulator sequences. We discovered that 
both EMS4 and EMS9 contained mutations in baeS but not in any of the other sequenced 





 strains (EMS1-10) and determined that it was 
mutated in all strains except EMS7, the mutant that failed to overproduce Spy or Im7 
(Table 3.3). BaeS is a putative histidine kinase that together with the proposed response 
regulator BaeR makes up the two-component BaeSR envelope stress response regulation 
system
57, 164-166
; this system regulates spy and a few other periplasmic stress genes.   
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The baeS gene had in total 5 different mutations identified in 9 EMS strains. EMS7 was the only 
mutated strain that did not contain a mutation in baeS. It was also the only mutated strain which 
did not increase the amount of bla-Im7 L53AI54A tripartite fusion protein (Figure 3.6).  
 
BaeS has a periplasmic domain, two transmembrane helices, and a cytoplasmic 
domain, which can be further divided into a highly conserved histidine kinase domain 
and the HAMP (Histidine kinases, Adenylyl cyclases, Methyl binding proteins, 
Phosphatases) linker. HAMP is a common structural element between the sensor domain 
and the kinase domain of a histidine kinase, presumably mediating the signal transduction 
between the two domains
168
. Mutations in BaeS are mapped to various regions of BaeS 
(Figure 3.9). R150W, isolated independently three times, is in the periplasmic domain of 
BaeS. P192L is in the HAMP linker of BaeS. The rest of the mutations are located in the 
histidine kinase domain of BaeS. Therefore, BaeS might be altered in the ability to sense 
periplasmic stress, to transmit the signal from its sensor domain to its kinase domain, or 
to modulate its kinase activity. P192, E264, D268, and R416 are highly conserved amino 
acids among BaeS homologs from different bacterial species. Transcriptional analysis of 
EMS4 revealed not only a massive up-regulation of spy mRNA but also a significant 
induction of the two other clearly defined downstream targets of BaeSR:  mdtA and acrD.  
Moving the baeS-R416C mutant allele from EMS4 into a fresh unmutagenized strain 
background by P1 transduction gave very similar inductions for these three genes, 
suggesting that baeS-R41C was sufficient to cause the constitutive activation of the 
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BaeSR envelope stress response (Table 3.4 on page 74). Other mutations might have a 
similar effect but we have not yet tested them. 
 
 
Figure 3.9 Mutations mapped to various regions of BaeS 
Predicted domain division of BaeS. BaeS has a periplasmic sensor domain and a cytoplasmic 
histidine kinase domain, connected by a HAMP linker. TM: transmembrane helices. Mutations in 
BaeS are located on various regions of BaeS. Information on the predicted domains of BaeS was 
acquired from http://www.uniprot.org/uniprot/P30847. 
 
3.2.3.2 Mutations in baeS are necessary and sufficient for increased PenVR and Im7 
levels  
To establish whether the mutation present in EMS4 (baeS-R416C) is sufficient for 
enhanced Im7 expression, we conducted a number of genetic experiments. We moved the 
baeS-R416C mutant allele from EMS4 into a fresh, un-mutagenized strain and found that 
the levels of Im7 and PenV
R
 were indeed very similar to the levels observed in EMS4. 
These results demonstrate that the baeS-R416C mutation is sufficient to enhance Im7 
expression.  In the reciprocal experiment we replaced the baeS-R416C mutation from 
EMS4 with a wild type sequence, resulting in the high PenV sensitivity originally 
observed in the unmutated parental strain, demonstrating that the baeS-R416C mutation is 
also necessary for increased PenV
R




The experiments were performed as follows.  The baeS-R416C mutant allele was 
moved into the wild-type SQ1306 background by P1 co-transduction with a linked 
marker yegL::kan (~10 kb upstream of baeS) from the Keio knockout collection
169
.  
Penicillin resistance co-transduced at a rate of 100% with the baeS-R416C mutation.  (All 
kan
R
 colonies tested (including SQ1640) that received the baeS-R416C mutation as 
assayed by PCR amplification and sequencing the baeS gene were penicillin resistant.)  
All kan
R
 transductants tested that received only the yegL::kan marker but remained wild-
type for baeS (including SQ1594) were penicillin sensitive (Figure 3.10 a). We were able 
to show that baeS mutations were sufficient to enhance the level of Im7 once transferred 
to a wild type strain (Figure 3.10 b).  
In the reciprocal experiment, when the baeS wild-type gene was moved by P1 co-
transduction with the yegL::kan marker into the EMS4 background, each time the baeS 
wild-type gene was acquired (e.g., SQ1608), the EMS4 background became penicillin 
sensitive. Each time the baeS-R416C mutation was not replaced by wild type sequence 
(e.g., SQ1606), the strain remained penicillin resistant. Identical results were obtained 
upon moving the baeS-E264K mutant allele in and out of the wild-type and EMS9 strain 
backgrounds. These results clearly demonstrated that the mutations in baeS are necessary 
for the phenotypes we observed (Figure 3.10 a).   
To test if alterations in spy expression or other genes under baeS control were 
responsible for PenV
R
, we disrupted the spy, baeS, baeSR, mdtABCD, and acrD genes in 
EMS4. The spy gene, baeS alone, and baeSR were necessary for PenV resistance, but 




Figure 3.10 baeS mutations are necessary and sufficient to cause Spy and Im7 
overproduction 
 a, Log-phase cells of different strains were normalized to A600=1, serially diluted and plated onto 
plates containing different concentrations of penicillin V. The highest dilutions of cells at which 
cells still grew at each PenV concentration were plotted against PenV concentrations to generate a 
titration curve.  Penicillin resistance of EMS4 is due to the presence of the baeS-R416C mutation. 
Strains that contain the baeS-R416C mutation (SQ1606 and SQ1640) are penicillin resistant, 
whereas those that are wild-type for baeS (SQ1594 and SQ1608) are penicillin sensitive.  See text 
for details. b, Im7 L53AI54A was overproduced in strains with wild-type backgrounds that have 
received (via P1 co-transduction) the baeS-R416C mutation (SQ1761) or the baeS-E264K 
mutation (SQ1762), but not in strain that remains wild-type for baeS (SQ1763). c, Similar spot 
titer experiments were performed as described in panel a. Deletion of the spy gene, baeS alone, 
and baeSR in the baeS R416C background dramatically decreased the PenV resistance to the 
levels similar to that of a wild type strain (SQ1306), indicating that these genes were necessary 
for PenV resistance. The mdtABCD gene and acrD were not necessary for PenV resistance since 
their deletions had no effect on PenV resistance. For ease in comparison, the order of the traces 
left to right corresponds to the strain order given top to bottom. 
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3.2.3.3 Spy overexpression is necessary and sufficient to lead to the phenotypes, even 
in the absence of a functional Bae pathway 
To determine if Spy overproduction alone is responsible for the enhanced levels of 
the unstable Im7 protein, or whether other BaeSR regulated proteins are involved as well, 
we overproduced Spy from the pTrc promoter to levels similar to those seen in the EMS4 
mutant, both in wild-type strains and in baeSR null strains. Overexpression of Spy, even 
in the absence of a functional BaeSR system, led to similar levels of soluble Im7 in the 
various destabilized Im7 mutants as were observed in EMS4 by SDS-PAGE analysis 
(Figure 3.11). More precise quantification of Im7 and Spy levels (obtained using an 
Agilent Bioanalyzer 2100) showed that upon Spy overexpression, periplasmic Im7 levels 
increased 100- to 700-fold (Table 3.1).  We conclude that Spy overproduction is 




Figure 3.11 Overexpression of Spy increased the amount of soluble Im7 in the 
periplasm 
Spy overexpression is sufficient to enhance Im7 levels in both wild-type and ΔbaeSR 
backgrounds to the levels seen in EMS4.  Plasmid-encoded Im7 and its destabilized variants were 
expressed in SQ765 wild-type (wt) or ΔbaeSR backgrounds, with or without the co-expression of 
plasmid-encoded Spy (designated as Spy++).  
73 
 
3.2.4 Spy has chaperone activity in vitro 
Though sequences homologous to Spy are present in a wide variety of bacterial 
species, very little was previously known about Spy function.  Deletion of spy was 
reported to cause slight induction of degP and rpoH, two genes that are under the control 
of rpoE, a stress response system involved in outer membrane protein biogenesis
170
. This 
observation led to the suggestion that Spy may also be involved in this process
170
. 
However, we were unable to detect significant induction of these or other periplasmic 
stress regulated genes upon deletion of spy in our strain background with quantitative 
reverse transcription polymerase chain reaction (qRT-PCR) (Table 3.4), suggesting that 
spy deletion does not cause significant defects in membrane integrity. 
Our results that overexpression of Spy leads to the accumulation of an otherwise 
highly unstable protein, however, suggested that Spy might function as a chaperone that 
facilitates protein folding in the bacterial periplasm. To assess chaperone activity, we 
purified Spy and tested its influence on the aggregation of a number of substrate proteins 
in vitro. We first tested the effect of Spy on the aggregation of thermally denatured 
malate dehydrogenase (MDH) and found that addition of increasing amounts of Spy led 
to a significant reduction of protein aggregation (Figure 3.12 a).  Even sub-stoichiometric 
quantities of Spy effectively inhibited the aggregation process, suggesting that Spy is a 
highly efficient chaperone.  Analysis of the effects of Spy on urea-denatured MDH 
(Figure 3.12 b) revealed a similar result and showed that Spy effectively prevents MDH 
from aggregating. We also found that Spy, which is strongly induced by ethanol
57
, 
protects MDH from ethanol-mediated aggregation (Figure 3.12 e). Ethanol is a long 
known protein denaturant and one of the most potent inducers of the E. coli heat shock 
response
170
.  Given that heat, urea and ethanol differ dramatically in their mode of protein 
unfolding, we concluded that Spy must have a general affinity for unfoled proteins. 
To assess whether other proteins are protected against stress-induced protein 
unfolding by Spy as well, we compared the aggregation of chemically denatured aldolase 
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the absence and presence 
of Spy (Figure 3.12 c,d). Again, we observed a strong suppression of protein aggregation 
when stochiometric amounts of Spy were present. We have shown that Spy 
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overexpression leads to the accumulation of higher levels of normally unstable proteins 
(Figure 3.7 and Figure 3.11). These results strongly suggested that Spy is a newly 
discovered general chaperone in the periplasm of E. coli.  
 
Table 3.4 Effect of Spy overproduction and deletion of the spy gene on the message 





















spy bae,cpx 279 204-342 253 201-295 NA NA 1.5 104 
1.2-2.0  
 104 
mdtA bae,cpx 74 53-101 61 45-80 1.4 1.2-1.7 4.5 3.1-6.5 
acrD bae 13 9.7-18.7 16 13-19 1.0 0.8-1.2 1.7 1.1-2.3 
rseP rpoE 1.1 1.0-1.4 0.7 0.6-0.8 0.9 0.7-1.1 1.1 0.9-1.4 
rpoH rpoE 1.1 0.9-1.4 1.2 1.0-1.4 1.1 1.0-1.3 0.9 0.6-1.1 
yebE cpx,rpoE 1.4 1.0-1.8 1.6 1.3-1.8 1.3 1.1-1.6 0.9 0.7-1.3 
cpxP cpx 1.3 1.0-1.5 1.3 1.1-1.5 1.2 1.0-1.4 0.8 0.7-0.9 
dsbA cpx NA NA 1.5 1.1-2.2 1.1 0.7-1.6 1.1 1.0-1.3 
osmB rcs 1.6 1.3-2.0 0.7 0.5-0.9 2.3 1.4-3.6 0.4 0.2-0.9 
pspA psp 1.6 1.3-2.0 2.3 2.0-2.6 1.0 0.9-1.2 3.1 2.0-4.8 
degP rpoE,cpx 1.1 0.9-1.4 1 0.7-1.3 1.2 0.9-1.6 0.7 0.6-0.8 
ompF rpoE,cpx 0.3 0.3-0.4 1.3 1.5-2.1 0.9 1.0-1.4 2.1 0.4-0.7 
ompC rpoE,cpx 0.7 0.6-0.7 1.6 1.1-1.4 1.0 0.8-1.1 0.8 1.4-2.8 
ibpA rpoH 0.7 0.5-1.0 1.4 1.4-1.9 0.9 0.7-1.4 0.9 0.5-1.0 
tolC  1.8 1.5-2.3 1.8 1.3-1.5 1.2 0.8-1.0 0.5 0.9-1.0 
marR  1 0.8-1.1 0.9 0.8-1.0 1.0 0.8-1.4 1.4 1.1-1.8 
Genes exhibiting more than a factor of 5 change in mRNA levels are shown in bold. Genes 
exhibiting a factor of 2.5 to 5 change in mRNA levels are shown in italics. The listed genes were 
chosen because they: (1) were the most induced in the various regulatory systems [as described 
previously57, the factor change under an active regulatory system was: mdtA (5.3/baeR); degP 
(56.3/rpoE); rseP (7.4/rpoE); yebE (9.8/cpx); osmB (11.4/rcs), and pspA (11.8/psp)], (2) 
contributed to intrinsic drug resistance (marR, tolC, mdtA, acrD, ompC, and ompF), or (3) 
function in protein folding (degP, dsbA, and ibpA). DegP is a protease, DsbA is a disulfide 
catalyst, and IbpA is a cytoplasmic chaperone.  
NA, not applicable. 
Strains used: 1. SQ1306, 2. SQ1698, 3. SQ1712, 4. SQ1731, 5. SQ765, 6. SQ1796. See Table 3.6 





Figure 3.12 Spy has chaperone activity
§
 
a–e, Spy suppresses protein aggregation as monitored by light scattering. Aggregate formation in 
the absence (0:1) and presence of increasing amounts of Spy (ratios given are Spy:substrate) was 
monitored for thermally-denatured MDH (a), urea-denatured MDH (b), guanidine-denatured 
aldolase (c), guanidine-denatured GAPDH (d) and ethanol-denatured MDH (e). f-h, Spy 
enhances protein refolding as assessed by recovery of enzymatic activity. Refolding was 
monitored in the absence (0:1) and presence of Spy for thermally-denatured MDH (f), guanidine-
denatured MDH (g) and guanidine-denatured LDH (h). Error bars indicate the standard deviation 
of 3 independent measurements. Ultracentrifugation and gel filtration studies (Figure 3.15 on 
page 82) indicate that Spy is dimeric in solution so Spy concentrations are given as a dimer. 
                                                 
§ I performed experiments as presented in panel a & f. The rest experiments were performed by Tim 
Tapley and Philipp Koldewey. Tim Tapley prepared this figure. 
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Most known ATP-dependent chaperones, such as the DnaK and GroEL systems, 
function as folding chaperones.  They use cycles of ATP-binding and hydrolysis to 
regulate substrate binding and release, thus facilitating protein folding.  In contrast, most 
known ATP-independent chaperones function as holding chaperones. They prevent 
protein aggregation under stress conditions, and transfer their substrates to ATP-
dependent folding chaperones upon return to non-stress conditions.  Although Spy is 
localized to the ATP-devoid environment of the bacterial periplasm, it appeared to 
support the accumulation and thus folding of Im7 variants under non-stress conditions.  
These results raised the intriguing possibility that Spy might function as an ATP-
independent folding chaperone. Alternatively, Spy might function as a very effective 
holding chaperone and transfer substrates to other ATP-independent folding chaperone 
for folding.  
 To investigate the possibility that Spy functions as a folding chaperone, we tested 
whether Spy aids in folding of denatured protein substrates in vitro. Our results suggested 
that Spy not only prevented protein aggregation but also significantly increased the 
refolding yield of both thermally and chemically denatured MDH and chemically 
denatured lactate dehydrogenase (LDH) (Figure 3.12  f-h). These assays clearly showed 
that Spy indeed functions as a highly efficient folding chaperone.  
Since the assays were performed in the absence of any cofactors, these results 
strongly suggested that Spy has intrinsic protein folding capacity, providing an excellent 
explanation how Spy overexpression is sufficient to significantly increases the amount of 
folded Im7 protein in vivo. 
3.2.5 Conditions induce spy  
Transcription of spy is regulated by the Cpx and the Bae stress response 
pathways
57
. The known induction signals of spy include spheroplasting
171
, 











, low pH, deletion of dsbA
174
, 
as well as overexpression of transcription activators. Conditions inducing spy are 
summarized in Table 3.5. 
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Table 3.5 Conditions that induce spy 
Conditions that induce spy Fold increase in spy 
message levels 
Method 
spheroplasting171 >15 spy promoter-lacZ 
indole164 14 (1.5 ΔbaeSR) qRT-PCR 
ethanol57,* ~4 microarray 
butanol* ~6 microarray 
condensed tannins (1%)172 494/18 qRT-PCR/microarray 
model apple juice (pH 3.7)175 7 Microarray 
HCl (pH 5.5)* ~3 Microarray 
ΔdsbA174 5 Microarray 
overexpression of misfolded PapG164 >8 spy promoter-lacZ 
overexpression of NlpE164 >9 spy promoter-lacZ 
mecillinam & cefsulodin* >3 microarray 
ZnCl2
173 ~3 spy promoter-lacZ 
copper-glycine173 >5 microarray 
BaeR overexpression (from pUCbaeR)176 640/140 qRT-PCR/microarray 
>20 spy promoter-lacZ 
cpxA24 (mutation constitutively activates 
CpxA)170 
>10 spy promoter-lacZ 
ΔbaeR176 2.2 qRT-PCR 
>20 spy promoter-lacZ 
ΔphoBR176 650 qRT-PCR 
ΔcreBC176 240 qRT-PCR 
Spy was induced by various conditions that activate the Cpx or Bae response. Indole treatment 
causes membrane derangement, resulting in the reduction of oxygen by semiquinones and the 
peroxidation of lipids177. lacZ: gene encoding β-galactosidase, a reporter to monitor transcription 
from the spy promoter. *: Unless specified, the data for microarray experiments were obtained 
from http://www.prfect.org/index.php?option=com_wrapper&Itemid=419 
 
The induction of Spy by these conditions led us to hypothesize that deletion of spy 
might result in growth defects in bacteria under these conditions.  We created a spy 
mutation in four different strain backgrounds: MG1655, MC4100, BW25113, and BL21. 
We then grew these strains under normal and spy-inducing conditions and compared their 
growth. In addition, we tested whether spy null strains exhibit deficient growth when the 
culture medium (or agar plate) contained chemicals known either as environmental 
pollutants
178
, or as those which induce heat shock responses
179, 180
. These chemicals 
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include ether, benzene, chlorpyrivos, 2,4-dichloroaniline, dioctylphthalate, 
hexachlorobenzene, pentachlorophenol, trichloreoethylene, isopropanol, propanol, 
methanol, sodium proprionate, formamide, 4-nitrophenol, phenol, sodium acetate, CdCl2, 
NaCl, H2O2, hypochloride, naladixic acid, menadione, 2,4-dinitrophenol, dibucaine, 
paraquat, and bile salts. Unexpectedly we did not observe any obvious growth defects of 
spy null strains resulting from contact with these chemicals including the ones induce spy. 
The only exception was tannic acid, a polyphenol, which I discuss in great details in the 
following section. We further tested various antibiotics and detergents, and chemicals 
known to inhibit the growth of strains which are devoid of functional Cpx or Bae 
pathways
181
.  They include puromycin, ampicillin, mecillinam, novobiocin, mitomycin C, 
cefsuolodin, nafcillin, cloxacillin, kanamycin, chloramphenicol, spectinomycin, 
geneticin, EDTA, Triton, SDS, gallic acid, nickel chloride and sodium tungstate. Here 
also, however, we did not observe any phenotypes. In summary, the only phenotype 
observed caused by the spy deletion is the sensitivity to tannic acid.  
3.2.6 Spy mediates resistance to tannic acid and protects activities of proteins from 
tannic acid inactivation 
Tannic acid is a specific commercial form of tannin. Tannins are synthesized by 
plants to protect against bacterial and fungal infections, and only small quantities are 
required to aggregate proteins, a feature that may be responsible for their antimicrobial 
activity
182
. Tannins have long been used in tanning leather and are present in red wine, 
tea, and unripe fruit.  It is thought that the astringent taste of food substances that contain 
tannins is due to the crosslinking of mouth proteins
183
. The astringent taste of strong tea is 
often reduced by addition of milk, which drives coprecipitation of the tannins with the 
disordered protein casein that is present in milk
183
. RT-PCR-based measurements indicate 
that spy mRNA is induced nearly 500-fold in response to tannin treatment
172
. The gene 
for ibpB, an E. coli small heat shock protein homologue also involved in inhibiting 
protein aggregation, is induced 48-fold by tannins, making it second only to spy in 
induction by tannins
172








Spy protects DsbB, aldolase, and alkaline phosphatase (AP) from tannin inactivation. Spy 
concentrations are given as a dimer. Error bars indicate the standard deviation from 3 independent 
measurements. a, Enzymatic activity of E. coli DsbB (0.5 M) over time incubated in 100 M 
tannic acid in the absence (0:1) or presence of increasing amounts of Spy (ratios given are 
Spy:substrate). b, Enzymatic activity of rabbit muscle aldolase (0.5 M) over time incubated in 
16 M tannic acid in the absence or presence of increasing amounts of Spy. c, The enzymatic 
activity of E. coli alkaline phosphatase (1 M) over time incubated in 500 M tannic acid in the 
absence or presence of increasing amounts of Spy.  d, Spy deletion strains are tannin sensitive.  
                                                 
** I performed the tannin sensitivity experiments as presented in panel d. Stephan Hofmann assisted 
with the spot titer. The activity measurements of enzymes were performed by Tim Tapley and Philipp 
Koldewey. Tim Tapley prepared panel a-c of this figure. 
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We tested the effects of Spy on tannin-mediated inactivation of the E. coli 
membrane protein DsbB (Figure 3.13 a), aldolase (Figure 3.13 b), and the E. coli 
periplasmic protein alkaline phosphatase (Figure 3.13 c). Spy protected all three proteins 
from tannic acid-induced activity loss. Thus, Spy induction may be involved in protecting 
cells from tannin-induced protein aggregation and inactivation. We found that spy null 
mutants are sensitive to tannins (Figure 3.13 d), consistent with the previously reported 
tannin sensitivity of baeSR null mutants
172
.  
3.2.7 Spy may not have a regulatory role like its homolog CpxP 
The Spy protein is 29% identical to CpxP, an inhibitory component of the CpxRA 
regulatory system. Both Spy and CpxP appear to be mostly -helical in structure (Figure 
3.14).  CpxP binds to the periplasmic domain of CpxA, inhibiting its autokinase activity. 
Presence of unfolded proteins causes the release of CpxP, thereby activating the Cpx 
response
184, 185
. These results suggested that CpxP might be acting as one of the very few 
known periplasmic chaperones, targeting itself and its unfolded protein cargo to the 
protease DegP for degradation
186, 187
. To assess whether Spy might be similarly involved 
in regulating BaeSR or the other periplasmic stress response systems, we carried out RT-
PCR (Table 3.4 on page 74) in strains either lacking or overexpressing spy. We found no 
notable influence on the expression of baeS, cpx, rpoE, rpoH, rcs or psp regulated genes, 
suggesting that Spy, unlike CpxP, may not be playing a major regulatory role. Instead, 
our results strongly suggest that Spy is directly functional as a molecular chaperone, 
supporting the folding of soluble proteins in the E. coli periplasm. 
3.2.8 Structure of Spy reveals an alpha helical cradle-shaped chaperone 
To gain insights into the mechanism of Spy’s chaperone action, our collaborators 
crystallized and determined the three-dimensional structure of Spy
††
. Spy contains 161 
residues of which 23 constitute the signal peptide that directs Spy to the periplasm. Our 
residue numbers refer to the mature, periplasmic form of Spy, which contains 138 
residues.  
                                                 
†† The crystal structure of Spy was solved by Miroslaw Cygler, Karen M. Ruane, and Rong Shi from 
McGill University, Canada.  Jim Bardwell, Miroslaw Cygler, and Zhaohui Xu analyzed the strucuture. 
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The crystal structure shows that Spy molecules associate into tightly bound dimers. 
Size exclusion chromatography, analytical ultracentrifugation (Figure 3.15) and dynamic 
light scattering analysis (data not shown) confirmed this oligomerization state and 
revealed the presence of Spy dimers also in solution. Each Spy monomer is highly -
helical, in agreement with the CD spectrum (Figure 3.14). 
 




Far UV circular dichroism (CD) spectra of Spy were collected and then analyzed using the 
CDSSTR algorithm on the Dichroweb server (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml) 
to assess secondary structure content. The raw data are shown as a solid red line; the dashed black 
line (which almost precisely overlays the raw data trace) represents the reconstructed spectrum 
computed based on the following secondary structure content: 77% helix, 4% strand, 5% turn and 
14% disordered. Residuals (the difference between the experimental spectrum and reconstructed 
spectrum) are shown in the inset. The related protein CpxP is also predicted by Jpred3 
http://www.compbio.dundee.ac.uk/www-jpred/ to be mostly -helical in secondary structure. 
The Spy dimer is formed through the antiparallel coiled-coiled interaction of 
helices 3 with 3’ (prime indicates the second monomer) and antiparallel interactions 
between 4 and 2’ (Figure 3.16). The shape of the dimer is rather unusual, with one 
surface highly concave and the other convex, highly reminiscent of a cradle. The bottom 
of this cradle is formed by helices 3, the sides by the connection between helices 1 and 
                                                 
‡‡ I performed the experiment. Tim Tapley analyzed the data. 
82 
 
2 and the tips by helices 1 and 4 (Figure 3.16 a). The disordered N- and C-termini 
potentially extend over the concave surface of the cradle (Figure 3.16 a.b). The thickness 
of the dimer is in most places equivalent to just the width of a single  helix. The 
contacts between the two monomers are extensive, burying a surface of ~1850 Å
2
 per 
monomer upon dimerization and suggest high stability of dimers. The most intimate 
contacts between the two monomers are at the ends of the cradle. The concave surface is 
also lined with many conserved apolar side chains including Leu34, Ile42, Met46, Pro56, 
Met64, Met85, Met97, Ile103, and Phe115, localized in two patches in the interior of the 
cradle giving it an overall apolar/hydrophobic character (Figure 3.16  b). The convex 
surface has on the other hand a hydrophilic character typical for water-soluble proteins. 
 
Figure 3.15 Size exclusion chromatography and analytical ultracentrifugation 
indicate that Spy is an elongated dimer
§§
 
a, Size exclusion chromatography performed over a range of Spy concentrations (0.1–50 M 
monomer concentration) yield an apparent molecular weight (MWapp) of ~45 kDa, which is 2.8 
times the expected size for monomeric Spy. The apparent molecular weight decreased only very 
slightly at very low Spy concentrations (100 nM). The inset shows the raw chromatograms. b, 
Concentration-dependent sedimentation velocity analytical ultracentrifugation analysis of Spy at 
indicated concentrations. Molecular weight () and Sedimentation coefficient () were derived 
from 2-dimensinal spectrum analysis and plotted as the function of the tested Spy concentration. 
The molecular weight determined was ~30 kDa, suggesting that Spy forms dimers (the calculated 
mass of the Spy monomer is 15.9 kDa). Inset: dc/dt boundary analysis of Spy at 62, 31 and 12.5 
M (concentration given as a monomer). Samples were spun at 42,000 rpm in 10 mM HEPES, 
100 mM NaCl, pH 7.5. 
                                                 






Figure 3.16 The crystal structure of the Spy dimer shown in three orientations; 
rotated by 90° along the vertical axis
***
. 
a. Ribbon drawing shows an all-alpha helical structure.  One subunit is colored light blue and the 
other is colored magenta.  The N- and C-termini as well as the secondary structural elements of 
the molecule are labeled.  b. The surface properties of Spy. The molecular surface of Spy is 
colored based on the underlying atoms: all backbone atoms, white; all polar and charged side-
chain atoms, green; all hydrophobic side-chain atoms, yellow.  Note the concave surface of the 
molecule has two significant yellow hydrophobic patches.  The lower right patch (P1) is 
composed of Leu34, Ile42, Met46 and Ile103.  The upper left patch (P2) is composed of Pro56, 
Met64, Ile68, Met85, Met93 and Met97. Lysine 77, which was labeled with bimane for some of 
the experiments shown in Figure 3.18 on page 88 is circled in red. c. Structural flexibility of Spy 
dimer. The molecular surface representing the Spy backbone atoms is colored based on the 
average backbone B-factors for each residue. Note the rim lining the concave surface has higher 
B-factors indicating greater structural flexibility. In particular, the N- and C-termini are highly 
mobile. d. The cluster of hydrophobic residues at the tip of the cradle. These residues are well 




CLUSTAL W (1.83) multiple sequence alignment††† 
 
gi|194438564      ----ADTTTAAPADAKP----------------------MMHHKGKFGP----HQDMMFK 30 
gi|238894281      ----AETTT-APSDSKPM---------------------MMHHKGGPG-----QHDMMFK 29 
gi|258635767      ---AADNLTPPPAGSEKP---------------------MHKPPMRHG-----GMDMMFK 31 
gi|253686940      -----NEASKGPGPEHKM---------------------MMKEGREHRGM--MGPDAMFK 32 
gi|259908592      ---AADNLTPPPAGAEKP---------------------GMQKPPRHG-----GPHEMFK 31 
gi|251791069      ------ADTSMPDQGARM---------------------MKHHDGGRGERGMMEENMMFK 33 
gi270264557       ----ADTTAAPATAADAA---------------------PMKMMHHKGE----GKGGPFA 31 
gi|85059846       -----ADTATAPAASESA---------------------KMYHHPKHGP----MMEQMFK 30 
gi|49176443       ----AEVGSGDNWHPG--------------------------EELTQ----RSTQSHMFD 26 
gi|152972721      ----AEVVTSVNWLPG--------------------------DEGGQ----RGSQSHMFD 26 
gi|270265193      ----ADTTSETAPTPG--------------------------NDAITR-VPG--QHHMFD 27 
gi|238764463      --------ADKAGATD---------------------GWCHGDGAMMNKKDGRGHHNMFD 31 
gi|258637607      ----AETTTIDEMHQN--------------------------GGLTTGSMTQNPQSHMFD 30 
gi|271502506      IEHHSSVDSDASAESNT-----------------PQVGNCYRDDSATKREES--QQGMFD 41 
gi|85060157       -------ADNNTLES-------------------------WQQDAITHRIQES-HYSMFD 27 
gi|238921654      -------DEGEPVCS------------------------WYQGNDMMQQSMD--HNYMFD 27 
gi|300714680      -----AVTTTDEMHQD--------------------------NAATR-SMTQIPQSHMFD 28 
gi|253686545      ------AESGDAPASGW-----------------------HIDDSATKGVSG--QQGMFD 29 
gi|253991780      ----ETTNTTHAATTPGICAS---CGY-------KSSEGHHYHNN-EAGDN----DHLFN 41 
gi|227354740      ----ETSNTNNQPAGQQQYNDNYHCGYGYGMHDGRDNRGHRGQRGHMMGNNNFGESRMFN 56 
gi|284008856      ----ETADVNLAATQSAKQIQAVKHDSPISK---RNITRDRLCNPYDIFVP------LIK 47 
gi|139522416      ----DTADTDDTPEAANPSPYCLSYEH-------KRDSGYYRSDEHNYNYS-----YVFG 44 
gi|290477254      ----GTAGTDN-VIADDFSQYCMPYGN-------KNNVSYCLNDERNYNYS-----CIFA 43 
gi|188533989      ---AADNLTPPPSGAEKT---------------------MMPERPHHG-----GPHEMFK 31 
gi|259906788      -------ATTGEMHQD--------------------------DGTNR-TLRQVPQSNMFD 26 
gi|37528606       ----GTASTMHAATVPGNCAP---CEY-------KNVGSYHYRNNNDIGDN----DHMFN 42 
                                                                            :  
 
                                                 
*** Jim Bardwell, Miroslaw Cygler, and  Zhaohui Xu prepared this figure. 
††† Jim Bardwell performed and analyzed the Spy sequence alignment and prepared this figure. 
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amino acid # -->     34      42 45,46        56        64                   85         
gi|194438564      DLNLTDAQKQQIREIMKGQRDQMKRPP--LEERRAMHDIITSDTFDKVKAEAQIAKMEEQ 88 
gi|238894281      GLNLTDAQKQQIRDIMKSQRENMKRPS--LEERRAMHDLIASDTFDKAKAEAQIDKMEAQ 87 
gi|258635767      GLNLTDAQKKQMHDIMRESHKDFKRPS--LEERRANHALIASDTFDRAKAEAQAEKMTAN 89 
gi|253686940      ELNLTEAQKQQVKDIMKESREKMHKAM--QDDRREMHSLIASDTFDTAKAQAQLDKADAE 90 
gi|259908592      GLNLTDAQKLQVRNIMKAAHKGMKRPS--LEDRRAVHSIIASDHFDRAKAEAQATQMSAN 89 
gi|251791069      GLNLTDEQRQKMRDIMENAKKDRTRPS--AEERTQWHSLIAADSFDKTKAEAMVNKMAEA 91 
gi270264557       GLNLTEQQRQQMRDIMKESHQNRGAGV--KEERQALHNLVASDSFDEAKAKSQIDAISKA 89 
gi|85059846       GLDLTTAQREQMRDIARDAMKNMKKPS--ADEHKQLHDVIAADNFDSSKAQALVTSMTQA 88 
gi|49176443       GISLTEHQRQQMRDLMQQARHEQPPVN--VSELETMHRLVTAENFDENAVRAQAEKMANE 84 
gi|152972721      GISLTEQQRQQLRDLMQRARHDRLPVN--VSEMETMHRLVTAENFDENAVRAQAEKMAQE 84 
gi|270265193      GVSLTEQQRQQMRDLMRQARHDLPGVN--VAEMEAMHKLVTADKFDEAAVYAQAETMAQQ 85 
gi|238764463      GVNLTEQQRQQMRDLMRQSRQEQPRVN--LAEREAMHKLVTADKFDEAAVRAQAEKMSKD 89 
gi|258637607      GIELTEHQRQQMRDLMQQARLERPAVS--FQDIETMHDLVIADKFNESAIRLQAEKIAQA 88 
gi|271502506      GVRLTEHQRQQMRDLMRQVRHEQPTYE--ANDVEIMHRLVTAEKFDAPAVQAQVAKMVQA 99 
gi|85060157       DVKLTEQQRQQMRDLMSLAGRDAPRIN--ISEMERLHTLVTDKTFDEAAVREQTEKMAQE 85 
gi|238921654      GVNLTEHQRQQMRDLMQTTRHGFAGVK--LHDIEAMHRLVTAEQFDEIAVKTLAEKMAQE 85 
gi|300714680      GINLTEQQRQQMRDLMQQARHERSSIS--INDLEQLHEKIIADKFDEAAYKAQLDKIAQA 86 
gi|253686545      GVRLTEQQRQQMRDLMHQSRQDKPAFN--AEDVKAMHKLVTAETFDEAAVRAQITRMMSV 87 
gi|253991780      GITLTERQRQQMRDLMAQKHQQRSSMLMNRAEREEMRKLVTAKDFDEAAVKAQAEKMAKY 101 
gi|227354740      GITLTEQQRTQMRDLMRQHHQDRFNNSDFRQRHENMHKLITADKFDEAAVRAQIQDMDKQ 116 
gi|284008856      GITLSERQRQQMRDLMASQRQQSFKKNVSREERETLHDLMTADIFDEVAFRATAEKLSQE 107 
gi|139522416      GITLTEQQRQQMWDLVKKQHLHEQSIIDMRVERQKMYHLLIEREFDEAAVRLQLEKIAEK 104 
gi|290477254      GVSLTEQQRQQIWDLVKKQRLHEKPVADIRAERRKMYSLLDSTNFDEAAVRSQLEKIAKE 103 
gi|188533989      GLELTDAQKLQMRSIMKAAHKDMKRPS--AEDRRALQSIIASDTFDRAKAEAQATKMSAN 89 
gi|259906788      GISLTEQQRQEMRDLMQQARYDRSPIS--ISDLDQLHELIIADKFDKAAYEAQAKKIAHA 84 
gi|37528606       GITLTEQQRQQMRDLVGQKHQPRSSMSMSPTEREEMRKLVTAKDFDGVAVKALIERMIRC 102 
                   : *:  *: :: .:                        :    *:               
 
 amino acid # -->        97   103-4-6-7   112 115 
gi|194438564      RKANMLAHMETQNKIYNILTPEQKKQFNANFEKRLTERPAAKGKMPAT-AE--------- 138 
gi|238894281      HKAMALSRLETQNKIYNILTPEQKKQFNANFEKHLTERNAPAGKMPAP-AE--------- 137 
gi|258635767      AKERAVAMMETQNKLYNVLTPEQKKQFNANFEKRLTEKRPHDGKMPPPPAEGE------- 142 
gi|253686940      HKARMLNGLETKNKIYNVLTPEQKKQYNDNFEKRLTQPPRPDGKPVP--AE--------- 139 
gi|259908592      SQQRTMLMLETQNKMYNVLTPEQKKQFNQNFEKRLAEKPQHEDRMPP--ADD-------- 139 
gi|251791069      NKAHMLKRLELHNQMYNVLTPEQKKQFNDNFAKRQQEPVAP--KAP-------------- 135 
gi270264557       QSEHMLERAKAENKMYNLLTPEQKKQYNENYQKREQKMMDHMNKMKSKMTTEQ------- 142 
gi|85059846       QNERMLAHLEMQNKMYNVLTPTQKQEFNKKFEEHQTKIMEHGNN---------------- 132 
gi|49176443       QIARQVEMAKVRNQMYRLLTPEQQAVLNEKHQQRMEQLRDVTQWQKSSSLKLLSSSNSRS 144 
gi|152972721      QVARQVEMAKVRNQMYHLLTPEQQAVLNAKHQQRMDQLREVARMQKGSAMMLSSSSNTLQ 144 
gi|270265193      QVKRQVEMARVRNQMYNLLTPQQKSVLDQKHQQRMQQMEQQISGLQQTSAQKLSMTE--- 142 
gi|238764463      QIDRQVEMAKVRNQMFNLLTPEQKAVLNQKHQQRIEQMQQAPAAQ-PSSAQK-------- 140 
gi|258637607      QVEQNIVMARVRNQMYHLLTPAQQATVQKNYERRLDEMRRLSELQPSSPLQAVSSTSSNQ 148 
gi|271502506      QIARQVEIARVSNQMYNMLTPEQKAVLNQKHEQAMQAVRQQMPAS-DSSSQNLQLSRQGQ 158 
gi|85060157       QVARQVEMARVRNQMYNLLTPEQQQILEQKHLQRVSDLKLQMADKISTSAQKPAVNE--- 142 
gi|238921654      SVIRQVEMARIRNMVFNLLTSDQKAQLNARYQQKIAGWQQQIAYMQNSSAQK-------- 137 
gi|300714680      EVSRQVEMARIRNQMYHLLTPAQQDVLNEKHQQRMSEMRKLTNMQQASSLQAVSSTGSNQ 146 
gi|253686545      QIERQIQMTRVRNQMYNLLTPAQKEILDVKHKQRMKEMQQQISMFNQMAAPAPGTTNQTE 147 
gi|253991780      DIERQVEMARIHHQMYQLLTPEQQVQLEQQHRQYMSQLSN-------------------- 141 
gi|227354740      AIERRVEMAKVHNQMYQLLTPEQKAQLEKNYQQRVSSVSQQNQQTQEKAN---------- 166 
gi|284008856      IVEQQIEMARIYHQFYKLLTHDQKMILEKQHQKQLSRSKY-------------------- 147 
gi|139522416      NIDLGVEIARIRNQMYQLLTPEQKERLYKRYEGQTAQEMH-------------------- 144 
gi|290477254      NVDLSVEIARIRNQIYQLLTTEQKVQLQRRYEVRVNREMN-------------------- 143 
gi|188533989      GQQRALSMMETQNKLYNVLTAEQKKQFNQNFEKRLAEKPHHQDGMPP--ADD-------- 139 
gi|259906788      EVARQVEMGRVRNQMYHLLTPQQQSILQQKHQQRLGELRRLTNMQLSSPLQAASSTDSTP 144 
gi|37528606       NVEHQVEMARIHHQMYQLLTPEQQAQLEQHYRQRMSQLPN-------------------- 142 





Figure 3.17 Alignment of sequences homologous to Spy. 
The NCBI nr database was searched using blastp using the E. coli MG1655 Spy protein sequence 
gi|194438564. All sequences that showed a E value of <0.001 were selected (225 sequences in 
total) and a distance tree of these sequences with treeview default NCBI settings was displayed.  
This tree showed that Spy homologues were present in a wide variety of enterobacteria, 
proteobacteria, and some cyanobacteria. Then one sequence (leaf) from each branch of the tree 
was selected to provide a good representation of the diversity present.   The selected sequences 
were aligned with ClustalW (www.ebi.ac.uk/clustalw) using the default parameters. The proteins 
are identified by their gi numbers, first sequence shown gi|194438564 is E. coli Spy.  For this 
sequence the signal sequence was omitted, so that the numbering is for the mature portion of the 
Spy protein.  The residues highlighted in yellow and numbered at the top of the alignment are 
those mentioned in the main text. The colors and consensus symbols shown are the ClustalW at 
EBI default values namely: (the following information is taken directly from the website 
www.ebi.ac.uk/clustalw).  
AVFPMILW RED Small (small+ hydrophobic) 
DE BLUE Acidic 
RK MAGENTA Basic 
STYHCNGQ GREEN Hydroxyl + Amine + Basic - Q 
―Consensus symbols:  an alignment will display by default the following symbols denoting the 
degree of conservation observed in each column: "*" means that the residues or nucleotides in 
that column are identical in all sequences in the alignment. ":" means that conserved substitutions 
have been observed, according to the color table above. "." means that semi-conserved 
substitutions are observed.‖ 
3.2.9 Substrate binding to the concave side of the cradle‡‡‡ 
Based on the crystal structure and the fact that many previously identified substrate 
binding sites of chaperones are hydrophobic in nature, we hypothesized that the concave 
side of the cradle may serve as substrate-binding site of Spy. In addition, based on our 
recent findings that the acid-activated periplasmic chaperone HdeA functions as a largely 
disordered protein when it supports the refolding of acid-denatured proteins
188
, we 
considered whether the disordered regions of Spy had a similar role.  
In order to test these hypotheses, two cysteine variants of Spy were generated by 
Philipp Koldewey; one with a unique cysteine at position 24, which is in the disordered 
N-terminal region of Spy on the concave side of the cradle (Figure 3.16  b). Another 
cysteine was engineered at position 77, which is on the opposite (convex) side of Spy 
                                                 
‡‡‡ Philipp Koldewey performed all the experiments in this section. 
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(Figure 3.16 b). These unique cysteine residues were used to fluorescently label Spy with 
monobromobimane, a small thiol specific fluorophore. We decided to use casein as 
substrate protein since it is natively unfolded and soluble. Thus, neither aggregation nor 
refolding of the protein should interfere with our measurements. Fluorescence anisotropy 
was used to investigate whether the introduced mutations affected substrate-binding. As 
shown in Figure 3.18 a, both labeled Spy variants exhibited an increase in anisotropy 
upon casein binding, suggesting that they retain the ability to bind substrates. This result 
agreed with studies using analytical gel filtration, which revealed the presence of an 
apparently stable complex between Spy and casein (Figure 3.18 b). These results 
suggested that the two substituted amino acids are either not directly involved in substrate 
binding or that their substitutions did not strongly affect substrate binding.  
We then measured fluorescence emission spectra to monitor potential 
environmental changes in the vicinity of the two cysteines, which would serve as direct 
read-out for substrate interaction at or near those specific sites. As shown in Figure 3.18 
c-d, the fluorescence of bimane attached via Cys24 is partially quenched and slightly 
blue-shifted upon binding of casein. In contrast, the fluorescence of bimane attached via 
Cys77 is slightly increased by casein binding and no shift in the emission maximum was 
detected.  These results suggested that substrate binding occurs on the concave side of the 
cradle, possibly within the cradle itself. The small change of bimane fluoresence 
observed at Cys77 could be due to an overall conformational change in the small Spy 
protein that occurs upon substrate binding.  
In order to confirm that casein was a suitable substrate protein, i.e., that it is 
bound in the bona fide substrate binding site in our fluorescence experiments, a 
competition assay between MDH and casein was carried out. Because we know that Spy 
enhances the refolding of chemically denatured MDH, we reasoned that addition of 
casein should decrease the MDH refolding rate if indeed casein and MDH bind to the 
same apolar surface of Spy. As shown in Figure 3.18 e, an equimolar addition of casein 
significantly decreases the refolding rate of MDH. We interpret this as being due to a 
direct competition for the same site on Spy, namely the conserved apolar cradle we had 




Figure 3.18 Spy binds the disordered model substrate protein casein on the concave 
side of the cradle
§§§
. 
a, Fluorescence anisotropy of bimane-labeled Spy H24C (squares) and Spy K77C (circles) before 
and after addition of an equimolar amount of casein. b, Analytical gel filtration of Spy alone, 
casein alone, or a 1:1 mixture of Spy and casein. The MW of a dimer of Spy is 31kD, but it elutes 
as a 44 kDa molecule, which is consistent with the elongated form of the dimer as seen in the 
crystal structure.  The actual MW of casein is 23-26 kDa. c, Normalized fluorescence emission 
spectra of bimane-labeled Spy H24C in the absence (solid line) or presence (dashed line) of an 
equimolar amount of casein. d, Normalized fluorescence emission spectra of bimane-labeled Spy 
K77C in the absence (solid line) or presence (dashed line) of an equimolar amount of casein. e, 
Competition assay between casein and MDH for Spy binding. Refolding of chemically denatured 
MDH alone (open squares), MDH+casein (1:1; closed squares), MDH+Spy (1:1; open circles) or 
MDH+casein+Spy (1:1:1; closed circles) was monitored by recovery of enzymatic activity. 
Recovered activity is plotted as a fraction of the activity of native (i.e. non-denatured) MDH. 
                                                 




It may seem surprising that a chaperone as effective as Spy has remained 
unstudied in an organism as well characterized as E. coli. However, because chaperones 
are usually effective only in stoichiometric quantities, chaperone assays are generally not 
sensitive enough to enable their purification from crude lysates by activity. Instead, 
chaperones have often been first identified because their genes are induced in protein 
unfolding conditions. Our approach of linking folding to selectable markers opens up the 
possibility of directing evolution to alter the in vivo folding environment to specifically 
enhance the folding of a given unstable protein and provides a new route for chaperone 
discovery. In our experiments, the vast majority of mutations that resulted in improved 
folding of the unstable Im7 protein induced the Spy protein, suggesting that the 
overproduction of this chaperone is the most genetically accessible way of enhancing the 
levels of unstable Im7 protein. Although Spy chaperones the folding of a wide variety of 
substrate proteins in vitro, Spy overproduction in vivo is clearly not a panacea that solves 
all in vivo protein folding problems. The baeS-R416C mutation, for instance, did not 
increase PenV resistance of tripartite fusions between -lactamase and RNaseI or the 
highly aggregation-sensitive mutant of maltose binding protein (MBP-G32DI33P). 
Instead, our approach offers a method to force bacteria to tailor their in vivo folding 
environment to stabilize specific test proteins. Applying our selection to other poorly 
folded test proteins may prove useful in the customization of bacteria to stabilize specific 
poorly folded proteins, in facilitating chaperone discovery efforts, and in enhancing our 
understanding of the in vivo protein folding environment.  
Spy has a unique cradle shape that is unlike any other chaperone with known 
structure. It lacks a significant globular core and would therefore be expected to display 
higher flexibility than the average globular protein. Its thinness places a disproportionate 
number of side chains on the protein surface.  The Spy protein cradle is so thin that a 
number of residues including Leu34, Ile42, Met46 and Ile103 form both part of the 
structural ―core‖ of the Spy structure and also part of a surface exposed patch. The 
highest backbone temperature factors (B-factors) are observed in surfaces and bumps 
extending from the concave side of the cradle, particularly in the connectors between 
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helices 1 and 2, which form the sides of the cradle and suggest potential for bending 
and twisting of the molecule (Figure 3.16 c).  The shape combined with observed 
flexibility is suggestive of a mechanism for Spy action that involves the shielding of 
aggregation-sensitive regions on substrate proteins, which are revealed upon partial 
unfolding, by interaction with the relatively apolar surface present on the interior 
(concave) side of the cradle structure. This overall mechanism is consistent with the 
proposed mechanisms for a wide variety of chaperones that shield aggregation regions of 
proteins. A common structural feature in chaperones that enable them to specifically 
recognize folding intermediates are exposed hydrophobic surfaces.  These surfaces serve 
to bind to hydrophobic segments existed in folding intermediates and release them to 
bulk solvent in a controlled fashion.  The surfaces can be quite extensive, as seen in 
GroEL, or rather limited as seen in Hsp70
189
. While the near million-dalton GroEL with 
its ring structure can bind an entire polypeptide chain in an enclosed manner, the cradle-
shaped small chaperone Spy will likely bind a segment of chain in a more open fashion.  
However, one could also imagine a scenario where two or more Spy dimers form a 
surface coat to enclose the substrate polypeptide. The flexible termini might provide 
additional, extended non-specific contacts with the substrate protein as seen with the 
close approach of His24 to the substrate. This histidine lies in a disordered region, 5 
residues beyond the first residue resolved in the crystal structure, which is located at the 
interior corner of the cradle (Figure 3.16 b). This binding mode is consistant with the lack 
of fluorescence quench of derivatized Lys77 upon substrate binding. This residue lies on 
the outside (convex) side of the cradle. 
The highly flexible nature of Spy may allow the chaperone to accommodate a 
variety of partially unfolded protein substrates.  It has been proposed that structural 
disorder could play a fundamental role in the function of many chaperones
190
. The basis 
of their high flexibility, which is usually a high ratio of charged to hydrophobic residues, 
allows chaperones to keep their bound substrate proteins soluble and to prevent their 
aggregation. The extremely high flexibility of the periplasmic chaperone HdeA, for 
example, appears to allow this chaperone to bind numerous substrate proteins and prevent 
aggregation
188
. Spy may thus act as a cradle shaped wrapper that thinly coats proteins, 
protecting them from aggregation and possibly proteolysis as well. The levels of unstable 
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Im7 mutants go from barely detectable levels to nearly 10% of the periplasm upon Spy 
overproduction, likely because it is very effective in preventing in vivo proteolysis by 
promoting well folded proteins. This wrapper has two surfaces, a concave interior 
hydrophobic surface designed to interact with substrates, and a convex hydrophilic outer 
surface designed to maintain solubility of the chaperone-substrate complex.  This 
mechanism is consistent with the high abundance of Spy under stress conditions and may 
explain how Spy is able to increase the levels of unstable proteins in the cell by up to 
nearly 700 fold. 
Although suppression of protein aggregation does not require energy, release and 
refolding of bound substrate proteins usually does
40
. ATP is absent in the periplasm and 
in our assays was not required for the refolding function of Spy, indicating that the 
chaperone activity of Spy is ATP-independent. Thus, Spy appears to be one of the very 
few chaperones that actively support protein refolding in the absence of any obvious 
energy source, suggesting that Spy uses a different mechanism to control substrate 
binding and release from previously characterized chaperones. How Spy enables 
refolding in the absence of energy cofactors is a provocative question for future research. 
At this point we can only speculate that the apparently highly dynamic nature of the Spy 
structure may allow structural fluctuations that not only allow it to mold to various 




3.4.1 Strains and plasmids used in this study 
Table 3.6 Strains and plasmids 
Strain Genotype or relevant characteristics Source 
EMS1 SQ1306, baeS R150W This study 
EMS2 SQ1306, baeS R150W This study 
EMS3 SQ1306, baeS P192L This study 
EMS4 SQ1306, baeS R416C This study 
EMS5 SQ1306, baeS R150W This study 
EMS6 SQ1306, baeS D268N This study 
EMS7 SQ1306, PenVR, CdCl2
R This study 
EMS8 SQ1306, baeS D268N This study 
EMS9 SQ1306, baeS E264K This study 
EMS10 SQ1306, baeS R150W This study 
SQ765 MG1655 (F¯ λ¯ ilvG¯ rfb-50 rph-1), ΔhsdR This study 




SQ1405 EMS4, pCDFTrc-ssIm7wt This study 
SQ1406 EMS4, pCDFTrc-ssIm7L53AI54A This study 
SQ1407 EMS4, pCDFTrc-ssIm7I22V This study 
SQ1408 EMS4, pCDFTrc-ssIm7F84A This study 
SQ1409 EMS9, pCDFTrc-ssIm7wt This study 
SQ1410 EMS9, pCDFTrc-ssIm7L53AI54A This study 
SQ1411 EMS9, pCDFTrc-ssIm7I22V This study 
SQ1412 EMS9, pCDFTrc-ssIm7F84A This study 
SQ1413 SQ1306, pCDFTrc-ssIm7wt This study 
SQ1414 SQ1306, pCDFTrc-ssIm7L53AI54A This study 
SQ1415 SQ1306, pCDFTrc-ssIm7I22V This study 
SQ1416 SQ1306, pCDFTrc-ssIm7F84A This study 
SQ1436 SQ1306, pCDFTrc This study 
SQ1594 SQ1306, yegL::kan This study 
SQ1640 SQ1306, baeS R416C, yegL::kan This study 
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SQ1606 EMS4, yegL::kan This study 
SQ1608 EMS4, baeS wt, yegL::kan This study 
SQ1843 EMS4, spy::kan This study 
SQ1529 EMS4, baeSR::kan This study 
SQ1521 EMS4, baeS::kan This study 
SQ1838 EMS4, mdtABCD::kan This study 
SQ1848 EMS4, acrD::kan This study 
SQ1698 SQ765,  ΔyegL, baeS R416C This study 
SQ1700 SQ765,  ΔyegL, baeS E264K This study 
SQ1712 SQ765, ΔyegL This study 
SQ1761 SQ1698, pCDFTrc-ssIm7L53AI54A This study 
SQ1762 SQ1700, pCDFTrc-ssIm7L53AI54A This study 
SQ1763 SQ1712, pCDFTrc-ssIm7L53AI54A This study 
SQ1804 SQ765, pCDFTrc-ssIm7wt, pTrc-spy This study 
SQ1805 SQ765, pCDFTrc-ssIm7L53AI54A, pTrc-spy This study 
SQ1806 SQ765, pCDFTrc-ssIm7I22V, pTrc-spy This study 
SQ1807 SQ765, pCDFTrc-ssIm7F84A, pTrc-spy This study 
SQ1808 SQ765, pCDFTrc-ssIm7wt This study 
SQ1809 SQ765, pCDFTrc-ssIm7L53AI54A This study 
SQ1810 SQ765, pCDFTrc-ssIm7 I22V This study 
SQ1811 SQ765, pCDFTrc-ssIm7 F84A This study 
SQ1731 SQ765, Δspy This study 
SQ1777 SQ765, ΔbaeSR This study 
SQ1825 SQ1777, pCDFTrc-ssIm7wt, pTrc-spy This study 
SQ1826 SQ1777, pCDFTrc-ssIm7L53AI54A, pTrc-spy This study 
SQ1827 SQ1777, pCDFTrc-ssIm7I22V, pTrc-spy This study 
SQ1828 SQ1777, pCDFTrc-ssIm7F84A, pTrc-spy This study 
SQ1829 SQ1777, pCDFTrc-ssIm7wt, pTrc99a This study 
SQ1830 SQ1777, pCDFTrc-ssIm7L53AI54A, pTrc99a This study 
SQ1831 SQ1777, pCDFTrc-ssIm7I22V, pTrc99a This study 
SQ1832 SQ1777, pCDFTrc-ssIm7F84A, pTrc99a This study 
SQ1833 SQ1777, pCDFTrc, pTrc-spy This study 
SQ1796 SQ765, pTrc-spy This study 
All strains were derivatives of E. coli K-12 strains. 
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Plasmid Relevant characteristics Source 
pBR322bla::GS linker Im7 
L53AI54A 
Im7 L53AI54A inserted into bla at aa197 via 
GS linker 
Foit et al.102 
pBAD33dsbA::GS linker Im7 
L53AI54A 
Im7 L53AI54A inserted into dsbA at aa99 via 
GS linker 
This study 
pCDFTrc Expression vector with the CloDF13-derived 
CDF replicon191, Trc promoter and 
kanamycine resistant marker 
This study 
pCDFTrc-ssIm7 wt Im7 wt with signal sequence of dsbA cloned 
into pCDFTrc vector 
This study 
pCDFTrc-ssIm7 L53AI54A Im7 L53AI54A with signal sequence of dsbA 
cloned into pCDFTrc vector 
This study 
pCDFTrc-ssIm7 I22V Im7 I22V with signal sequence of dsbA 
cloned into pCDFTrc vector 
This study 
pCDFTrc-ssIm7 F84A Im7 F84A with signal sequence of dsbA 
cloned into pCDFTrc vector 
This study 
pET28bsumo-spy Spy without signal sequence cloned into 
pET28bsumo vector, for Spy purification 
This study 
pTrc99a Expression vector Pharmacia 




3.4.2 Cloning and strains construction 
Plasmid construction.  The wild-type dsbA gene including the ribosome binding 
site was amplified from the MG1655 genome with primer 1 (5’CGC GGG TAC CAG 
GAG GAA TTC ATG AAA AAG ATT TGG CTG GCG3’) and primer 2 (5’CGC GTC 
TAG ATT ATT TTT TCT CGG ACA GAT ATT TCA C3’), and was cloned into 
pBAD33a via KpnI and XbaI sites. A 30-amino acid GS linker
102
 was introduced into 
dsbA with a procedure similar to that described previously
102
, using primer 3 (5’CGC 
GTC CGG GAG CGG TTC CGG AAG CGG AGG AGG TGG TTC AGG CGG AGG 
TGG AAG CCA GAC CAT TCG TTC TGC TTC TGA TAT CCG CGA TGT ATT TAT 
C3’) and primer 4 (5’CGC GTC CCG GAT CCT GAG CTC GAG CCA CCA CCA CCA 
GAA CCA CCA CCA CCG GTT TTC TGT ACG CCT TCA AAC AGC GGA ACA 
GTC ACT TTG TC3’). Im7 L53AI54A, amplified using primer 5 (5’CGC GGG ATC 
CGA ACT GAA AAA TAG TAT TAG TG3’) and primer 6 (5’CGC GGG ATC CGC 
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CCT GTT TAA ATC CTG GC3’) with pBR322bla::GS linker Im7 L53AI54A
102
 as 
template, was inserted into the linker region via the BamHI site.  
Vector pCDFTrc for Im7 expression was constructed by ligation of the 0.9 kb 
NdeI- ApaI fragment from the pTrc99a derived vector pssTrx
99
 and the 2.8 kb NdeI-ApaI 
fragment from pCDFDuet-1 (Novagen). The resulting plasmid was digested by AgeI and 
NheI, and the larger fragment was ligated through the same restrictions sites with a linear 
fragment containing the kanamycin resistant marker and its promoter. The NdeI site was 
then changed to the BamHI site by QuickChange mutagenesis (Stratagene) to create the 
pCDFTrc vector. C-terminal 6-His tagged Im7 (wild-type and 3 variants) was inserted 
into the pCDFTrc vector via the BamHI site using primer 7 (5 GCG CGG ATC CAT 
GGA ACT GAA AAA TAG TAT TAG3 ) and primer 8 (5 GCG CGG ATC CTT AAT 
GGT GAT GGT GAT GAT GGC CCT GTT TAG CTC CTG GCT TAC C3 ). A two-
step polymerase chain reaction (PCR) was performed to add the signal sequence of dsbA 
in front of the Im7 gene. Step 1: primer 9 (5 GCG CGG ATC CAT GAA AAA GAT 
TTG GCT GGC3 ) and primer 10 (5 GTG TAA TCA CTA ATA CTA TTT TTC AGT 
TCC GCC GAT GCG CTA AAC GC3 ) were used to amplify the signal sequence of 
dsbA. In a different reaction, primer 11 (5 GCG TTT AGC GCA TCG GCG GAA CTG 
AAA AAT AGT ATT AGT GAT TAC AC3 ) and primer 12 (5 GCG CGG ATC CTT 
AAT GGT GAT G3 ) were used to amplify the Im7 gene. Primers 10 and 11 reverse 
complement each other and correspond to 15 base pairs (bp) of the dsbA signal sequence 
and the first 32 bp of the coding sequence of Im7. Step 2: full length amplification 
products that were generated from the above two reactions were used as templates to 
amplify the Im7 gene that now contained the dsbA signal sequence, using primers 9 and 
12. The resulting fragment was ligated into pCDFTrc via the BamHI site to obtain 
pCDFTrc-ssIm7.  Although the dsbA signal sequence was added, Im7 remains under the 
control of the trc promoter, which is different than those promoters that drive either 
bla::Im7 expression (bla) or DsbA:Im7 expression (pBAD).  These Im7 expression 
plasmids are under the CDF copy control mechanism, which is independent from the 
copy control mechanism that governs either the bla::Im7 fusion (the pMB1 ori) or the 
dsbA::Im7 fusion (the p15A ori).  
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To obtain pTrc-spy, the vector pssTrx was digested with NdeI and BamHI and then 
ligated with the PCR-amplified spy gene that had been cleaved with the same restriction 
enzymes. Spy was amplified from the MG1655 genome with primer 13 (5 GCG CCA 
TAT GCG TAA ATT AAC TGC ACT G3 ) and primer 14 (5 GCG CGG ATC CTT ATT 
CAG CAG TTG CAG GCA3 ).  
Gene disruption.  The spy, baeS, baeSR and mdtABCD genes were disrupted 
through recombination between short homologous DNA regions according to the method 
of Wanner
192
. This method involves amplifying the kanamycin resistant gene and 
flanking by Flp recognition sites using primers that also contain homology to the gene to 
be disrupted. Primers for gene disruption were as follows. spy: 5 GAA AGC CGT AAT 
AAA TAA CTG AAA GGA AGG ATA TAG AAT ATT CCG GGG ATC CGT CGA 
CC3  and 5 GTG GAC AAG ACC GGC GGT CTT AAG TTT TTT GGC TGA AAG 
ATG TAG GCT GGA GCT GCT TCG3 ; baeS: 5 CAA AAT GTA GCT ATT TCG 
CGG CGA AAA AGG AGC GCG CAA TTC CGG GGA TCC GTC GAC C3  and 
5 CAA AAT ACG CGG TGT GTT TTC GTC GAT TGG TAA CTC GGT GTA GGC 
TGG AGC TGC TTC G3 ; baeSR: same forward primer as for baeS disruption and 
reverse primer 5 GAA CGC CAT CTC CGG CTA ACA AAA TAA TGT CGC TAA 
AAT GTA GGC TGG AGC TGC TTC G3 ; mdtABCD: 5 TTC CGC GAA ACG TTT 
CAG GAA GAG AAA CTC TTA ACG ATG ATT CCG GGG ATC CGT CGA CC3  
and 5 CAG AAC TTC ATT GCG CGC TCC TTT TTC GCC GCG AAA TAG CTG 
TAG GCT GGA GCT GCT TC3 .  Following amplification and linear recombination into 
the chromosome, the kanamycin resistance gene was removed by transformation with a 
plasmid that encodes the flip recombinase.  Since this procedure requires a step of 
introducing the cells with an Amp
R
 plasmid pKD46 (that encodes the λ red recombinase), 
the Amp
R
 pBR322bla::GS linker Im7 L53AI54A plasmid in SQ1306 and EMS4 was 
cured by a selection on fusaric acid agar plates as described previously
193
.  After the 
target gene was disrupted in the resulting strain, pKD46 was cured by growth at high 
temperature as previously described and pBR322bla::GS linker Im7 L53AI54A was 
retransformed. The gene acrD was disrupted by P1 transduction with donor phage 
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prepared from the acrD::kan strain from the Keio collection
169
.  Kanamycin (30 g/ml) 
was used for the selection of gene disruption. 
3.4.3 Mutagenesis and selection 
Mid-log phase culture (A600nm≈ 0.5, 40 ml) of SQ1306 was harvested and washed 
twice with 40 ml buffer A (10.5 g/L K2HPO4, 4.5 g/L KH2PO4, 1 g/L (NH4)2SO4, and 0.5 
g/L sodium citrate•2H2O). Cells were pelleted and resuspended in buffer A to a 
normalized cell density of A600nm= 1.0. Then, 2 ml aliquots were supplemented with 30 l 
of the mutagen ethyl methanesulfonate (EMS) (Sigma, 99%) and incubated at 37 °C with 
200 rpm shaking for 15 to 180 min. Cells of each aliquot were pelleted and washed twice 
with 5 ml buffer A. Cells were finally resuspended in 2 ml buffer A and the survival 
percentage following mutagenesis was determined by titering the cells on LB agar plates. 
The remaining cells were supplemented with 15% v/v glycerol and stored at 80 °C. 
Cells treated with EMS for less than 60 min showed a 100% survival rate, whereas 
survival decreased to 25% after treatment for 180 min. For selection of clones with 
increased PenV resistance, each pool of EMS treated cells was grown at 37 °C for 4 
hours. Cell density was normalized to A600nm=1.0, and a serial dilution was made in a 
sterile 170 mM NaCl solution. A100 l aliquot of the 10
3
 dilution (approximately 10
5
 
cells) was spread on LB agar plates supplemented with 1500 g/ml PenV and 0.2% w/v 
arabinose. After 18 hours incubation at 37 °C, the penicillin resistant colonies were 
picked, inoculated, and screened for cadmium resistance via a spot titer method 
(described below). A total of 263 penicillin resistant colonies were obtained from 18 
plates. No cells resistant to 1500 g/ml PenV were observed in the absence of 
mutagenesis. 
3.4.4 Phenotypic assays 
Spot titers for PenV and cadmium resistance.  Spot titers were measured to 
quantify the relative PenV and cadmium resistance conferred by the β-lactamase-Im7 or 
DsbA-Im7 tripartite fusions. The cells were grown, serially diluted in 10-fold increments 
and plated as described in the experimental procedures of Chapter 2 with the following 
modifications: 2 l of each dilution was plated onto LB plates supplemented with 0.2% 
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arabinose and 1,500 to 6,000 g/ml PenV or 0.075 to 0.6 mM CdCl2. For each strain, the 
maximal cell dilutions allowing cell growth at each PenV or cadmium concentration were 
plotted against PenV or cadmium concentrations, in order to generate a titration curve. 
Ratios of minimal inhibitory concentration (MIC) values (MIC mutant/ MIC wt) were 
calculated from the titration curve as described in Ref
102
. Firstly, the maximal penicillin 
or cadmium concentrations that cells can survive to at each dilution were obtained from 
the curve. The ratios of MIC mutant/ MIC wt at each cell dilution were then calculated. 










Quantitative RT-PCR. Total RNA was extracted from mid-log phase cultures 
using the RNeasy Mini Kit (Qiagen). For SQ1796, cells were induced to overexpress Spy 
by culturing with 1 mM IPTG for 3 hours at 37 °C. Genomic DNA contamination was 
removed with a TURBO DNA-free kit (Ambion). Extracted RNA (1 µg) was used for the 
reverse transcription polymerase chain reaction (RT-PCR) using SuperScript III reverse 
transcriptase kit (Invitrogen) with RNase inhibitor (Invitrogen) in a 30 l reaction. Fifty 
nanograms of cDNA was used per 10 l q-PCR reaction as described previously
57
 with a 
Mastercycler EP Realplex real-time PCR system (Eppendorf). Primers were designed by 
D-lux
TM
 Designer (Invitrogen: http://escience.invitrogen.com/lux/). Cycle threshold (Ct) 
values were calculated with the Realplex software (Eppendorf) and then analyzed with 
REST 2009 (Qiagen). 
3.4.5 Protein purification and biochemical assays 
Spy purification.  The gene for spy minus its signal sequence was amplified from 
the MG1655 genome using primer 15 (5 CGC GGG ATC CGC AGA CAC CAC TAC 
CGC AG3 ) and primer 16 (5 CGC GCT CGA GTT ATT CAG CAG TTG CAG GCA3 ) 
and ligated into a pET28b-based vector
194
 (generously provided by the Ming Lei lab at 
the University of Michigan) with sequences encoding a 6-His-SUMO tag fused at the N 
terminus. The expressed His-SUMO tag can be specifically removed by ULP1 protease, 
leaving a single serine residue at the N terminus of the protein. E. coli BL21(DE3) 
bearing the pET28bSUMO-spy plasmid was grown at 37 °C to early log phase in LB 
media containing 100 g/ml of kanamycin and then shifted to 20 °C; Spy expression was 
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induced by addition of IPTG to 0.1 mM. After 16 hours of expression, cells were pelleted 
by centrifugation and resuspended in lysis buffer containing 50 mM Tris-HCl pH 8.0, 
400 mM NaCl, 10% glycerol, 3 mM 2-mercaptoethanol, 0.5 mg/ml lysozyme, 0.05 
mg/ml DNase, 0.2 mM phenylmethylsulfonyl fluoride (PMSF) and 1 tablet of protease 
inhibitor cocktail (complete mini EDTA-free, Roche) per 10 ml. Cells were lysed using a 
French press for 3 cycles at 1300 psi. After centrifugation for 1.5 hours at 14,000 rpm at 
4 °C, the supernatant was mixed with Ni-NTA agarose beads (Qiagen) and rocked for 2 
hours at 4 °C to allow binding of the His-tagged Spy protein. The beads were washed 
with 40 bead volumes of lysis buffer, allowed to settle, and resuspended in lysis buffer 
containing 75 g/ml ULP1 protease (provided by the Ming Lei lab at the University of 
Michigan). After overnight digestion at 4 °C, the mixture was applied to a mini-
chromatography column (Novagen Cat. No.69673-3), and the cleaved Spy protein was 
collected in the flow-through.  Spy was further purified by ion exchange 
chromotography. The cleaved Spy protein solution, which contained 400 mM NaCl, was 
diluted 6-fold with 20 mM HEPES, 0.5 mM EDTA, 5 mM 2-mercaptoethanol, at pH 6.5 
before loading onto a 5 ml SP-FF cation exchange column (GE healthcare). Spy was then 
eluted with a linear gradient from 0-0.6 M NaCl in 20 mM HEPES, 0.5 mM EDTA, 5 
mM 2-mercaptoethanol, pH 6.5. The resulting Spy protein was estimated to be >95% 
pure as analyzed by SDS-PAGE, and was stored in small aliquots at 80 °C. Prior to each 
experiment, Spy was then exchanged into the appropriate matching buffer (typically 40 
mM HEPES, 100 mM NaCl, pH 7.5) with a PD-10 desalting column (GE Healthcare).  
Quantification of proteins.  The amount of the tripartite fusion protein -
lactamase-Im7L53AI54A in SQ1306 and EMS1-10 was quantified by Western blot with 
anti- -lactamase antibody using whole cell lysate as described previously
102
 with minor 
modifications. To quantify plasmid-encoded Im7 (wild-type and variants) expressed in 
the absence of the fusion, cells were grown to mid-log phase in LB medium at 37 °C. Im7 
protein expression was induced with 2 mM IPTG for 2 hours. Addition of IPTG also 
induces the expression of Spy when the pTrc-spy plasmid is present. Periplasmic 
extractions were prepared as described previously
195
, and the proteins were separated 
using a Bioanalyzer 2100 (Agilent) with the high sensitivity protein 250 kit and the 
conditions specified by the manufacturer. To visualize the tiny signal corresponding to 
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Im7 present in the absence of Spy expression, a pico labeling protocol was applied 
(Agilent technical note, publication number: 5990-3703EN). Prior to labeling, 
periplasmic extractions were diluted to different extents to ensure the linear relationship 
between Im7 amount and signal. Protein ratios were determined by integrating the 
trough-to-trough peak area.  The high sensitivity 250 kit and the pico labeling protocol 
allowed the visualization and quantification of the very small amount of Im7 present in 
the absence of Spy, an amount that was not detectable on either Coomassie blue stained 
SDS-PAGE gels or on the Agilent bioanalyzer using either the 80 or 230 protein kits.  
Although excellent for determining the ratio of a single defined protein present in 
different sample preparations, we reasoned that differences in labeling efficiencies 
between different proteins would make this protocol suboptimal for quantifying 
percentages of the total protein.  Instead, the percentage of Spy and Im7 was quantified in 
overproducing strains using the protein 80 kit (Agilent) without labeling. Areas 
corresponding to Spy or Im7 peaks were compared to the total area of all proteins present 
in the periplasmic extract. In the absence of Spy, the Im7 peak was not detectable; 
therefore, the percentage of Im7 was calculated by dividing the Im7 percentage in the 
presence of Spy overexpression with the fold increase of Im7 level.  For example, Im7 is 
10% of total periplasm in SQ1405. Im7 expression increased 34-fold in SQ1405 
compared to SQ1413. The percentage of Im7 in SQ1413 was therefore calculated to be 
0.3%.  The percentage of Spy present in periplasmic extracts in different EMS strains was 
quantified similarly with the protein 80 kit.  
CD spectra and analysis
****
.  Far UV CD spectra (240-185 nm) of Spy were 
obtained using a Jasco J-810 spectropolarimeter. Spectra of 5 M Spy in 10 mM sodium 
phosphate buffer, pH 7.5 were collected at 20 °C using a 0.1 cm path length quartz 
cuvette. Analysis to predict secondary structure content used the CDSSTR algorithm and 




                                                 




Analytical gel filtration.  The oligomeric state of Spy was investigated by 
analytical gel filtration using a Superdex75 column (GE Healthcare). Due to the very low 
intrinsic extinction coefficient of Spy, fluorescein-labeled protein was used for 
experiments performed at low protein concentrations. Labeling with fluorescein 
isothiocyanate (FITC) (Invitrogen) was performed according to instructions from the 
manufacturer.  Various concentrations of Spy (0.1–50 M, concentration given as a 
monomer) were injected onto the column using a 100 L loop, and the protein was eluted 
with HN buffer (40 mM HEPES-KOH, 100 mM NaCl, pH 7.5). The apparent molecular 
weight of Spy was determined by comparison to a calibration curve generated with 
globular proteins of known molecular weights. The low molecular weight standard kit 
was purchased from GE healthcare and used as suggested by the manufacturer. 
Fluorescence Labeling. Labeling of Spy variants (H24C and K77C) was 
performed by first reducing both mutant proteins in 50 mM sodium phosphate buffer (pH 
8) with 10 mM DTT, on ice for 1 h. Excess DTT was removed with a NAP5 desalting 
column (GE Healthcare). Spy mutants were then incubated with a 3-fold molar excess of 
monobromobimane in 50 mM sodium phosphate buffer (pH 8) for 1 h at RT. Excess dye 
was removed with NAP5 desalting columns. Labeling efficiency was determined 
spectrophotometrically. A saturated stock solution of monobromobimane (Invitrogen) 
was prepared and the concentration was determined as suggested by the manufacturer, 




. A defined dilution of the free dye in sodium phosphate buffer 
was prepared and the extinction coefficient ε at 398 nm                                                     




) as well as a correction factor (1.15 = A280/A398) for 
the absorbance at 280 nm were calculated. The absorbance at 398 nm was then used to 
determine the concentration of the dye in the labeled sample and the concentration of the 




) was finally calculated by subtracting the 
proportional absorbance of the dye at 280 nm from the total absorbance of the sample 
using the correction factor. The label efficiency appeared to be 1.00 for H24C and 0.98 
for K77C. 
Fluorescence Anisotropy. Bimane-labeled Spy mutants (0.5 μM final 
concentration) were incubated in 40 mM Hepes buffer containing 100 mM NaCl (pH 7.5) 
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at 20°C for 5 min in the absence of casein, then an equimolar amount of casein was 
added. Anisotropy (r) was calculated according to the following equations: 
G = Ihv/Ihh        [1] 
r = (Ivv – G*Ivh)/(Ivv + 2GIvh)      [2] 
where G is the instrument correction factor, r is anisotropy, and I is the 
fluorescence intensity measured with polarizers in the orientations indicated by the 
subscripts
198
. Anisotropy was recorded with a Cary Eclipse Spectrofluorimeter using λex 
= 398 nm (10 nm bandpass) and λem  = 466 nm (10 nm bandpass). 
Fluorescence Emission Spectra. Bimane-labeled Spy mutants (0.5 μM) were 
incubated in 40 mM Hepes, 100 mM NaCl  (pH 7.5) at 20°C for 5 min. Emission spectra 
were then recorded before and after addition of a 3-fold molar excess of casein. Emission 
spectra were recorded from 408-650 nm, using an excitation wavelength of 398 nm (5 nm 
spectral bandpass). 
3.4.6 Chaperone activity assays†††† 
Aggregation assays.  Thermal aggregation of malate dehydrogenase (MDH) was 
monitored by light scattering at 43 °C. MDH from pig heart mitochondria (Roche) in 50 
mM potassium phosphate, 0.5 mM EDTA, pH 7.5, was diluted to a final concentration of 
154 nM into pre-warmed 40 mM HEPES-KOH (pH 7.5) in the absence or presence of 
various concentrations of Spy. Aggregation of MDH at 43 °C was monitored by light 
scattering at excitation/emission wavelength of 360 nm using a F-4500 fluorescence 
spectrophotometer (Hitachi).  
Guanidine-denatured MDH, aldolase, and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) were prepared by incubating 50 M of the respective protein in 
5.4 M guanidine HCl, 50 mM Tris, 20 mM DTT, pH 7.5 for ≥ 2 hours at room 
temperature. Urea-denatured MDH was prepared by incubating 50 M MDH in 6.6 M 
urea containing 10 mM DTT for >1 hr at room temperature. MDH, Aldolase, and 
                                                 
†††† I wrote the methods for MDH aggregation and refolding assays. The rest methods in this section 
were written by Tim Tapley. 
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GAPDH were then diluted to final concentrations of 500, 300, and 500 nM, respectively, 
into HN buffer (40 mM HEPES-KOH, 100 mM NaCl, pH 7.5) pre-equilibrated at 20 °C 
in the absence or presence of various concentrations of Spy. Aggregation of ethanol-
denatured MDH was monitored by incubating 1 M MDH in HN buffer containing 10% 
v/v ethanol at 30 °C in the absence or presence of various concentrations of Spy. Light 
scattering was monitored using a Varian Eclipse spectrofluorimeter equipped with a 
Peltier temperature control unit. Excitation (2.5 nm spectral band-pass) and emission (5 
nm spectral band-pass) were set to 500 nm. The light scattering signal of proteins in the 
absence of Spy was used for normalization. Aldolase from rabbit heart muscle, alkaline 
phosphatase from E. coli, and GAPDH from baker’s yeast were purchased from Sigma. 
MDH from pig heart mitochondria was purchased from Roche. 
MDH refolding assay.  MDH activity was assayed as described previously
199
. 
Briefly, 5–50 l of the reaction mixture (inactivation or refolding) was mixed with 950 l 
substrate (0.15 mM NADH and 1 mM oxaloacetate in 50 mM sodium phosphate buffer, 
pH 8.0). The absorbance change at 340 nm was monitored and the initial slope was 
calculated and divided by the value corresponding to 100% activity (i.e., that of an 
equivalent concentration of native MDH) to obtain the percentage of native MDH 
activity. To measure the thermal inactivation of MDH, 5-50 l aliquots were removed at 
various times and assayed for MDH activity. To initiate refolding of thermally unfolded 
MDH, samples were shifted to 25 °C at a defined time after the start of thermal 
inactivation, and aliquots were taken to monitor reactivation. 
LDH refolding assay.  LDH (from rabbit muscle, Roche) was exchanged into HN 
buffer (40 mM HEPES, 100 mM NaCl, pH 7.5) using a NAP5 desalting column (GE 
Healthcare).  LDH was then denatured by addition of guanidine HCl to a final 
concentration of 3.8 M and incubated at room temperature for >2 hours. The influence of 
Spy on LDH refolding in HN buffer at 20 °C was then tested by diluting denatured LDH 
166-fold into HN buffer, to a final concentration of 0.3 µM in the absence or presence of 
0.5 M Spy. Aliquots were tested at various times for LDH activity according to a 
protocol provided by Sigma. The activity assay buffer contained 1.1 mM pyruvate and 
0.12 mM NADH in 100 mM sodium phosphate, pH 7.5. LDH activity was measured by 
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monitoring the conversion of NADH to NAD
+
, which results in a decrease in absorbance 
at 340 nm. 
MDH refolding competition assay. Competition assay with denatured Malate 
dehydrogenase (MDH) and α-casein was performed as described for MDH alone except 
that different amounts of α-casein were added to the Spy-WT containing buffer before 
denatured MDH was added. Ratios of casein: MDH of 1:1, 4:1 and 8:1 were used. 
Tannic acid inactivation of enzyme activity.  All samples were equilibrated for 5 
min at 20 °C before addition of tannic acid (Sigma). Spy was added just prior to 
temperature equilibration. Aliquots were taken from the assays at different time points 
(0–60 min), added to the activity assay buffer, and assayed in triplicate. 
Bacterial alkaline phosphatase (Sigma) was incubated in HN buffer (40 mM 
HEPES-KOH, 100 mM NaCl, pH 7.5) at a final concentration of 1 M in the absence or 
presence of increasing amounts of Spy and supplemented with 500 M tannic acid. Then 
5 l aliquots were removed at various times and assayed for alkaline phosphatase activity 
by mixing with 995 l alkaline phosphatase activity buffer (100 mM glycine, 1 mM 
MgCl2, 1 mM ZnCl2, 6 mM p-nitrophenyl phosphate, pH 10.4). Alkaline phosphatase 
activity was determined by monitoring absorbance changes at 405 nm due to the 
formation of p-nitrophenol resulting from cleavage of inorganic phosphate from the p-
nitrophenyl phosphate substrate (according to the protocol provided by Sigma).   
DsbB was purified as previously described
200
. DsbB (0.5 M) was incubated with 
100 M tannic acid in a buffer containing 50 mM Na phosphate, pH 6.0, 300 mM NaCl, 
0.1% n-dodecyl- -D-maltopyranoside at 20 °C in the presence or absence of Spy. At the 
time points indicated, 4 l of the sample was mixed with 196 l DsbB activity buffer (50 
mM Na phosphate, pH 6.0, 300 mM NaCl, 25 M DsbA, and 25 M ubiquinone Q1), 
and DsbB activity was determined as previously described
200
.  
Aldolase (0.5 M) was incubated with 16 M tannic acid in a buffer containing 
100 mM K phosphate, pH 7.5, 0.5 mM EDTA at 20 °C in the presence or absence of Spy. 
At the indicated time points, 5 l aliquots were withdrawn and mixed with 196 l 
aldolase activity buffer (0.1 M Tris, 1.9 mM fructose 1,6-diphosphate, 0.13 mM -
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NADH, 5 units -glycerophosphate dehydrogenase/triosephosphate isomerse, pH 7.5), 
and aldolase activity was determined by monitoring the decrease in absorbance at 340 nm 
due to conversion of -NADH to -NAD
+
, according to the protocol provided by Sigma. 
Spy sediments upon ultracentrifugation as a 30 kDa species, indicating that Spy forms a 
dimer in solution.  Thus, except where specifically noted, all concentrations of Spy given 
in this manuscript are of the dimer.  The ratios of Spy:substrate were also calculated 
based on the assumption that Spy is active as a dimer.    
3.4.7 Structural analysis‡‡‡‡ 
Crystallization. Initial crystallization conditions of the His6-Spy were identified 
using the AmSO4 suite (Qiagen Inc, Canada).The SeMet substituted protein was 
crystallized under the same conditions. The best diffracting crystals were obtained by 
mixing 1 μl protein in the final buffer with 1 μl of reservoir solution containing 0.3 M 
CdCl2 and 2.4 M AmSO4, under the vapor diffusion hanging drop method.  Prior to data 
collection the crystals were cryoprotected in paratone and flash frozen in liquid nitrogen. 
Data collection and processing.  The diffraction data were collected from a single 
crystal at the CMCF-1 beamline at the Canadian Light Source (CLS), Saskatoon, 
Saskatchewan at the Se absorption edge (wavelength of 0.9792 Å) to 2.6 Å resolution.  




Structure determination and refinement. The structure was solved by the single 
anomalous diffraction method. Of the 22 expected selenium atoms in the asymmetric 
unit, 8 were located and refined using autoSHARP
202
. These sites were used to obtain 
preliminary phases. The model was build manually in Coot
203
 using the Se sites as 
reference points. Of the 146 residues (138 protein + 8 tag), 92 showed clear backbone 
density in each monomer. Several cycles of refinement using REFMAC5
204
  followed by 
model rebuilding were carried out. The final refinement was performed with PHENIX
205
 
and included the TLS model for thermal motions. The pertinent data are shown in Table 
                                                 
‡‡‡‡ Miroslaw Cygler wrote this section. 
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3. The coordinates and structure factors have been deposited in the Protein Databank with 
accession code 3O39. 
Table 3.7 Data collection and refinement statistics for Spy 
 
Data collection  
Space group P62 
Cell dimensions   
a, b, c (Å) 68.97, 68.97, 124.28 
Resolution (Å)* 50-2.6 (2.66-2.6) 
R merge* 0.116 (0.575) 
Mean I/σI* 37.1 (2.9) 
Completeness (%)* 97.8 (5.2) 
Multiplicity* 

























Rms Derivations  
Bond length (Å) 0.014 
Bond angle (°) 1.32 
PDB code 3O39 







Chapter 4  
Discussion and future direction 
4.1 Further characterization of Spy 
4.1.1 Identification of the in vivo substrates of Spy 
Spy has been shown to be an efficient ATP-independent chaperone in vitro. In vivo, 
its massive expression greatly enhanced periplasmic Im7 expression. The mechanism by 
which Spy binds substrate proteins is not entirely understood. It is particulary interesting 
how Spy can aid in substrate refolding in an energy independent manner.  It is also 
unclear what the physiological substrates of Spy are. I propose several experiments to 
address these questions. To identify the physiological substrates, I plan to use two-
dimensional (2D) gel electrophoresis to compare the periplasmic contents from the wild 
type, spy null, and Spy overexpression strains. This technique has proven to be effective 
in the identification of substrates for DsbA and DsbC
206
. 
Preliminary experiments were carried out to compare the periplamic contents from 
a wild type strain (SQ1712) and a strain with the baeS 416C mutation (SQ1698, see the 
strain list in Chapter 3 for details) that led to the massive production of Spy. Pseudo-2D 
gel experiments performed with an Agilent 2100 bioanalyzer shows that the Spy 
overexpression strain SQ1698 contains more periplasmic proteins than the wild type 
strain SQ1712 (Figure 4.1). This observation suggests that Spy stabilizes a number of 
periplasmic proteins, and that these proteins might be potential substrates of Spy. I plan 





Figure 4.1 Pseudo 2D gel of the periplasmic samples from a wild type and a Spy-
overexpression strain 
Approximately 300 ml of mid-log phase cells (A600=0.5) grown in LB medium were harvested for 
periplasmic extraction (methods as described in Ref.206). The periplasmic contents were 
precipitated by incubating the periplasmic samples with 15% TCA on ice for 1h, followed by 
centrifugation at 13,000 rpm for 20 min. The pellets were washed twice with ice-cold acetone, air 
dried, and resuspended in 450 μl of reducing 2D buffer. The first dimension of the pseudo 2D gel 
was separated by isoelectric focusing with an Agilent 3100 off-gel machine. Samples (150μl) 
were loaded into each well on top of the IPG strip and were separated into 12 fractions along a 
pH gradient, ranging from pH 3-10. After separating the first dimension, fractionated proteins 
were recovered from each well in the sample buffer. Each fraction was then subjected to analysis 
using an Agilent 2100 bioanalyzer with protein 80 chips (as described in Chapter 3). Periplasm: 
periplasmic extraction from SQ1698 or SQ1712 without any further treatment; TCA precipitated: 
periplasmic extraction from SQ1698 or SQ1712 precipitated by 15% TCA and resuspended in the 
2D sample buffer. TCA precipitation was efficient to precipitate almost all the proteins in the 
periplasmic extracts. These experiments show a number of differences in proteins expressed in 
the baeS R416C mutant compared to the wild type strain, in addition to Spy overproduction. 
These proteins might be in vivo substrates for Spy that were stabilized by Spy overproduction. 
 
4.1.2 Identification of the substrate binding sites of Spy 
The crystal structure suggests that Spy forms a cradle-shaped dimer with 
unstructured regions at both ends and a cluster of hydrophobic residues inside of the 




function of many chaperones
190
. It is also well accepted that exposed hydrophobic 
surfaces in chaperones enable them to specifically recognize protein folding 
intermediates.We propose that both of the unstructured regions and the hydrophobic 
regions of Spy are potentially involved in substrate recognition, substrate binding, and 
substrate protection of Spy’s chaperone action. We therefore would like to identify the 
substrate binding site(s) of Spy through mutagenesis study of these regions.  
The structured fragment of Spy contains residues from Phe29 to Thr124. The 28 N-
terminal residues and 14 C-terminal residues could not be resolved in the crystal 
structure, indicating that they are highly disordered. Trypsin digestion of the mature Spy 
protein reveals a protease-stable fragment composed of residues 21-130
§§§§
. This 
fragment includes the structured fragment of Spy with additional eight N-terminal and six 
C-terminal residues. These additional residues are resistant to trypsin, although they are 
disordered, probably due to the lack of protease cleavage sites in them. We wonder 
whether the protease-resistant fragment of Spy containing residues 21-130 retains basal 
chaperone activity and whether the unstructured regions at the N- and C-termini aid in the 
chaperone activity. To identify whether the unstructured regions at the N or the C 
terminus contribute to the chaperone activity of Spy, I am going to make various 
truncation mutants of Spy and measure their activities both in vivo and in vitro. I will first 
make the Δ1-28 and the Δ125-138 mutants of Spy separately and in combination. If these 
truncated regions turn out to be important for the chaperone activity of Spy, I will shorten 
the truncated part to identify the minimal region at the termini required for Spy’s 
chaperone activity.  
We suggest that substrates bind to the concave side of Spy and hypothesize that 
mutations affecting the hydrophobic environment of the concave side of Spy would 
diminish its chaperone activity.  I will focus on the residues that are implicated in the 
hydrophobic exposed-surface and are involved in the hydrophobic core, namely Pro56, 
Met64, Ile68, Met85, Met93, Met97, Leu34, Ile42, Met46 and Ile103 (Figure 3.16). I 
plan to make serine substitutions to these residues and test chaperone activity of the 
mutants. I will start with making the L34S, L42S, I68S and I103S single or 
                                                 
§§§§ Tim Tapley and Philipp Koldewey performed the experiment. 
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combinational mutants since these mutated residues are conserved or semi conserved 
among Spy homologs in different species (Figure 3.17). This strategy will hopefully help 
to identify substrate binding residues in Spy. 
4.2 Use of the dual selection system to customize the folding of other test proteins 
4.2.1 Problems of protein solubility 
The dual selection system works in the periplasm of E. coli.  As discussed in 
Chapter 1, this particular compartment facilitates the formation of disulfide bonds, which 
is important for the stability and activity of many recombinant proteins. Therefore, we 
propose to test if the dual selection system could be adapted to customize the folding 
environment of proteins with disulfide bonds. 
Initially, I planned to clone six disulfide bond-containing proteins into bla (the gene 
encoding TEM-1 -lactamase) on the pBR322 vector. These proteins include bovine 
pancreatic trypsin inhibitor (BPTI), RNaseI, RNaseA, a truncated version of tissue 
plasminogen activator (vtPA), urokinase (uPA), and proinsulin (Figure 4.2). However, I 
have only been successful in cloning of BPTI and RNaseI. The insertion of the larger 
proteins with more complex disulfide patterns exclusively led to frame shifts in the 
cloned genes. The constitutive expression of these proteins from the bla promoter might 
be toxic to the cell; as a result, the cell responded by only allowing variants with 
disrupted reading frames to grow. To circumvent this problem, I cloned these genes into 
the -lactamase gene, bla, on a low copy vector under the control of a pBAD promoter 
(pBAD43). The tight regulation of the pBAD promoter, in the absence of the inducer, 
finally enabled me to obtain the constructs. When arabinose is present (0.2%),  cells 
containing such a construct still exhibit normal growth rate, indicating there is no major 
effect of the fusion proteins when expressed at lower levels. Therefore, fusion proteins 
made in the pBAD43 vectors were used for further analysis. Similarly, genes encoding 
these proteins were inserted into dsbA on the pBAD33 vector. The plasmids pBAD33 and 
pBAD43 are both under arabinose control, but have different origin of replication and 



























Figure 4.2 Proteins with multiple disulfide bonds 
Six test proteins with multiple disulfide bonds are inserted into bla on the pBAD43 vector via a 
30aa or a 60aa glycine-serine (GS) linker depending on the size of the protein. The disulfide bond 
patterns of these proteins are shown below their crystal structures. RNaseI is an E. coli protein 
located in the periplasm, so it is a physiological relevant substrate to study periplasmic folding 
modulators. The other proteins are from eukaryotic origins. BPTI and proinsulin contain 3 
nonconsecutive disulfide bonds (red); RnaseA contains 3 nonconsecutive and one consecutive 
disulfide bonds (black); vtPA, a truncated form of tissue plasminogen activator, contains 8 
nonconsecutive and one consecutive disulfide bonds; uPA, the urokinase-type plasminogen 
activator, contains 10 nonconsecutive and two consecutive disulfide bonds; RnaseI, contains one 









In studying the PenV resistance of these fusion constructs, I found an interesting 
correlation of the size of the inserted proteins, the number of nonconsecutive cysteines, 
and their PenV or Cadmium resistance. Larger proteins usually require sophisticated 
machinery to help efficient folding and quite often, these proteins have more disulfide 
bonds than the smaller ones. Proteins such as vtPA and uPA are therefore the most 
difficult targets to fold, leading to the lowest PenV or cadmium resistance (Figure 4.3).  
Intriguingly, the size of the protein seems to be a more important factor than the number 
of disulfide bonds (compare the R
2
 values of the upper left and lower left panels in Figure 
4.3). For example, the big protein, pepsinogen, confers very low PenV resistance to the 
cell when made as a fusion protein with β-lactamase, even though this protein contains no 
disulfide bonds (Figure 4.3). 
The periplasmic disulfide isomerase DsbC has been shown to increase the 
expression and disulfide bond formation in E. coli and eukaryotic proteins having non-
consecutive disulfide bonds. For example, overexpression of DsbC results in 16-fold 
higher yields of active vtPA
207
 and its absence causes ~ 10-fold decrease of RnaseI 
activity
206
 and a nearly 100-fold decrease of uPA activity
208
 compared to expression in 
wild type strains. Therefore, my initial test was focused on whether DsbC overexpression 
increases the PenV resistance of cells containing β-lactamase tripartite fusions with the 
six test proteins shown in Figure 4.2. To my surprise, neither the deletion of dsbC nor its 
overexpression changes the PenV resistance (data not shown and Figure 4.4 a) of strains 
except for the one expressing bla-RNaseI fusion, which showed slight dependence on 
DsbC (data not shown). On the other hand, a strain expressing vtPA alone in the absence 
of fusion partner still showed dependence on DsbC (Figure 4.4 b). Therefore, the fusion 
partner might slightly inhibit the efficient interaction of DsbC with the test proteins, or 
create additional folding problems that DsbC was not able to solve.  
To figure out the reason for DsbC-independence, I first determined whether the 
fusion proteins were secreted into the periplasm as expected. NaN3 (0.02%) was used to 
block the Sec-dependent translocation and the size of the fusion proteins were checked by 
SDS-page followed by western blot with antibody against β-lactamase. I discovered that 




Figure 4.3 Bigger protein or protein with more nonconsecutive disulfide bonds 




The minimal inhibitory concentration (MIC) for PenV or cadmium of strains expressing the 
tripartite fusion proteins was determined by spot titer as described in methods in Chapter 3. The 
MICs for PenV or cadmium are plotted against the molecular weight or number of non-
consecutive disulfide bonds of different inserted proteins. Linear regression was used to evaluate 
the correlations. Larger proteins are often more difficult to fold, resulting in lower antimicrobial 
resistance (upper panels). Disulfide bonds, especially the nonconsecutive ones, require effective 
oxidation and isomerization machinery to form correctly. This created an extra burden on the 












Figure 4.4 The fusion proteins with β-lactamase showed independence of DsbC for 
folding 
a, RNaseA fused with -lactamase was expressed in a wild type or a dsbC¯ strain following 
induction with 0.8% arabinose.  DsbC was overexpressed from a Trc promoter with DsbC’s 
signal sequence or with the Tat signal sequence in the dsbC strain. The penicillin V resistance of 
different strains was assayed by spot titer experiment as described in methods in Chapter 3. 
Neither the deletion of dsbC nor overexpression of DsbC changes the PenV resistance of cells 
expressing pBAD43bla-RnaseA. Using a Tat-dependent signal sequence seems to increase the 
amount of DsbC even further but still failed to increase PenVR. Similar results were obtained for 
β-lactamase fusion constructs with vtPA, uPA, BPTI, and pepsinogen. b, vtPA expressed alone in 
the absence of any fusion partner clearly showed dependence on DsbC. Periplasmic extracts were 
prepared from each strain at mid-log phase and vtPA activity was assayed for its ability to 
hydrolyze a chromogenic substrate (spectrozyme PL) resulting in the absorbance at 405nm. Little 
vtPA activity was detected in the dsbC null strain (blue curve). Weak activity of vtPA was 
detected in the wild type stain (magenta curve), and overexpression of DsbC from a plasmid 
substantially increased vtPA activity (orange and green curves). pvtPA: plasmid encoding vtPA. 




Figure 4.5 The fusion proteins are secreted into the periplasm 
Cells were grown to mid-log phase without arabinose induction. Then, 0.02% of NaN3 was added 
to one group of cultures to block the Sec-dependent translocation. After incubation at 37°C for 
30min, arabinose was added to a final concentration of 0.2% to induce the fusion proteins. After 
additional 3h incubation, cells were spun down and the whole cell lysates were prepared by 
boiling the cell pellets in reducing sample buffer containing 2% of SDS. The fusion proteins were 
detected with western blot using the anti-β-lactamase antibody, which was previously shown to 
effectively detect bla-Im7 fusion constructs. For each fusion protein compared (with or without 
NaN3 treatment), the lower band represents a smaller molecular whose signal sequence was 
cleaved off upon successfully translocation. The higher band represents the species that was 
trapped in the cytoplasm with an intact signal sequence. When the Sec pathway functioned 
normally, there was only one band for all the fusion proteins as well as the Bla-linker, indicating 
a complete translocation. Results were similar for bla-linker-BPTI/RNaseI proteins (not shown).    
  
Another reason why overexpression of DsbC failed to increase penicillin resistance 
of cells expressing the fusion proteins might be that these fusion proteins are insoluble 
and DsbC is not able to help insoluble proteins. To check the solubility of the secreted 
proteins, I prepared the soluble and insoluble fractions of each test strain. After lysozyme 
treatment and three cycles of freezing and thawing, the soluble and insoluble materials 
were separated by centrifugation. For bla-BPTI (wild type or its variant C14SC38S), only 
half of the protein was soluble. For proinsulin and RNaseA, the majority of the tripartite 
fusion proteins were associated with the insoluble fraction, though some soluble proteins 
were detectable. For uPA, vtPA, and RnaseI, unfortunately almost all the fusion proteins 
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are insoluble. On the other hand, at least 90% of bla-linker was soluble and more than 
half of bla-Im7 (wt and F84A variant) was soluble (Figure 4.6). I concluded, therefore, 
that the insolubility of the fusion proteins might largely mask any DsbC-dependence of 
those fusion proteins. 
 
Figure 4.6 Solubility test of the fusion constructs 
Cells for protein solubility test were grown to mid-log phase, then induced with 0.2% arabinose 
and 0.3% maltose for 3h before harvest. The cell pellets were resuspended in PBS buffer 
containing 1 mg/ml lysozyme, and then subjected to freezing and thawing in a dry ice/ethanol 
bath and an ice cold water bath. After three cycles, the cell suspension was nearly clear. 1 unit of 
DNase was added to the cell suspension to remove DNA and facilitate downstream application. 
Insoluble materials were pelleted by centrifugation at 13,000 rpm for 20 min at 4°C. The 
supernatant was carefully transferred to another tube and the pellet was resuspended in PBS to the 
original volume. Samples were then separated by SDS-PAGE and blotted with antibody against 
β-lactamase or MBP. The internal control, MBP, was shown to associate with the soluble fraction 
for most samples. For Bla-Im7 wt/F84A and Bla-BPTI wt/C14SC38S samples, there was some 
insoluble MBP detected, which might be an artifact because of incomplete cell lysis. Therefore, 
the 50% solubility of those proteins was underestimated. P: insoluble fraction (pellet). S: soluble 
fraction. 
 
Until now, in contrast to ClpB, DsbC has not been reported to actively solublize 
protein aggregates. A number of events must occur to link protein folding to antibiotic 
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resistance in this situation: firstly, the fusion proteins have to be rescued from 
aggregation, and then the folding of the substrate proteins must be promoted to enable the 
assembly of active β-lactamase to confer antibiotic resistance. Alternatively, the cells 
must be efficient at folding these eukaryotic proteins to prevent aggregation in the first 
place, which might be more difficult compared to rescuing an unstable yet soluble 
prokaryotic protein, Im7. Spy overproduction, unfortunately, was not able to solve these 
problems, at least for the case of RNaseI. The selection for chromosomal mutations that 
solubilize difficult targets such as RNaseI and aid in their folding would definitely 
enlarge our understanding of periplasmic chaperones and possibly identify novel 
periplasmic disaggregation chaperones. 
4.2.2 Is the dual selection system really necessary? 
The dual selection system was used to identify potential periplasmic folding 
modulators. In the PenV selection and cadmium screening process, only colonies that 
showed a strong increase of the resistance to both antimicrobials were chosen to be 
further analyzed. Nine of the ten resistant EMS strains turned out to have a mutation in 
baeS.  EMS7, the only strain that does not contain a mutation in baeS, however, showed 
an extremely high level of cadmium resistance and a slight PenV resistance. Moreover, 
the same mutation of baeS in EMS6, EMS8, and EMS10 conferred similar levels of PenV 
resistance but different levels of cadmium resistance (Figure 3.6 in Chapter 3). 
Furthermore, the reconstituted strain SQ1640 (SQ1306, baeS R416C, yegL::kan ) showed 
almost the same level of PenV resistance as EMS4 (Figure 3.10 in Chapter 3), but 
apparently lower cadmium resistance than EMS4 (data not shown). Therefore, these EMS 
strains probably contain other mutations that contribute to intrinsic cadmium resistance.  
For these reasons, we wondered whether the cadmium selection system is really 
necessary. To test this, the baeS genes in other EMS strains (EMS11-22) were amplified 
and sequenced
*****
. These 12 EMS strains were PenV resistant but were only slightly 
more cadmium resistant than the starting strain, SQ1306, or as cadmium sensitive as 
SQ1306. Surprisingly, 8 of the 12 EMS strains were found to contain mutations in baeS. 
                                                 
***** The experiment was performed by Jennifer Pfizenmaier. 
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EMS14, EMS15, and EMS21 contain the P255S mutation in baeS. EMS17 has the 
G421D mutation, EMS19 has the P255L mutation, EMS20 has the G261D mutation, and 
EMS18 has the G324DR416H mutation in baeS. EMS13 contains the same baeS E264K 
mutation as in EMS9, with a similar PenV resistance as EMS9. Western blot showed that 
the total amount of bla-Im7 L53AI54A was similar in EMS9 and EMS13 (data not 
shown), and all of the EMS strains with a baeS mutation increased the Bla::Im7 
L53AI54A total amount (data not shown). Thus, it seems that the screening for cadmium 
resistance is not absolutely necessary, as long as the level of the fusion proteins is 
measured. Though cadmium screening provides a quick and robust identification of 
interesting mutants, considering the high toxicity of the cadmium, we suggest using the 
measurement of protein level as a second screening method as described in section 3.2.2 
in Chapter 3. This strategy was used to select for folding factors of MalE31, an 
aggregation prone mutant of the periplasmic maltose binding protein (MBP).  
4.2.3 Example on -lactamase-MalE31††††† 
As previously discussed, the presence of disulfide bonds makes the folding process 
more complicated for large, aggregation-prone proteins. To test the folding functions 
alone, we studied the folding of a disulfide bond-free but aggregation prone protein, 
MalE31 (MBP G32DI33P), in the β-lactamase system. MBP captures maltose in the 
periplasm and transports the bound maltose to the inner membrane ABC transporter 
MalFGK, which then undergoes conformational changes to release maltose into the 
cytoplasm. MBP is among the proteins whose folding pathways have been extensively 
studied. It has variants exhibiting different folding abilities with measured 
thermodynamic stability values
209
. One of its variants, MalE31, forms aggregates in the 
periplasm. Upon insertion of the different variants into the β-lactamase system, we 
established a qualitative correlation of PenV resistance and the thermodynamic stability 
of MBP variants (Figure 4.7). It is noteworthy that the MalE31 variant showed 
dramatically decreased PenV resistance compared to other MBP variants, which are not 
aggregation prone (Figure 4.7). 
                                                 
††††† These experiments were performed by Jennifer Pfizenmaier. I supervised the cloning procedure 




Figure 4.7 Destabilized MBP variants confer lower PenV resistance 
Penicillin V resistance of cells expressing different MBP variants fused to β-lactamse were 
determined by spot titer experiment as described in methods in Chapter 3. The maximal dilutions 
of cells which still allowed the cell growth at each penicillin V concentration were plotted against 
penicillin V concentrations. a, The titration curves show that the highest PenV resistance comes 
from the relatively most stable variant of MBP, namely the wild type. The aggregation prone 
variant G32DI33P (MalE31) results in the lowest level of PenV resistance. b, Measured 
thermodynamic stabilities of MBP variants as presented by ΔΔG0 values209. A positive value in 
ΔΔG
0 
corresponds to a decrease in stability. Accordingly, the G19C variant is less stable than the 
A276G variant. This variant, however, survives to higher PenV concentration than the A276G 
variant in the spot titer experiment. Therefore, the PenV resistance provided a qualitative measure 
of the stability of -lactamase-MBP fusion proteins.  
 
We thought with the Bla-MBP G32DI33P system, we could select for 
chromosomal mutations that solubilize and probably stabilize the highly aggregation-
prone proteins. We used western blot with anti-β-lactamase or anti-MBP antibody to 
screen for increased solubility. Initially we obtained mutants that contain more soluble 
protein; however, these mutants all turned out to be revertants to wild type MBP after we 
sequenced the bla-MalE31 plasmid. We attributed this problem to the homologous 
recombination of the bla-malE31 gene with the chromosomal wild type malE, and we 
deleted the endogenous malE to prevent this problem. We also constructed a plasmid to 
overexpress MalE31 in the absence of any fusion context, which would provide 





this aggregation-prone variant. With the anti-MBP antibody, both the levels of MBP itself 
or in the fusion context with β-lactamase could be simultaneously detected. We are now 
working on the mutagenesis and screening of a malE null strain containing both plasmids.  
4.2.4 PolyQ-containing proteins are not aggregating in the periplasm, suggesting 
the existence of disaggregation factors 
Neurodegenerative diseases are usually linked to the abnormal expansion of a 
polyglutamine (polyQ) track in disease-associated genes
210
. The expanded polyQ domain 
causes the affected protein to become aberrantly folded and aggregation-prone, which is 
toxic for the organism. Morimoto et.al proposed a mechanism for the toxic effects of the 
polyQ aggregates based on studies of the temperature-sensitive/polyQ C. elegans strains 
(reviewed in Ref. 
211
). In their model, the polyQ proteins exert toxicity by putting stress 
on the general cellular folding machinery. Under normal growth conditions, misfolded 
proteins are adequately dealt with by the cellular folding surveillance system and the 
chaperone network. However, the expression of polyQ proteins overwhelmed the system, 
leading to the imbalanced homeostasis and toxicity. The toxic effect of polyQ, therefore, 
is not restricted to just causing one particular protein to aggregate and lose its function. 
Consistent with this model, the insertion of a polyQ track into proteins that are 




To study the effect of polyQ on the conformational changes and folding of proteins, 
peptides containing different lengths of polyQ were synthesized and characterized
213
. 
PolyQ monomers are disordered, and associate into aggregates when the length is greater 
than 16 residues
213
. Although the aggregates formed by Q16 are still soluble, those 
formed by Q20 or longer are sedimentable over time
213
. With their intrinsic aggregation-
prone properties, these longer polyQ tracts destabilize and cause partial unfolding of the 
proteins into which they are inserted, and mediate the aggregation of the unfolded 
intermediates by interglutamine interactions
214
.  The length threshold of a polyQ track to 






With the dual selection system, I wondered whether the insertion of polyQ would 
cause aggregation of the tripartite fusion proteins and result in PenV or cadmium 
sensitivity. I inserted 20Q, 45Q, 51Q, and 87Q into both β-lactamase and DsbA via a 30 
amino acid serine-glycine linker, and tested the resistance of the corresponding strains. 
Although insertion of 20Q had almost no effect, insertion of 45Q, 51Q, and 87Q 
dramatically decreased resistance to PenV and cadmium, respectively (Figure 4.8).   
 
Figure 4.8 Insertion of polyQ into the dual selection system 
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a, PolyQ tracks of different lengths were inserted into pBAD33bla-linker (β-lactamase cloned 
into pBAD33). The expression of the tripartite fusion proteins was induced by the addition of 
0.8% arabinose in the LB plates. The spot titer curves showed that resistance of the cells towards 
PenV decreased when the length of polyQ increased. The 45Q curve overlapped the 51Q curve. 
None: no polyQ insertion in β-lactamase.  b, Similar trend of cadmium resistance was shown: the 
insertion of longer polyQ resulted in lower cadmium resistance. PolyQ was inserted into 
pBAD33DsbAlinker and the fusion proteins were induced by 0.1% arabinose. Insertion of 20Q 
into DsbA had almost no effect on cadmium resistance as was reflected by the overlap of the 20Q 
curve and no insertion curve. None: no polyQ insertion into DsbA. 
To test whether the decreased resistance was caused by decreased protein 
solubility, or by the conformational constraints from the larger inserts, I examined the 
solubility of the tripartite fusion proteins with β-lactamase.  Surprisingly, the insertion of 
45Q, 51Q, and 87Q did not result in aggregation of the tripartite fusion proteins; instead, 
the majority of the fusion proteins were recovered from the soluble fraction (Figure 4.9). 
Examination of the stacking gel showed no insoluble materials. The soluble fraction of 
the polyQ-containing proteins showed two adjacent bands, probably indicating the 
degradation of the fusion protein. The two bands may not be the precursor and the mature 
form of the fusion protein, since the smaller band was absent in the whole cell samples. 
This phenomenon was only restricted to proteins with the polyQ insert but not the Bla-
linker protein, suggesting that the degradation was caused by the insertion of polyQ. 
However, the degradation did not separate β-lactamase into two parts completely; 
otherwise this would lead to bands of even lower molecular weights. Therefore, the 
polyQ insertion might still stick together after partial protease digestion, leading to a 
slightly smaller fusion protein.  
A similar experiment was carried out to examine the solubility of the cytoplasmic 
aminoglycoside phosphotransferase protein with polyQ insertions
‡‡‡‡‡
. Insertion of the 
same polyQ tracts into a cytosolic protein clearly diminished the solubility of the fusion 
proteins (Figure 4.10). Even the insertion of only 20 consecutive glutamines made more 
than half of the fusion protein insoluble. The insertion of 87Q made more than 90% of 
the fusion protein insoluble. These results clearly demonstrated the ability of polyQ to 
induce the aggregation of the affected proteins in the cytoplasm.  As I discussed in 
                                                 
‡‡‡‡‡ The experiment was performed by Ajmal Malik. 
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Chapter one, the environment of the periplasm differs greatly from that of the cytoplasm. 
Therefore, the inability of polyQ-containing proteins to aggregate in the periplasm might 
be the consequence of residing in a different environment. On the other hand, no 
aggregation might reflect a more powerful periplasmic chaperone net work and a folding 
surveillance system which better buffers the homeostasis of the periplasm.  
 
 
Figure 4.9 Bla-polyQ tripartite fusion proteins are soluble in the periplasm 
Cells expressing different tripartite fusion proteins were grown to mid-log phase and induced 
with 0.2% arabinose and 0.3% maltose (for MBP induction) for 3 hours before harvest. To 
prepare whole cell lysates, cells were normalized to A600=1.0, spun down and resuspended in 
reducing loading buffer containing 2% SDS. Some samples were treated with 88% formic acid to 
solubilize possible amyloid-like aggregates. After the addition of formic acid, samples were spun 
in a speed vacuum for 1h until all the formic acid was evaporated. Then the dried samples was 
resuspended in reducing loading buffer and sonicated until all the materials were solubilized.  To 
prepare soluble and insoluble fractions, cells were lysed by the freeze-thaw method as previously 
described. The soluble fraction was the supernatant after spinning the samples at 13,000 rpm for 
30min. The pellet was resuspended in an equal amount of reducing SDS buffer to make the 
insoluble fraction. After boiling for 5min, the whole cell lysates or the soluble/insoluble fractions 
were separated by SDS-PAGE and were blotted by anti- -lactamase antibody or anti-MBP 
antibody. S: soluble fraction; P: pellet; W: whole cell; F: formic acid treated. Bla-linker: β-






Figure 4.10 PolyQ induces aggregation when inserted into a cytosolic protein
§§§§§
 
Q20, Q45, and Q87 were inserted into the cytoplasmic protein aminoglycoside 
phosphotransferase. Cells were fractionated into soluble and insoluble fractions in a similar 
procedure as described in Figure 4.9. The majority of the fusion proteins were insoluble and the 
insolubility increased upon the length increase of polyQ. S: soluble fraction; P: pellet.  
 
The formation of periplasmic amyloid fibers has not previously been reported. 
CsgA and CsgB form curli, the functional bacterial amyloids, on the surface of E. coli
216
. 
If the outer membrane channel for the secretion of the curli subunits is blocked, CsgA 
and CsgB are confined in the periplasm
217
. Instead of polymerizing into fibers, these curli 
subunits are degraded by proteases. This observation, together with the inability of the 
polyQ-containing proteins to aggregate in the periplasm, suggested the possible existence 
of a powerful disaggregation system for the amyloidogenic proteins. Searching for 
chromosomal mutations that promote periplasmic amyloid formation would help to 
elucidate the mechanisms of amyloidosis, identify factors to prevent its occurance, and 
                                                 
§§§§§ The figure was prepared by Ajmal Malik. 
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contribute to futher understanding of the folding and unfolding environment of the 
periplasm. 
 
To summarize my thesis work, I have used directed evolution techniques to 
optimize the folding environment of the bacterial periplasm. I investigated the important 
role of the CXXC active site in thiol-disulfide oxidoreductases from the thioredoxin 
superfamily. Our results and previous results in the literature indicated that this active site 
has the remarkable ability to confer a large number of very specific properties on 
thioredoxin related proteins, including redox potential, enzymatic reactivity, interaction 
with substrate proteins and reoxidants, as well as the ability to function as a disulfide 
isomerase. This is a good example of the way that nature can use a particular scaffold to 
evolve functional properties of enzymes.  
For my second project, I developed a dual selection system based on the previously 
established β-lactamase system. This dual selection can conveniently monitor protein 
folding in vivo by linking protein folding to the bacterial resistances towards two 
different antimicrobials.  I used this system and directed evolution techniques to identify 
periplasmic folding modulators that can improve the folding of a very unstable test 
protein. I uncovered Spy as a novel chaperone and performed experiments (with 
contributions from others) to show that Spy is acting independently of any energy 
cofactor as an effective folding chaperone. In collaboration with Prof. Cygler we obtained 
the crystal structure of Spy. The structure reveals a flexible cradle-shaped dimer, with an 
apolar concave surface. We plan to carry out experiments to identify the physiological 
substrates of Spy and to investigate its chaperone mechanism. Our strategy opens up new 
routes for chaperone discovery and the custom tailoring of the in vivo folding 




Appendix    
Major cytoplasmic and periplasmic folding modulators 
 Cytoplasmic folding modulators 
 Chaperones involved in the de novo folding of cytosolic proteins 
The folding of a cytoplasmic protein may start after the polypeptide is released 
from the ribosome (posttranslationally), or it may occur cotranslationally. Chaperones 
can participate in early stages, when the polypeptide is still being synthesized. This is 
functionally significant, since the N-terminus of a nascent polypeptide chain is exposed 
in a partially folded, aggregation-sensitive state during translation. Chaperones are often 
required to protect these nascent polypeptide chains, and to block the nonnative inter-
chain interactions
218
. In bacteria, trigger factor binds directly to the ribosomal subunit in 
proximity to the polypeptide exit site (reviewed in Ref. 
219
). It binds linear polypeptides 
and thus maintains elongated polypeptides in a non-aggregation state until sufficient 
structural information for proper folding becomes available via continued chain 
elongation. Trigger factor has a peptidyl-prolyl cis-trans isomerase (PPIase) domain and 
therefore has the ability to catalyze prolyl cis-trans isomerization.  Evidence showed that 
trigger factor occupies almost 90% of ribosomes in vivo
220
. Around 70% of trigger factor 




Cytosolic polypeptides that need further assistance are passed on to the ATP 
dependent DnaK-DnaJ-GrpE chaperone system for folding (reviewed in Ref. 
11
). DnaK is 
the prokaryotic homolog of eukaryotic Hsp70 proteins
221
. It consists of an N-terminal 
nucleotide binding domain, and a C-terminal substrate binding domain. The latter can be 
further divided to a β sandwich subdomain and an α-helical lid
222
. Substrates are 
delivered to ATP-bound DnaK by its cochaperone DnaJ (an Hsp40 homolog) (Figure 
5.1). DnaJ accelerates ATP hydrolysis leading to closure of the α-helical lid and tight 
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substrate binding by DnaK. DnaJ then dissociates from DnaK, and the nucleotide 
exchange factor GrpE binds to DnaK. GrpE induces ADP dissociation and ATP binding 
to DnaK, resulting in the lid opening and substrate releasing. Released substrates may 
then directly acquire their native conformations, or they may rebind to DnaK for another 
cycle of chaperone-assisted folding. Alternatively they can be transferred to a 
downstream chaperonin system for additional refolding. Binding to DnaK protects the 
hydrophobic regions of unfolded substrates, but there is also evidence suggesting that 
DnaK unfolds kinetically trapped folding intermediates, to convert them into productive 
folding intermediates (reviewed in Ref. 
223
). Besides DnaK-DnaJ, E. coli K12 strains 
encode two other proteins with homology to Hsp70 and five additional partner J-domain 
proteins (reviewed in Ref. 
224
). It should be noted that there is partial overlap between 
trigger factor clients and DnaK-DnaJ clients, and DnaK-DnaJ can work in conjunction 
with trigger factor while the polypeptide is still being synthesized on the ribosome. 
However, DnaK does not bind to the ribosome directly as trigger factor does. Around 
20% of proteins adopt their native structures with the help of the DnaK-DnaJ-GrpE 
chaperone system.  
The remaining 10% of the proteins are captured by the GroEL-GroES chaperonin 
system for effective folding (reviewed in Refs.
225-227
). Chaperonins are large, double 
ringed protein complexes that provide a cage-like cylindrical structure for a polypeptide 
to fold inside.  GroEL (an Hsp60 homolog) forms a double ring structure of two stacked 
heptamers. The co-chaperone GroES (an Hsp10 homolog) binds to one end of the ring 
and seals the chamber. Substrate proteins bind GroEL initially through interaction with 
its hydrophobic patches at the end of the open ring (Figure 5.2). The subsquential binding 
of ATP and GroES to the substrate binding end of GroEL causes a conformational 
change of the chaperonin leading to the enlargement of the chamber and the displacement 
of the substrate into the chamber.  The conformational change of GroEL may cause the 
unfolding of the substrates, so that misfolded proteins have another chance to fold 
correctly. The chamber of GroEL is thought to act as a micro-folding environment where 
the substrates are shielded and aggregation is no longer a problem. The inner wall of the 
chamber is highly hydrophilic and net negatively charged, properties thought to promote 
folding of substrate proteins by accumulating ordered water molecules, thereby 
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generating the force to bury exposed hydrophobic residues in the substrates
228
. The 
releasing of substrate proteins is coupled to ATP-ADP exchange. Once the bound ATP is 
hydrolyzed on one ring, another substrate, together with an ATP molecule and a second 
GroES, can bind to the other ring of GroEL, triggering the release of both the folded 
substrate and the GroES that was initially bound on the opposite side (Figure 5.). In vivo, 
GroEL-GroES clients are usually between 20-50 kDa with α/β or α+β domain topologies. 
However, GroEL is capable of binding almost half of the proteins of the E. coli proteome 





Figure 5. 1 DnaK-DnaJ-GrpE reaction cycle 
Both the figure and figure legend were adapted from Fig 5 in Ref.230 (1) DnaJ delivers substrate 
to ATP-bound DnaK. The ATP-bound state of DnaK has high association and dissociation rates 
for substrates. (2) Hydrolysis of ATP to ADP, accelerated by DnaJ, results in closing of the α-
helical lid (yellow) and tight binding of substrate by DnaK. DnaJ dissociates from DnaK. (3) 
Dissociation of ADP catalyzed by GrpE. (4) Opening of the α-helical lid, induced by ATP 
binding, results in substrate release. (5) Released substrate either folds to native state (N), is 




Figure 5. 2 GroEL-GroES reaction cycle 
The figure was adapted from Fig. 2 in Ref. 226. a, GroEL forms an asymmetric double ring 
structure with GroES (cyan)  to seal one of the rings. While a substrate protein is folding in the 
closed ring (not shown on the figure), another non-native substrate (green) may be delivered to 
the open ring of GroEL. b, ATP binding to the apical ring of GroEL triggers a conformational 
change that results in substrate capture into the chamber. ATP binding also sends a signal to the 
opposite ring to eject its ligands: GroES, folded substrate (not shown), and ADP. c, substrate 
encapsulation is completed upon binding of GroES. Substrate folds in the hydrophilic chamber. 
ATP is then hydrolyzed to ADP, which primes the substrate release by weakening the affinity of 
GroEL and GroES. d, substrate release is triggered by the binding of ATP, another substrate, and 
another GroES (not shown) to the ring on the opposite side. e, a new round of substrate refolding 
cycle begins.   
 
To summarize, trigger factor, DnaK-DnaJ-GrpE, and GroEL-GroES are the main 
chaperones that mediate de novo protein folding in the cytoplasm. Trigger factor does not 
rely on an energy source to perform its chaperone function. The other two systems use 
ATP hydrolysis coupled to conformational changes to provide energy.  
 Cytosolic chaperones involved in stress response 
Under stress-induced denaturation conditions, DnaK-DnaJ-GrpE and GroEL-
GroES systems refold denatured proteins. Interestingly, those chaperones, along with 
many others, are themselves heat shock proteins whose synthesis is strongly induced by 
high growth temperatures
49
. Their increased expression under heat or other stress 
conditions that increase cellular protein misfolding indicates an important role for them in 
combating stress.  The DnaK-DnaJ-GrpE and GroEL-GroES systems often work in 
cooperation with other heat shock cytoplasmic chaperones that usually function as 
holding chaperones. Under severe stress conditions, these holding chaperones prevent 
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unfolded proteins from irreversible aggregation and from overloading the DnaK-DnaJ-
GrpE and GroEL-GroES systems. When the stress conditions are relieved, the holding 
chaperones pass the unfolded proteins to DnaK-DnaJ or GroEL-GroES for active 
refolding. Holding chaperones include Hsp33, Hsp31, and small heat shock proteins, 
IbpA and IbpB.  
Hsp33 was originally identified as a heat shock protein, but its chaperone function 
is redox regulated on the posttranscriptional level, which distinguishes it from other 
temperature-regulated cytosolic chaperones
231
. It has four conserved redox sensitive 
cysteines, which coordinate a zinc atom under normal growth conditions 
232
. The reduced 
form of Hsp33 has no apparent chaperone activity; however, under oxidative stress 
conditions, such as treatment with hypochlorite, the cysteines in Hsp33 become oxidized, 
leading to intramolecular disulfide bond formation and release of zinc. This also causes 
partial unfolding, dimerization of the protein, and exposure of a high affinity substrate 
binding site for unfolded proteins (reviewed in Ref. 
94
). It is noted that under severe 
oxidative stress conditions that act to decrease cellular ATP levels, the efficiency of 
DnaK-DnaJ-GrpE can be compromised. Therefore, under these circumstances, cells rely 
mainly on Hsp33 to manage oxidative protein misfolding
233
. Oxidized Hsp33 is reduced 
by the glutaredoxin and thioredoxin systems, which do not dissociate substrates from 
Hsp33 but rather prime Hsp33 for fast inactivation
234
. When conditions return to normal, 
interaction of Hsp33-substrate complexes with the functional DnaK-DnaJ-GrpE system, 
releases substrate proteins from Hsp33 and transfers the substrate to refolding either by 
the DnaK-DnaJ-GrpE system alone or this system acting together with GroEL-GroES
234
. 
Hsp31(YedU) forms homodimers and is thought to capture early unfolded 
intermediates under stress conditions
235
. Its mode of action relies on temperature-driven 
conformational changes to expose hydrophobic regions to capture substrates. Hsp31 does 
not require energy; however, binding of ATP inhibits its chaperone activity at a high 
temperature, probably by restricting the substrate binding site
236
. Hsp31 has also been 
shown to have peptidase activity
237






IbpA and IbpB are small heat shock proteins (MW=16 kDa). They were identified 
by their ability to associate tightly with inclusion bodies formed either during 
heterologous protein production
239
 or from endogeneous E. coli proteins that aggregated 
due to heat shock
240, 241
. Evidence shows that IbpA and IbpB are not only involved in heat 
defense, but might also be involved in resistance towards oxidative stress
242-245
. The 
binding of IbpA and IbpB to aggregated proteins protects the enzymatic activity of the 
aggregated proteins
246
, slows down the proteolytic removal of aggregates
247
, maintains 
proteins in a disaggregation-competent state
248, 249
, and facilitates subsequent refolding of 
proteins by the ATP-dependent chaperones DnaK-DnaJ-GrpE
250
.  
 Cytosolic chaperones involved in solubilizing protein aggregates 
If both holding chaperones and folding chaperones fail to rescue the unfolded 
substrates from aggregation, E. coli possesses a third line of defense to combat the 
deleterious effects of protein aggregation. Through destructive (ClpAP, ClpXP, ClpCP
251, 
252) or non-destructive protein disaggregation pathways, aggregates are digested or 
solubilized. An enzyme called ClpB (an Hsp104 homolog), which functions to actively 
solubilize aggregates, is central to the non-destructive disaggregation pathway
18, 253
.  
ClpB belongs to the AAA+ (ATPases associated with various cellular activities) 
superfamily of ATPases and works in conjunction with the DnaK chaperone system. 
DnaK assists the disaggregation process during the initial steps probably by extracting 
polypeptides from aggregates. It does this by presenting the unstructured regions of those 
polypeptides to ClpB and modulating the ATPase cycles of ClpB
254
. DnaK might also 
assist in the refolding process of the solubilized polypeptides. ClpB unfolds substrates by 
forcibly threading polypeptide chains through its central cavity and it is highly selective 
for unstructured regions within proteins
255
.  The energy for substrate threading and 
release are provided by coupling ATP hydrolysis to these processes. Interestingly, 
ClpB/DnaK seem to be preferred to facilitate the extraction of substrates from the small 
heat shock proteins
256
, indicating a greater dis-aggregation role of DnaK than of GroEL. 
Due to the size limitation of its encapsulated folding cavity, GroEL may not be as 
powerful in disaggregation as the ClpB/DnaK system. In fact, interaction with GroEL 
might drive larger proteins towards the formation of inclusion bodies
257
. However, once 
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the aggregates are solubilized, the addition of GroEL-GroES increases the refolding 
yield
258
.   
Other chaperones involved in stress response include the Hsp90 homolog HtpG
259
, 
which may assist de novo protein folding in slightly stressed E. coli cells
260
. 
 Cytosolic chaperones involved in protein translocation 
After achieving their native conformation, cytosolic proteins are retained in the 
cytoplasm. However, those proteins that are destined to have a periplasmic location, a 
cell envelope location, or to be exported to the extracellular space, need to be transported 
to their appropriate locations. Secreted proteins are made as precursors with N-terminal 
signal sequences. These sequences direct the precursors to the translocon and are cleaved 
off when the precursors reach their final destinations. The majority of secreted proteins 
are transported posttranslationally in an extended ―export-competent‖ conformation by 
the Sec-dependent pathway 
261
. A subset of proteins are exported via the signal 
recognition particle (SRP)-dependent pathway in a cotranslational manner. A third 
secretion pathway, Tat (twin-arginine dependent pathway), exclusively deals with folded 
proteins or partially folded proteins
262
. This pathway allows the secretion of proteins that 
assemble subunits or bind cofactors in the cytoplasm prior to their secretion
262
. 
Although not thoroughly studied, generalized cytoplasmic folding factors might 
interact with precursor proteins, helping to regulate their folding and in some cases, 
guiding the precursors from the ribosome to the translocon (reviewed in Ref. 
263
). Indeed, 
the chaperonin GroEL has been shown to form stable complexes with purified precursors 
from the Sec dependent secretion pathway
264
 and may also interact with the peripheral 
membrane protein SecA, a protein known as a central component of the translocation 
machinery
265
. Similarly, trigger factor functions in both the Sec- and SRP- dependent 
secretion pathways. Trigger factor functions by binding nascent polypeptides, holding 
them in an unfolded state for a relatively long time, allowing them to be efficiently 
engaged by the translocation-specific chaperone, SecB
266
. Trigger factor also binds the 
ribosome-nascent polypeptide complex simultaneously with SRP until the complex 
reaches the membrane-bound SRP receptor FtsY
267
. In the case of substrates destined for 
Sec-dependent transport, binding of trigger factor to ribosome-nascent polypeptides 
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prevents the binding of SRP, thus ensuring the specificity of SRP for binding rather 
hydrophobic signal sequences
266
. It is noteworthy that the effects of these chaperones in 
translocation in vivo are still ambiguous, and they may not be absolutely required for 
efficient translocation. For example, the involvement of trigger factor increases and 
stabilizes the precursor of leech carboxypeptidase inhibitor (pre-LCI) in the cytoplasm, 
and binding to trigger factor can lead to precursor accumulation and decreased efficiency 
for translocation across the inner membrane
268
.  
The Sec translocation-specific chaperone, SecB, has anti-folding properties and a 
broad substrate specificity, similar to other general holding chaperones. Importantly, it is 
capable of targeting its substrates to SecA for subsequent translocation through the 
SecYEG translocon
269, 270
. SecB is a tetramer consisting of a dimer of dimers
269, 270
. It is a 
highly acidic protein with two hydrophobic grooves on the tetramer surface that serve as 
the polypeptide binding sites. Substrate proteins are thought to wrap into the surface 
grooves of SecB in an extended conformation. In such a conformation they are protected 
from aggregation. The chaperone role of SecB is not restricted to the secretion pathway, 
since overexpression of SecB has been shown to be able to suppress the growth defect of 
strains lacking both TF and DnaK
271
. In vitro, SecB has been shown to disaggregate the 
insulin B-chain
272
. Another Sec-specific factor, SecA, performs multiple functions. In 
addition to its well established function of guiding the translocation process
273
, SecA also 
possesses chaperone activity of promoting the folding of nonsecretory proteins
274
. Thus, 
SecA acts in the quality control to ensure that only unfolded precursors are translocated.  
Cytosolic chaperone systems might also help in the maturation process of some 
proteins secreted via the Tat pathway. DnaK was found to be important for stabilizing 
such proteins
275
 and together with another chaperone, SlyD, serve as general Tat-signal 
binding proteins
276
. DmsD, a Tat-specific chaperone, was shown to interact with general 
chaperones to escort its substrate through a cascade of chaperone-assisted folding 
events
277
. Additional studies will hopefully further clarify the influence of cytosolic 
chaperones on the folding process of extracytoplasmic proteins. 
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 Periplasmic folding modulators 
The periplasmic environment is very different from the cytoplasmic environment. 
Due to the permeability of the outer membrane, the properties of the periplasm are 
largely dependent on the surrounding medium. In contrast to the reducing, highly 
buffered, and energy-rich environment in the cytoplasm, the periplasm is an oxidizing, 
relatively unbuffered compartment that lacks any obvious energy source, such as ATP 
that is required for many cytoplasmic folding chaperones to work. Therefore, the 
periplasmic folding modulators must use different mechanisms to couple substrate 
binding and release.  
 Specialized chaperones 
 SurA and LolA- chaperones for outer membrane proteins or lipoproteins 
SurA has been suggested to have a role in the biogenesis of outer membrane 
proteins. The gene surA was originally identified as essential for survival in stationary 
phase
48
. Strains devoid of surA are slightly mucoid in rich medium and are sensitive to 
bacitracin, vancomycin, and bile salts, suggesting that SurA plays a role in maintaining 
the integrity of the outer membrane
26
. Mutants null with respect to surA also have 





,  and OmpC. SurA also possesses PPIase activity but it’s chaperone activity is 
independent of its PPIase activity, since a mutant of surA lacking its two PPIase domains 
almost completely complements surA in vivo and this SurA variant has undiminished 
chaperone-like activity in vitro
279
. SurA is a dumbbell shaped molecule with an extension 
in the core structure module, which might be a potential substrate binding site
280
. 
Surprisingly, the crystal structure of the N-terminal chaperone domain of SurA closely 
resembles the C-termimal substrate binding domain of trigger factor, despite the lack of 
sequence homology between SurA and trigger factor
219
.  
Selection for short peptides that bind SurA using the phage display technique 
suggested that SurA binds preferentially to an aromatic-polar-aromatic-nonpolar-proline 
(Ar-polar-Ar-nonpolar-Pro) motif. The first three residues of this motif occurs quite 
frequently in outer membrane proteins
281
. Other techniques less stringent for detecting 
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binding affinity confirmed the preference of SurA to bind aromatic residues
282
.  All of the 
above evidence leads to the role of SurA in outer membrane protein biogenesis. 
However, there is currently no clear evidence for the involvement of SurA in periplasmic 
protein folding
26
.   
LolA is a specialized chaperone involved in outer membrane lipoprotein biogenesis 
(reviewed in Ref. 
283
). It was originally identified as a protein essential for releasing the 
major outer membrane lipoprotein (Lpp) from the inner membrane
284
. LolA was later 
shown to facilitate the release of other outer membrane lipoproteins, such as Pal, NlpB, 
Slp,  and RlpA
285
. The LolA-dependent release was thought to be crucial for the efficient 
and specific incorporation of lipoproteins into the outer membrane
285
. The released 
lipoprotein forms a complex with LolA and is targeted to the outer membrane lipoprotein 
receptor LolB
286
. The lipoprotein is then released from LolA and transferred to LolB
287
. 
Lipoproteins are highly hydrophobic due to their N-terminal lipids; therefore, LolA and 




 PapD, FimC-chaperones involved in pili biosynthesis 
Pili are adhesive organelles occuring on the bacterial surface. Like other secreted 
proteins, the translocation of pili subunits across the inner membrane, through the 
periplasm, and their secretion to the outside of the cell, followed by assembly on cell 
surface, occur with the help of chaperone proteins (reviewed in Refs.
288-291
). The PapD-
like superfamily of periplasmic chaperones is specialized for pili biogenesis. There are 
more than 30 papD-like chaperones that facilitate the assembly of pili and non-pili 
organelles (reviewed in Ref.
292
). PapD itself and FimC are the two most studied members 
of the PapD superfamily. PapD assembles P pili
293
 and FimC assemble the Type 1 pili
294
, 
respectively. These chaperones interact with newly translocated pili subunits in the 
periplasm and facilitate their release from the inner membrane
295, 296
. Binding to these 
chaperones stabilizes the pili subunits, caps their interactive surfaces, and prevents the 
aggregation of these subunits in the periplasm
296, 297
. In the absence of PapD-related 
chaperones, pili subunits are subject to aggregation in the periplasm. This aggregation is 
sensed by the Cpx and σ
E
 stress response pathways, leading to an increased level of the 
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degP protease, which facilitates the removal of pili aggregates. The activation of these 
stress response pathways also induces DsbA, an enzyme responsible for the catalysis of 
disulfide bond formation within pili subunits
295, 298, 299
.  
Following secretion and binding in the periplasm, the chaperone-pili subunit 
complexes are targeted to the outer membrane usher
300, 301
, which forms a donut-shaped 
channel big enough for the pili subunits to pass through
302
. Binding of the chaperone-
subunit complexes to usher drives the release of pili subunits from the chaperone, and 
stabilizes usher in an assembly-competent conformation, which in turn, allows the 
initiation of pili assembly
303
. In contrast to many other chaperone systems, PapD-like 
chaperones work as monomers. They act to allow the folding of pili subunits to occur 
during pili assembly
296
. Folded subunits remain bound to the chaperones until they reach 
the outer membrane usher, where upon they are released
296
. The PapD chaperone donates 
a β strand to the pili subunits. This enables the pili subunits to fold
304
 in a process termed 
donor strand complementation
305
. When the pili subunits polymerize, the β strand, which 
was donated by the PapD chaperone to one pili subunit, is displaced by the N-terminal 
extension of another pili subunit in a process termed donor strand exchange
304
. As a 
result, PapD is absent from the final assembly of pili subunits. PapD and FimC are thus 
highly specialized chaperones that provide steric information for pili subunit folding. 
 Generic chaperones: FkpA, Skp and HdeA 
A global screening for genes that suppress one of the extracytoplasmic stress 
responses, the 
E
 response, identified fkpA and two other chaperone genes, surA and 
skp
306
. Overexpression of FkpA prevents the formation of inclusion bodies by a defective 
folding variant of the E . coli maltose-binding protein, MalE31
36
.  The overproduction of 
FkpA alone or as a fusion partner also increases the yield and/or solubility of 





, and retroviral envelope proteins
308
. The chaperone-like 
activity of FkpA is hypothesized to be due to its interaction with early folding 
intermediates that prevents their aggregation. Additionally, the interaction of FkpA with 
partially unfolded protein species may drive a productive protein refolding pathway. 





. Its crystal structure reveals a V-shaped homodimer. The N-terminal domain of 
FkpA is responsible for its chaperone activity and dimerization, and the C-terminal 
domain is responsible for its PPIase activity
309
. Consistent with the substrate diversity of 
FkpA, the whole molecule exhibits structural flexibility
310
. FkpA protects periplasmic 
proteins or recombinant proteins expressed in the periplasm; there is no evidence for its 
participation in outer membrane biogenesis. 
Skp was initially suggested to assist in outer membrane protein folding because of 




, OmpC, and 
LamB
311
. It is thought that Skp assists outer membrane proteins (OMPs) both to fold and 
to insert them into the outer membrane. Skp may function cooperatively with 
lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative 
bacteria, to maintain the unfolded OMPs in a state ready for membrane insertion
313
 . 
Strains depleted of skp are viable
311
. However, these strains show a decreased steady state 
level of outer membrane proteins
311
, and have an altered outer membrane structure and 
physiology
312
. Proteomics and in vivo expression studies suggested that Skp has a broad 
substrate specificity that includes both outer membrane proteins and native periplasmic 
proteins
32
, as well as recombinant proteins expressed in the periplasm
33-35
, supporting its 
role as a general chaperone in the periplasm.  
The 17 kDa protein Skp forms a homo-trimer in solution, and the structure 
resembles a jellyfish
314
. The main body of this chaperone consists of a tightly packed β-
barrel, which is surrounded by the C-terminal helices of the three subunits
315, 316
. The 
jellyfish-shaped cavity formed by these tentacles can almost accommodate a folded-like 
structure of proteins of ~ 25 kDa
315
. However, if its unfolded substrates exist as molten 
globules, which are more loosely packed, the maximal capacity of Skp would be 
smaller
315
. A working model has been proposed
315
 where one Skp trimer captures a single 
OMP
317
 as soon as it translocates into the periplasm. Skp sequesters the hydrophobic 
regions of OMP inside of its cavity. This seems to not only prevent aggregation of OMPs 
or premature folding of these regions, but also allow independent folding of the other 
domains outside of the cavity
318
. Skp then binds lipopolysaccharide (LPS) to facilitate the 
delivery and insertion of OMP into the outer membrane. Consistent with this model, Skp 





. These two different states might represent different 
stages in the association/dissociation cycle of Skp from the outer membrane. 
 In contrast to FkpA and Skp, which fulfill chaperone functions under normal 
physiological conditions, HdeA mediates acid resistance in pathogenic enteric bacteria
38, 
39
. The gastrointestinal tract of mammals has a pH of 1 to 3. In this pH range proteins 
generally denature
320, 321
. The hdeA gene is among those induced under acidic 
conditions
322
. HdeA is proposed to use a novel strategy to modulate its chaperone 
function. It exists in an ordered conformation as a dimer under normal growth conditions 
and is inactive in this conformation and does not bind proteins. Acidic pH induces a rapid 
conformation change in HdeA, allowing it to adopt a disordered monomer form as a 
chaperone that is able to bind substrates
188, 323
. The hydrophobic regions of HdeA that are 
exposed under acidic conditions play a major role in substrate protection. The exposure 
of its highly charged terminal segment allows the HdeA-substrate complex to be 
soluble
324
.  HdeA is one of the smallest chaperones known (MW~ 9.7kDa) yet its active 
form is able to adopt different conformations that allow the binding of a broad range of 
substrates
188
. The hdeB gene is in the same operon as hdeA, and has been reported to have 
a similar phenotype as HdeA does, which confers protection at acidic pH
325
. However, 
our lab has been unable to show any chaperone activity for HdeB using the protein 
substrates that HdeA protects from aggregation
******
. During the renaturation process, 
substrates are slowly released from HdeA in such a way that the concentration of 
aggregation-prone intermediates is kept below the threshold where they could aggregate; 
therefore, the substrates are devoid of aggregation, and could be effectively refolded
326
.  
Compared to the essential role of generic cytoplasmic chaperones such as GroEL, 
the effects of periplasmic folding modulators seem to be less important, since deletion 
mutations in the genes for periplasmic chaperones generally cause no or little phenotypic 
response.  However, certain combinations of two or more knockout mutations in 
periplasmic chaperones (e.g., skp and degP
312
, surA and ppiD
327
) cause severe 
phenotypes, indicating that they may play very important though overlapping roles.  
                                                 
****** Tim Tapley’s results. 
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 Peptidyl prolyl isomerase 
Peptidyl prolyl cis/trans isomerase (PPIases) catalyzes the cis-trans isomerization 
of peptide bonds with proline (Xaa-pro bond; Xaa, any amino acid before proline). This 
isomerization step is a rate limiting step in the folding process of many proteins
41
. SurA, 
PpiD, FkpA and PpiA are the known periplasmic PPIases.  
SurA and FkpA, as previously discussed, are two PPIases that also have chaperone 
activity. Interestingly, studies show that the prolyl isomerase domains alone have a 
relatively narrow substrate specificity. However, the presence of the chaperone domains 
enables the efficient transfer of protein substrates to the prolyl isomerase site. This 
confers these enzymes with a broad substrate specificity
328
. The other two PPIases, PpiD 
and PpiA, have not yet been demonstrated to have chaperone activity. 
The gene ppiD was isolated as a multicopy suppressor of surA in a genetic 
screen
329
. Deletion of the gene results in reduced levels of OMP, hypersensitivity to 




.  PpiD is 
anchored to the inner membrane with a catalytic domain facing the periplasm
329
. Similar 
to Skp, PpiD has been demonstrated to influence the release of newly synthesized outer 
membrane proteins from the cytoplasmic membrane into the periplasm
330
. Since PpiD is 
anchored in the inner membrane near the SecYEG translocon, it was proposed that PpiD 
interacts with substrate polypeptides as soon as they emerge from the translocon. Skp 
could then bind to substrates following their release into the periplasm
330
.  Though the 




PpiA is not particularly well characterized as an enzyme. Strains that are 
ppiA(rotA) null are viable, and show no detectable change in the steady-state expression 
level of periplasmic or outer membrane proteins
332
. Coexpression of PpiA showed no 
effect on recombinant protein expression
37
 and no influence on the kinetics of 
periplasmic protein folding
332




Prematurely terminated polypeptide, protein folding intermediates that are 
kinetically trapped off-pathway, and partially folded proteins that failed to be rescued by 
folding modulators are generally degraded. This prevents the accumulation of protein 





, ClpAP, ClpXP and membrane associated FtsH
335
 are ATP-
dependent proteases that mediate protein degradation in the cytoplasm. Aberrantly folded 
substrates are firstly recognized and captured by the ATPase domains in the proteases. 
These substrates are then unfolded and transferred to the protease domains of the 
proteases (reviewed in Ref. 
336
). Protein substrates are cleaved into peptides, which are 
further degraded by peptidases.  
In the periplasm, misfolded proteins are degraded by more than 20 
proteases/peptidases. The list of periplasmic proteases/peptidases is available at 
http://www.cf.ac.uk/biosi/staffinfo/ehrmann/tools/proteases/allproteases.html. Due to the 
lack of energy source in the periplasm, periplasmic proteases must act differently from 
ATP-dependent cytoplasmic proteases.   
The DegP (HtrA, Do) protease plays a leading role in removing the misfolded 
proteins in the periplasm (reviewed in Ref.
42, 43
).  The degP gene was initially identified 
through mutational analysis of strains that were unable to grow at elevated temperature
337
 
or failed to degrade abnormal periplasmic proteins
338
. DegP mediates the degradation of a 









, and the cytoplasmic protein TreF that is mislocated to the 
periplasm
339
, as well as recombinant proteins expressed in the periplasm
340
. However, 
DegP does not cleave well folded proteins, for example, native MalS
25
. It seems that 
DegP has a broad substrate specificity towards misfolded proteins.  In vitro, DegP 
recognizes heat-denatured proteins in general rather than a particular set of proteins
341
.  
DegP cleaves misfolded protein substrates at discrete Val/Xaa or Ile/Xaa sites (Xaa 
meaning any amino acid), which are normally buried in the hydrophobic core of native 
proteins
342
. DegP is a serine protease and its activity can be inhibited by 
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diisopropylfluorophosphate (DFP), but not by phenylmethylsulfonyl fluoride (PMSF) 
that inhibits most serine proteases
343
.   
The mature DegP monomer contains an N-terminal protease domain and two C-
terminal PDZ domains. PDZ domains are structural modules that mediate protein-protein 
interactions. DegP’s PDZ1 domain is important for its substrate recognition and protease 
activity, while PDZ2 domain is involved in maintaining the hexameric conformation
344
. 
The crystal structure of DegP suggests it to be a hexameric ―cage‖ composed of two 
trimeric rings. Each trimer of DegP forms a funnel-like structure in such a way that the 
three protease domains from each subunit form the top of the funnel and the six PDZ 
domains extend away.  The hexamer of DegP is
 
formed by the staggered association of 
two trimers. In the hexameric cage of DegP, the six protease domains constitute the top 
and bottom, whereas the 12 PDZ domains form the mobile side wall of the cage. The 
movement of the PDZ domains controls the accessibility of the proteolytic sites, which 
are located inside of the cage
345
. 
Interestingly, DegP has not only protease activity, but also chaperone activity
25
. 
Therefore, understanding the underlying mechanism of the functional switch of DegP is 
important. In particular, how does DegP distinguish a substrate that can be refolded from 
ones that are severely damaged and have to be degraded? It is demonstrated that 
temperature is an essential factor to govern the functional switch of DegP
25
.  At low 
temperatures (28°C and below), DegP shows more chaperone activity than protease 
activity. At higher temperatures (37°C and above), DegP predominantly shows protease 
activity. Studies on a mutant form of DegP (DegPS210A) that is devoid of protease activity 
showed that this mutant is active as a chaperone at any temperature, suggesting that the 
functional switch of being a protease or a chaperone could be mediated by minor changes 
in the structure of DegP which might be induced by the changing temperatures. 
Other periplasmic proteases that are potentially involved in protein quality control 
are Prc, Pet, and OmpT. Their absence was shown to result in reduced proteolysis of 
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